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Introduction 
1.1 GENERAL INTRODUCTION 
Presently in our society animal tests still form the main starting point for the 
assessment of the possible risk of chemicals with regard to human and animal 
health. Especially during the last three decades a series of more or less 
standardized whole-animal tests with a variety of laboratory animals has been 
devised under the auspices of agencies as OECD (Organization for Economic 
Cooperation and Development) and EEC (European Economic Community). These 
models are aimed at the identification of toxic properties of chemicals, both 
qualitative and quantitative, and form an obligatory element within the legal 
framework through which pesticides, drugs, food additives, and most other 
chemicals are registered. In most countries attempts are made continuously by 
toxicologists and other scientists to improve the predictive value and the 
cost-effectiveness of toxicity test systems. In this connection various initiatives 
have been taken to introduce in vitro models and some of them have indeed led to 
a succesful addition. 
In the development of new and useful in vitro model systems a number of 
mutagenicity tests should be mentioned especially (for review: Hollstein et al, 
1979). Examples of such biological systems using various bacteria, fungi, and 
mammalian cells are the Ames Salmonella/microsome test (Ames et al, 1975), 
Neurospora crassa tests (Broekman et al, 1984-) , and mouse lymphoma 
L5178Y(TK + / " /TFT) assay (Clive et al. 1979). Early validation studies showed 
that these tests seemed to predict carcinogenic potential also, and therefore they 
were adopted by the chemical industry for screening purposes. Subsequently, they 
were incorporated as an integral part into requirements for screening mutagenic 
and carcinogenic potential as laid down in national legislations . The developments 
in the genetic toxicology have stimulated considerably the attempts to develop in 
vitro models which could replace whole-animal studies, throughout the different 
areas of toxicological and other biomedical research. National and international 
organizations as FRAME (Fund for the Replacement of Animals in Medicinal 
Experiments) and ERQATT (European Research Group for Alternatives in Toxicity 
Testing), specialized centers as the John Hopkins Center for Alternatives to 
Animal Testing have been founded, and even a journal on development and use of 
alternatives to animal testing, ATLA (Alternatives To Laboratory Animals) has 
been launched in 1973. In the mean time the increasing ethical concern about the 
use of animals in our society influenced and supported these initiatives. 
Ever since the development of the Ames test and the growing awareness about 
its limited value in predicting carcinogenicity due to the complexity of mechanisms 
and organisms (Douglas et al, 1988; Ashby and Tennant, 1988), the search for 
alternatives to animal testing has followed two main strategies. First, initiatives 
have been taken to replace animal screening tests by in vitro screening tests. This 
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resulted in some interesting achievements. Several alternatives for the heavily 
criticized Draize rabbit's eye irritancy test, which was developed in the early 
1940's, have been proposed (ECETOC, 1988), including the HET-CAM test (Hen's 
Egg Test- ChorioAllantoic MembraneMLuepke and Kemper, 1986) and some very 
promising cell systems using BALB 3T3 cells (Bracher et al, 1987) and red blood 
cells (Pape et al, 1987). Although such in vitro tests are currently only used as 
prescreening tests, a real replacement of the Draize test seems possible once 
sufficient validation data have been obtained. Progress has also been made in the 
development of in vitro test systems for the assessment of teratogenicity. A large 
number of in vitro tests has been described using vertebrate and invertebrate 
embryo, organ, and cell cultures (for review see: Faustman, 1988). Several tests 
as MOT (Mouse Ovarian Tumor cells), HEPM (Human Emryonic Palatal 
Mesenchymal cells), and assays with primary cultures of rat embryo midbrain cells 
and limb bud cells have been proposed for screening purposes. As a substitute for 
the classical LD50 (dose which produces 50% mortality in a population of animals) 
test, batteries of cytotoxicity tests are being developed. Although some 
reasonable in v i t ro/ in vivo correlations have been obtained between cytotoxicities 
to 3T3-L1 cells and mouse i.p. LD50 values (Clothier et al, 1987; Clothier et al, 
1988), these tests will probably reflect no more than a rough estimation of a 
direct toxic potential. Even when acute in vitro toxicity tests may be useful in 
comparing related compounds, the unawareness about the mechanisms of toxicity 
will limit their predictive value. In the search for alternatives to animal testing, 
this limitation of most in vitro screening tests caused a gradual shift to a second 
strategy: one of studying mechanisms of toxicity and the factors which influence 
it , leading to the development of rational in vitro models. Following this strategy, 
the present thesis aims at contributing to this development. 
Several cell systems are currently used and improved for studying 
mechanisms of toxicity (for review see: Stammati et al, 1981). In the target organ 
toxicity the liver has received most emphasis. This is understandable because of 
its crucial role in biotransformation of chemicals. Freshly isolated hepatocytes are 
widely and succesfully used for studying mechanisms of toxicity (Guillouzo and 
Guguen-Guillouzo, 1986). However, due to the short-l i fe span of metabolic 
enzymes isolated hepatocytes can only be used for a short period of time. The 
maintenance of this biotransformation capacity limits the use of hepatic cell lines 
and primary cultures of hepatocytes. As a consequence, much effort is put in the 
abolishment of this most severe short-coming of hepatic culture and cell culture 
in general. A major break-through seems to be offered by the application of 
recombinant DNA technology (Phillips et al, 1987). Cell lines have been created 
with a stable activity of P450 isoenzymes (Doèhmer et al, 1988; Dogra et al, 
1990). 
In view of the importance of the kidney it is surprising that to date relatively 
few efforts have been made to develop cell models for studying mechanisms of 
renal toxicity. This organ, more specifically the proximal tubule, has been chosen 
in this thesis as the subject for development of such cell models . 
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In the development of a cell model for nephrotoxicity, we have chosen to study 
mechanisms of nephrotoxic glutathione conjugates. These model compounds enable 
an investigation of the functional presence of specific enzyme and transport 
systems in the cell model. The possible role of these systems in nephrotoxicity of 
chemicals in general and of glutathione conjugates derived from haloalkenes and 
halobenzenes in particular, will be dealt with in this introductory chapter. 
1.2 STRUCTURE AND FUNCTION OF THE KIDNEY, ASPECTS OF NEPHROTOXICITY 
The kidneys are paired organs, highly dynamic and complex, whose normal 
functions are to regulate the composition and volume of our body fluids. Processes 
as f i l t rat ion, reabsorption, excretion and metabolism, perform a crucial role in 
this homeostasis. The function of the kidney is a result of collaboration within a 
complex anatomical organization of numerous smaller units: the nephrons , broadly 
situated in cortex and medulla as indicated in figure 1.1. Each nephron consists of 
glomerulus, surrounded by a double-walled epithelial capsule (Bowman's capsule), 
proximal tubule, Henle's loop, and distal tubule. At the glomerulus the arterial 
blood is filtered into the proximal tubule. This, originally subdivided into pars 
convoluta and pars recta, can be subdivided ultrastructurally into three segments 
(Pfaller et al, 1985). The f i rst segment (S1) comprises roughly half of the 
convoluted portion and changes gradually into the second segment (S2). The 
second segment includes the very beginning of the pars recta. The third segment 
(S3) represents the rest of the straight part. Through this long tubule formed by 
the proximal tubule and the remaining parts of the nephron the f i l trate reaches 
the collecting tubule. Several nephrons deliver their fluid in a collecting tubule. 
These join each other into larger straight tubules: the papillary ducts of Bellini. As 
urine it reaches the bladder via the ureter. 
From the point of f i l tration to where it leaves the kidney as urine, the f i l trate 
undergoes drastic changes. The nephrons are supplied with an intricate network 
of capillaries, which provide a tight contact between the bloodstream and the 
epithelial cells lining the tubules. Water and substances that are useful for body 
metabolism are reabsored from the tubular lumen across the epithelium into the 
blood circulation, and waste products are excreted , both possibly accompanied 
with metabolism. In the end , less than 1% of the volume that is f i l trated remains 
as urine. 
The high blood flow of 25% of the resting cardiac output together with the 
specialized functions and the high metabolic activity, makes the kidney vulnerable 
to xenobiotics. Different parts of the kidney can be affected. Damage to the 
glomerulus has been reported for e.g. mercury, gold, and D-penicillamine 
(Weening, 1989). Cyclosporin A has presumably a main effect on the vascular 
system (Dieperink et al, 1989). Most frequently, the tubules (e.g. aminoglycosides 
(Walker and Duggin, 1988)) and/or the interstitium (e.g. lead (Goyer, 1989)) are 
involved. Of the nephrotoxic chemicals reported in the proceedings of the Third 
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B Proximal convoluted tubule 
Glomerulus. 
8owman's capsule 
Interlobular artery 
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Ureter Renal columns of Bertin 
Figure 1.1 The genera l organizat ion of a kidney ( A ) , and a nephron wi th i ts vascular supply ( B ) . 
I M , i nne r m e d u l l a ; I S O M , inne r s t r i p e o f t h e o u t e r m e d u l l a ; O S O M . o u t e r s t r i p e o f t h e o u t e r 
m e d u l l a . ( A d a p t e d f r o m J u n q u e i r a e t a l , 1977 and P fa l l e r e t a l , 1 9 8 5 ) . 
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Table 1.1 A selection of chemicals with nephrotoxic properties which primarily affect the 
proximal tubule. 
CHEMICAL DOSE/SPECIES SITE REFERENCES 
Acetaminophen 
Bromobenzene 
Cadmium chloride 
Cephaloridine 
Chlorobenzene 
Chlorotrif luoroethylene 
1,2-Dibromo-3-chloropropane 
1,2-Dichlorobenzene 
1,4-Dlchlorobenzene 
Dlmethylnltrosamlne 
Gentamicin 
Hexachlorobutadiene 
Hexafluoropopene 
3.5-N-(Dichlorophenyl)succlnli 
Lead acetate 
Ochratoxin A 
Pentachlorobenzene 
1,2.4,5-Tetrachlorobenzene 
Tetrafluoroethylene 
Tobramycin 
750 mg/kg s.c. 
male F344 
4.85 mmol/kg i.p. 
male C57BI/6J 
10 ppm in water o. 
ad l ibitum. 24 wks 
male Wistar King A 
400 mg/kg s.c. 
guinea pig 
6.75 mmol/kg i.p. 
male C57BI/6J 
220 ppm inh. 4 h. 
male F344 
40 mg/kg/day s.c. 
4 days, male F344 
10 mmol/kg i.p. 
male SD/C57BI/6J 
150 mg/kg/day o. 
4 wks, male F344 
60 mg/kg I.p. 
female Wistar 
15 mg/kg s.c. 
male + female 
Harlan rats 
15.6 mg/kg /day o. 
12 wks 
female Wistar(TNO) 
470 ppm inh. 4 h. 
male F344 
ilde 0.4 mmol/kg i.p. 
male F344/SD 
2% lead acetate o. 
10 wks, male + 
female Wistar 
5 ppm in diet o. 
90 days, male + 
female rats 
71 mg/kg/day o. 
28 days, male SD 
3.4 mg/kg/day o. 
28 days, male SO 
6000 ppm Inh. 6 h 
male Alderley Park 
15 mg/kg s.c. 
male + female 
Harlan rats 
PT(S3) McMurtry et al.1978 
PT Reld, 1973 
PT(S3) Nlshizhuml. 1972 
PT Tune and Fravert. 1980 
PT Reid. 1973 
PT Potter et al , 1981 
PT(S3) Kluwe. 1981 
PT Reld. 1973 
PT Bomhard et al , 1988 
PT(S2) Hard et a l . 1984 
PT Welles et al , 1973 
PT(S2,S3) Harleman and 
Seinen. 1979 
PT Potter et al , 1981 
PT Yang et a l . 1985 
PT Hirsch. 1973 
PT Munro et al , 1974 
PT Chu et a l . 1983 
PT Chu et al. 1983 
PT(S3) Odum and Green, 1984 
PT Welles et a l , 1973 
F344. Flsher 344 rats ; inh., inhalation: I.p.. Intraperitoneal; o., oral ; PT, proximal tubule; s.c. 
subcutaneous; SD, Sprague Dawley ra ts . 
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In ternat ional Symposium on Nephrotox ic i ty , more than 70% a f fec t the proximal 
tubule. A select ion of such chemicals is presented in table 1.1. The reasons fo r the 
select iv i ty of the nephrotox ic i ty can be mani fo ld . One of them is the presence of 
d i f fe ren t t r anspo r t systems and another is the metabol ic act iv i ty in the kidney. 
1.3 TUBULAR TRANSPORT SYSTEMS IN RELATION TO NEPHROTOXICITY 
The physiological role of the proximal tubule is one of excre t ion and 
reso rp t i on , schematical ly represented in f igure 1.2. Glucose, amino ac ids, prote ins 
and about 85% of the sodium chlor ide and water are reabsorbed f r o m the 
g lomerular f i l t r a t e . Was te products which are not g lomerular ly f i l t r a t e d are 
ex re ted through the tubule. As a consequence of th is funct ional o r ien ta t ion , the 
presence of uptake mechanisms capable of t ranspor t ing xenobiot ics across the 
luminal or serosal membrane can be of importance fo r a possible nephrotox ic 
e f f e c t . Aminoglycosides as gentamycin, tobramyc in , and amikac in , are glomerular ly 
f i l t r a t e d . At the proximal tubular brush border e lec t ros ta t i c binding can occur 
ensued by a concent ra t ion dependent pinocytot ic uptake (Por te r and Bennet t , 
1989) . Recently a mul t idrug t r a n s p o r t e r , known as P-glycoprote in or P170, was 
found concent ra ted on the luminal membrane of the proximal tubule (Thiebaut et a l , 
1987). This t r anspo r t e r seems to play an impor tant role in p ro tec t ing cel ls by 
ext rud ing xenobiot ics as act inomycin D, v inblast ine, and co lch ic ine. In te r fe rence 
w i th th is t r a n s p o r t e r might cause tox ic e f f ec t s (Gottesman and Pastan, 1988) . 
T ranspor t systems o f ten mentioned in re lat ionship wi th a proximal tubular 
nephrotoxic i ty are the organic anion and cat ion t r a n s p o r t e r . 
Most thoroughly studied is the organic anion t r a n s p o r t e r . It has an extensive 
var ia t ion in subs t ra tes , but all have an organic backbone and a negative charge in 
\gi> 'omerular filtration] 
anti-luminal 
Figur« 1.2 Schematic representation of excretion 
and resorption by the proximal tubular cell. 
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common (M0ller and Sheikh, 1983; Pritchard, 1987; Ullrich et al, 1987a ; 1987b ; 
1987c). Differences in patterns of inhibition of the transport of the different 
anions resulted in a subdivision in at least three transport systems termed as: 
sulfate, dicarboxylate and para-aminohippurate transport . However, this 
subdivision is relative; there is an overlapping specificity, and organic anions can 
be recognized by all three units (Fritzsch et al, 1989). 
In general the organic anion transporter is typified by the transport of 
para-aminohippurate (PAH), a model organic anion. In the mammalian kidney this 
transport is situated in the proximal tubule. Which segment is the most active in 
the PAH transport depends on the species involved (Möller and Sheikh, 1983). PAH 
transport occurs in the serosal and the luminal membrane. At the serosal 
membrane organic anions are actively transported into the proximal tubular cell. 
The exact driving force is still under debate. The sodium dependence of the PAH 
transport suggested before appears to be indirect. Presumably , a (Na* ,K*) -
ATPase causes a sodium gradient across the serosal membrane. A dicarboxylate 
is cotransported with sodium into the cell, and is subsequently exchanged against 
PAH (Burckhardt and Ullrich, 1989) . At the luminal membrane PAH is transported 
outside the proximal tubular cell via diffusion, possibly carrier mediated . At both 
membranes probenecid is a competitive inhibitor of the PAH transport (Pritchard, 
1987). 
Compared to the organic anion transport, relatively little is known about the 
organic cation transporter. The overall direction is from serosal to luminal 
membrane. Early studies , using tetraethylammonium (TEA) and 
N-methylnicotinamide as model ions, suggested that organic cations are 
transported across the luminal as well as the serosal membrane (Rennick, 1981). 
However, it now appears that the active step is located at the luminal membrane 
and seems to be driven by countertransport with protons secondary to 
Na + ,H ''"-exchange (Rennick, 1981; Wright, 1985; Rafizadeh et al, 1987). A potent 
inhibitor of TEA-transport is quinine (Rafizadeh et al, 1987). 
Dependent on the rate of transport at the luminal and serosal membrane high 
intracellular concentrations of xenobiotics can arise. The group of cephalosporin 
antibiotics seems to be transported by organic anion transporters. Probenecid 
decreases their nephrotoxicity (Tune and Fravert, 1980).The most nephrotoxic 
representative of this group is cephaloridine. Unlike the other cephalosporins, 
cephaloridine is not able to cross the luminal membrane by diffusion. Due to the 
positive charge at the quaternary nitrogen of the pyridinium substituent , the 
limited luminal transport seems to be mediated by an organic cation transporter, 
as evidenced by an increase in nephrotoxicity by other cations (Wold et al. 1979). 
Organic anion transport also seems involved in the nephrotoxicity of cisplatin 
(Fillastre and Raguenez-Viotte, 1989), and mycotoxins like ochratoxin A and 
citr inin. Probenecid decreases the clearance of cisplatin (Caterson et al, 1983), 
the mortality of rats after exposure to citr inin, as well as citrinin's renal 
accumulation and urinary excretion (Berndt and Hayes, 1982). In in vitro studies 
probenecid inhibits the accumulation of radiolabeled citrinin in cortical slices 
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(Berndt, 1983). In the nephrotoxicity of ochratoxin A probenecid has contradictory 
effects: It decreases the clearance of ochratoxin A, but it increases its 
accumulation and nephrotoxicity (Stein et al, 1985). 
One of the early indications that organic anion transport is also involved in the 
nephrotoxicity of haloalkenes was the observation that there were differences in 
organic ion accumulation in cortical slices of rats treated with hexachloro-
butadiene (HCBD) compared to the controls. The organic anion transport, as 
measured by means of PAH accumulation, was lowered, whereas the organic 
cation transport, as measured by means of TEA accumulation, was not affected 
(Berndt and Mehendale, 1979; Hook et al, 1982). Later studies showed that prior 
administration of probenecid protects rats against the nephrotoxicity produced by 
HCBD (Lock and Ishmael, 1985). 
In contrast to e.g. the cephalosporins, it appears that a metabolite of the 
haloalkenes is transported via an organic anion transporter . Together with the 
presence of transport systems, renal as well as extrarenal biotransformation thus 
is an important factor in targetting the nephrotoxic action of many xenobiotics to 
the proximal tubule. 
1.4 BIOTRANSFORMATION IN RELATION TO NEPHROTOXICITY 
The kidney is a metabolically active organ. Different xenobiotic-metabolizing 
enzymes are unevenly distributed within the kidney. Mixed-function oxidases 
exhibit a cortico-papillary gradient with the highest activity in the cortex (Zenser 
et al, 1978). In addition, the cytochrome P-450 present in the proximal tubule has 
several isoenzymes differentially distributed among the different cell types. In the 
inner medulla the prostaglandin endoperoxidase synthetase system has its highest 
activity (Christ and van Dorp, 1972). 
Examples of xenobiotics which need renal metabolic activation before 
becoming nephrotoxic are dealt with in several reviews ( Hook et al, 1979; Rush 
et al, 1984a; Walker and Duggin, 1988). Of those leading to toxicity in the proximal 
tubular epithelium, only haloalkenes and halobenzenes will be discussed below, 
since representatives of glutathione conjugates derived from these compounds are 
used in this thesis. 
1.4.1 Haloalkenes 
Haloalkenes appear as byproducts or are used as intermediates in the 
manufacture of plastics. They have been used as soil fumigants, are present in 
mixtures of pesticides, and are persistent environmental contaminants. Several 
haloalkenes are known nephrotoxins in experimental animals, and cause selective 
damage to the proximal tubule . Although chronic low-level exposure does occur in 
the work place, little information is available concerning a nephrotoxic risk for 
man, owing to the functional reserve of the kidney and the difficulties to relate a 
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possible nephrotoxic effect to exposure to one solvent (Bernard and Lauwerys, 
1989). 
Although effects of HCBD in experimental animals have been observed in 
convoluted as well as in straight limbs (Harleman and Seinen, 1979; Stott et al, 
1981), the S3 segment is the most vulnerable part. The necrosis is often 
accompanied by numerous casts in the loop of Henle and distal tubule, and is 
visible as a distinct band of damage in the outer stripe of the outer medulla with 
some extension into the medullary rays (Hook et al, 1983). Selective damage of the 
S3 segment was also reported for chlorotrifluoroethylene (Potter et al, 1981) and 
tetrafluoroethylene (Odum and Green, 1984), whereas hexafluoropropene resulted 
in necrosis throughout pars recta and pars convoluta (Potter et al, 1981). The 
mechanism of this nephrotoxicity has been subject of investigations for several 
years. Although considerable progress has been made, demonstrating a complex 
cooperation of extra- and intrarenal metabolism ( for reviews see: Lock, 1988; 
Anders et al, 1988), the exact reason for the site selectivity of the nephrotoxicity 
is still not clear. 
Exposure of male and female rats to HCBD resulted in a marked depletion of 
non-protein sulfhydryl groups in the liver, whereas renal levels were influenced 
only in female rats (Lock and Ishmael, 1981; Hook et al, 1983). This suggested the 
formation of glutathione conjugates by glutathione S-transferases (GST) in the 
liver. Microsomal and cytosolic studies demonstrated the formation of such 
glutathione conjugates of HCBD (Wolf et al, 1984). Usually conjugation with 
glutathione is regarded as the f i rst step in a detoxication patway (Fig. 1.3). After 
subsequent hydrolysis or transamination by Y~9,hJtamyltranspeptidase of the 
glutathione conjugate, and removal of the glycine moiety by dipeptidases, a cysteine 
conjugate is formed. This is acetylated into a mercapturic acid and excreted via the 
urine. However, for several haloalkenes glutathione conjugation can result in an 
activation followed by nephrotoxicity. 
Analysis of the bile of rats treated with HCBD, revealed the presence of both 
S-(1,2,3,4,4-pentachlorobutadienyl)glutathione (PCBD-GSH) and S-(1,2.3,4,4-
pentachlorobutadienyOcysteinylglycine (PCBD-CYSGLY). Biliary cannulation before 
administration of HCBD completely protected the rats from HCBD nephrotoxicity; 
however, dosing the rats orally with the bile caused the nephrotoxicity (Nash et al, 
1984). So apparently an enterohepatic cycle is involved in the nephrotoxicity of 
haloalkenes. 
The existence of an enterohepatic cycle enables the delivery of different 
metabolites of the mercapturic acid pathway to the kidney (Fig. 1.4). This aspect of 
xenobiotic metabolism has been reviewed previously (Inoue, 1985). Glutathione 
conjugates formed in the liver can be translocated to the caval perfusate as well as 
to the bile , dependent on the size of the molecule and the rate of glutathione 
conjugation (Wahlländer and Sies, 1979). At a low rate of synthesis, excretion in 
the bile is the predominant route . On their way to the intestinal lumen glutathione 
conjugates are metabolized into cysteinylglycine or cysteine conjugates. The 
responsible enzymes, yGl and dipeptidases, are present on canalicular (Inoue et 
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Figure 1.3 Detoxication of xenoblotics via the mercapturic acid pathway. 
al, 1983) and ductal membranes, in the bile and pancreatic juice, as well as on the 
luminal membrane of small-intestinal mucosal cells (Grafström et al, 1980) . After 
reabsorption , the cysteine conjugates are transferred to the kidney, directly or 
after acetylation in the intestine or liver. As a consequence of this enterohepatic 
cooperation, glutathione, cysteine, and N-acetylcysteine conjugates may reach the 
kidney. 
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At present several glutathione conjugates of haloalkenes and their metabolites 
are known nephrotoxicants. A key enzyme in this nephrotoxicity is the pyridoxal 
phosphate-dependent ß-lyase. Metabolism by this enzyme causes the generation of 
pyruvate , ammonia and a reactive thiol (Fig. 1.5) (Lock, 1988; Anders et al, 1988). 
The nature of the ultimate intermediate which is responsible for the cytotoxicity is 
still under investigation. Chlorofluorothionoacyl fluoride (Dekant et al, 1987) and 
difluorothionoacyl fluoride (Commandeur et al, 1989) have been suggested as 
reactive intermediates of S-(2-chloro-1,1,2-trif luoroethyl)-L-cysteine and 
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine respectively. 
Before a cysteine conjugate can become nephrotoxic it has to be delivered to 
the interior of the renal cell. For this there are two possibilities. Either the 
cysteine conjugate becomes available to ß-lyase after deacetylation of the 
N-acetyl-cysteine conjugate, or it is transported into the cell after being formed 
extra-cellularly by metabolism of the glutathione conjugate. The responsible 
enzymes, YGT and dipeptidases, are predominantly present on the luminal 
membrane of the proximal tubular cell (Tate and Maack, 1985). The nephrotoxicity 
of the N-acetyl-cysteine conjugate of HCBD and its accumulation in renal cortical 
slices can be inhibited by probenecid (Lock and Ishmael, 1985; Lock et al, 1986). 
Apparently a serosal organic anion transporter is responsible for the renal uptake. 
This transporter has also been suggested for the uptake of S-(1,2-dichlorovinyl)-
L-cysteine (Lash and Anders, 1986). 
1.4.2 Halobenzenes 
Halobenzenes are used for various purposes, among them: dye carr iers, 
pesticides, flame retardents, and intermediates in the manufacture of other 
chemicals. In contrast to several haloalkenes, e.g. HCBD, the toxic effects of 
halobenzenes are not limited to the kidney only. Effects on liver, lungs, and thyroid 
have also been reported (Reid, 1973; Chu et al, 1983). About the mechanism of 
nephrotoxicity of several halobenzenes less is known than about the mechanism of 
haloalkenes. QSH conjugates appear to be of importance. However, recently some 
halobenzenes have been reported to cause a nephrotoxicity, known as protein 
droplet nephropathy (PDN). Since an unawareness of this phenomenon might 
obscure the comparison of in vivo data of different halobenzenes, attention will be 
paid to PDN , before going into the mechanism which is subject of investigation in 
this thesis. 
Protein Droplet Nephropathy 
Several chemicals , among them halobenzenes, cause a nephrotoxicity known 
as Protein Droplet Nephropathy (PDN) (Table 1.2). It appears that this PDN is 
unique to the male rat. Kidneys of female rats, and of mice and dogs of both sexes 
are not affected. One of the reasons for this specificity is the presence of a 
protein : the a
 2 u -globulin. 
The a
 2 u -globulin is a low molecular weight protein and was described by 
Neuhaus and Roy (for references see: Kanerva et al, 1987b) in the late sixties and 
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seventies. It is synthesized in the male rat by hepatic parenchymal cells, and 
transferred to the kidney. After glomerular f i l trat ion, a
 2 u "globulin is poorly 
reabsorbed. Once absorbed a
 2 u -globulin can accumulate in the proximal tubular 
(S2) epithelium, due to poor hydrolysation. It is visible as hyaline droplets. 
Repeated testosterone injections can induce the formation of hyaline droplets also 
in ovarioectomized female rats (Kanerva et al, 1987b). The physiological function 
of a2u-globulin is presumably that of a pheromone carrier. 
The pathology of the nephrotoxicity after exposure to the chemicals 
summarized in table 1.2 , is similar. The diameter of the hyaline droplets in the 
proximal tubular epithelium increases and the inclusions become more angular and 
crystalloid (Stone et al, 1987). At the junction of the inner and outer bands of the 
outer zone of the medulla granular casts appear , followed by nephron obstruction 
and chronic nephrosis (Kanerva et al, 1987a). From studies by Lock and 
Charbonneau it seems that the a
 2u -globulin functions as a carrier and targets 
the xenobiotic or a metabolite to the proximal tubule. After dosing the rats with 
trimethylpentane the hyaline droplets consisted of a reversibly bound complex of 
a 2u -globulin and 2,4,4-trimethyl-2-pentanol (Charbonneau et al, 1987; Lock et 
Table 1.2 Chemicals or mixtures of chemicals that induce a Protein Droplet Nephropathy 
specific for the male ra t . 
CHEMICALS REFERENCES 
60 Solvent 
70 Solvent 
f-Butylcyclohexane 
C
 1 0 -C n Isoparaffinic solvents 
Decalln 
p-Dlchlorobenzene 
N,N-Diethyl-m-toluamide 
Diisobutyl ketone 
Isophorone 
Jet fuels (RJ-5, JP-4 , JP-5 , JP-7. JP-10) 
d-Limonene 
Methyl isobutyl ketone 
Naphtas (various) 
Pentachloroethane 
Perchloroethylene 
Stoddard Solvent 
Tetral in 
1,3,5-Trichlorobenzene 
2.2.4-Trimethylpentane 
o-Xylene 
Unleaded gasoline 
Carpenter et al , 1975a 
Murty et al , 1988 
Henningsen et a l , 1987 
Phillips and Egan, 1984 
Kanerva et al , 1987a 
Bomhard et a l , 1988 
Bomhard et a l , 1989 
Murty et al , 1988 
Murty et a l , 1988 
Parker et al , 1981; Murty et al, 1988 
Kanerva and Alden, 1987 
Murty et al , 1988 
Murty et al , 1988 
Goldsworthy et a l , 1988 
Goldsworthy et a l , 1988 
Carpenter et a l . 1975 b 
Murty et a l . 1988 
Bomhard et a l , 1989 
Stonard et a l , 1986 
Bomhard et a l , 1989 
Oison et a l , 1987 
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al, 1987). Probably, this binding causes a structural alteration of the protein, 
which influences its reabsorption and degradation. 
Recently Olson et al (1990) made a comparison between a
 2 u "globulin and 
human urinary proteins. Although traces of proteins similar to a
 2 u -globulin 
(a 1 -acid glycoprotein, a •) -microglobulin) are present in human urine, the very 
low urinary protein content, the relatively low amount of cationic proteins, and the 
high molecular weight of the most abundant urinary proteins . make this type of 
nephrotoxicity of no relevance for man. 
Of the halobenzenes, only chlorinated benzenes up to three chlorine atoms 
have been studied for their ability to induce PDN, and only p-dichlorobenzene and 
1,3,5-trichlorobenzene were positive (Bomhard et al, 1988; 1989) In this light , the 
male rat-specific nephrotoxicity reported for 1,2,4,5-tetrachlorobenzene, 
pentachlorobenzene and hexachlorobenzene (Chu et al, 1983; 1984) has to be 
regarded with some prudence. 
Glutathione conjugates 
Of the compounds which have been shown to be negative in the ability of 
inducing PDN, bromobenzene, chlorobenzene , and o-dichlorobenzene (Cameron 
et al 1937; Reid, 1973; Rush et al, 1984b) cause an extensive necrosis of the 
proximal convoluted renal tubules. Covalent binding in the rat kidney 6 h after 
dosage of 1 mmol/kg [ 1 * C3-chlorobenzene was 4 fold higher than after an equal 
dose of [ 1 4 CD-bromobenzene. In addition, the covalent binding as a result of 
0.5 mmol/kg [ 1 4 C3-o-dichlorobenzene was comparable with that of the labeled 
bromobenzene. After 24 h covalent binding was increased with 20% when 
bromobenzene was used, whereas covalent binding after exposure to 
chlorobenzene and o-dichlorobenzene decreased with 24% and 50% respectively. 
Inhibition of metabolism by piperonyl butoxide , an inhibitor of cytochrome P-450, 
prevented the nephrotoxicity, whereas phénobarbital mediated induction had the 
opposite effect (Reid, 1973). These studies indicated that a metabolite formed by 
cytochrome P-450 (presumably in the liver) is responsible for the nephrotoxic 
effect. The nature of this metabolite remained unclear for a long time . Sipes et 
al (1974) suggested biliary excretion of a bromobenzene glutathione conjugate 
followed by intestinal reabsorption. However, the proposed structure was not of 
importance for the nephrotoxicity. It was the metabolite o-bromophenol that 
reproduced the same nephrotoxicity even at a five fold lower dose (Lau et al, 
1984a). Liver microsomal incubations with bromobenzene and o-bromophenol 
demonstrated the formation of a bromohydroquinone. In addition, this was 
detected as a conjugate in the urine of rats treated with bromobenzene or 
o-bromophenol. Administration of bromohydroquinone (i.p.) to rats caused an 
identical nephrotoxicity as after o-bromophenol or bromobenzene exposure; 
however, the dose required was less than 10% of that of bromobenzene (Lau et al, 
1984b). Liver microsomal incubations with bromohydroquinone resulted in the 
formation of several mono- and disubstituted glutathione conjugates, and two of 
them were identified as 2-bromo-3-(glutathion-S-yl)hydroquinone (2-Br-3-(GSyD-
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Figure 1.6 Proposed pathway of bromobenzene 
metabolism to nephrotoxic glutathione conjugates. 
(Adapted f rom Monks et a l . 1985). 
HQ) and 2-bromo-(diglutathion-S-yl)hydroquinone (2-Br-(diGSyl)HQ (Monks et al, 
1985). Figure 1.6 summarizes the results of these studies in a postulated pathway 
of bromobenzene metabolism responsible for nephrotoxicity. Administration (i.V.) 
of glutathione conjugated (bromo)hydroquinones caused the same nephrotoxicity as 
after dosing bromobenzene (Monks et al, 1985; Monks et al, 1988a; Lau et al, 
1988a). The exact mechanism of nephrotoxicity of glutathione conjugated halo-
hydroquinones is not fully understood. Several in vivo experiments indicate that, 
similar to glutathione conjugates of haloalkenes , YGT is an important factor. 
Pretreatment of rats with acivicin (AT-125), an irreversible inhibitor of yGT 
(Allen et al, 1980; Schasteen et al, 1983) , can partly inhibit the nephrotoxicity of 
bromohydroquinone (Monks et al, 1985), 2-Br-(diGSyl)HQ (Monks et al, 1988a). 
and (tri-glutathion-S-yl)hydroquinone (triGSyl)HQ (Lau et al, 1988a). Also in vitro 
experiments using rat renal slices suggested a role for yGT (Lau et al, 1988b). 
A role for ß-lyase in the nephrotoxicity of glutathione conjugated 
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hydroquinones seems to be absent. In vivo experiments showed only minor or no 
effects of inhibition of ß-lyase by aminooxyacetic acid on the nephrotoxicity of 
2-Br-(diGSyl)HQ (Monks et al. 1988a) and (triGSyl)HQ (Lau et al, 1988a). 
Oxidation of the hydroquinone into the corresponding quinone is a more likely 
mechanism of nephrotoxicity, since thiophenols lacking the hydroquinone moiety 
cause no nephrotoxicity (Monks et al, 1988b). 
1.5 SCOPE OF THE THESIS 
A usefull cell model for studying mechanisms of toxicity requires the presence 
in vitro of characteristics which may play a role in this toxicity in vivo, and the 
possibility of demonstrating their involvement. From the foregoing it will be clear 
that nephrotoxic chemicals mostly affect the proximal tubule, and that 
transport- and metabolic enzyme systems play an important role. 
In chapter 2, monolayers of LLC-PKi - and of rat renal cortical cells , which 
are used in this thesis as in vitro model systems for the proximal tubule, are 
described. Since the mechanism of nephrotoxicity of HCBD is relatively well 
known, the glutathione conjugate of HCBD and its derivatives are used in part II as 
model compounds to investigate the usefulness of both in vitro systems for 
studying mechanisms of nephrotoxic glutathione conjugates. In chapter 3 and 4 
this is done for the LLC-PKi cell line, and in chapter 5 the primary cultures of rat 
renal cortical cells are dealt with. 
In part III glutathione conjugates derived from halogenated hydroquinones are 
subject of investigation. In a f i rst attempt to validate the in vitro test system and 
to see whether the mechanism of nephrotoxicity of glutathione conjugated 
bromohydroquinones is more generally valid, other halogenated (GSyl)hydro-
quinones (dichloro-(GSyl)hydroquinone and trichloro-(GSyl)hydroquinone ) were 
studied in vivo (Chapter 6). The information obtained in part II was used in the 
decision which cell system to use in investigating the role of YGT in the toxicity of 
glutathione conjugates derived from halogenated hydroquinones (Chapter 7). 
Finally, in part IV, a summary and concluding remarks are given in both English 
(chapter 8 ) and Dutch (chapter 9). 
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Monolayers of renal cortical cells as an in vitro model for proximal tubular 
epithelium 
2.1 INTRODUCTION 
Several in vitro models (e.g.: membrane vesicles, slices, isolated tubules and 
cells ) , have been used to investigate the physiology of the kidney. Some of them 
have also been used in studying mechanisms of nephrotoxicity . For studying initial 
interactions and mechanisms at the cell membrane, isolated membrane vesicles 
are very useful (Ishikawa et al, 1985; Inui et al, 1988). However, several 
experimental difficulties can occur: problems involving cell fractionation, 
alterations in membrane structure, interactions with other cellular components 
during isolation, and lack of vesicle homogeneity. An advantage of the use of 
slices often referred to is that the histological organization of the kidney stays 
intact and as a consequence the targetting of the toxicity can be studied . 
Although over the years the technique of preparing slices has significantly 
improved (Deutsch, 1936; Kacew and Hirsch, 1981; Ruegg et al, 1987) some of the 
disadvantages Chahwala and Harpur (1986) summarized , may still occur. Most of 
the cells are not directly exposed to the suspending medium, and the immediate 
environment of many cells is affected by the rates of diffusion of substances 
through the extracellular space of the slice. Many intracellular binding sites are 
exposed on the cut surfaces of the slice. Medium can penetrate only difficultly into 
the tubular lumen. The latter can also be a problem when isolated tubules are 
used. In addition, isolated tubules have only a limited'lifespan (1-6 h). Several 
methods of isolating renal tubules have been used (Schlondorff, 1986). The most 
widely used methods are based on enzymatic digestion of the tissue which might 
cause cellular damage. This counts also for suspensions of cells , either freshly 
isolated from a kidney or of cell lines . However, culturing these cells gives them 
time to recover from trauma and minor damage as a result of the isolation 
procedure. Their use has been subject of several reviews (Handler et al, 1980; 
Handler, 1983; Wilson, 1986; Sakhrani and Fine, 1983; Rabito. 1986). 
The structure and function of the kidney in general and of the proximal tubule 
in particular, requires that an in vitro model should allow to pay attention to the 
fact that in vivo luminal as well as serosal exposure of the proximal tubular cell 
can occur. Using monolayers of renal cortical cells offers a possibility to 
approximate this in vivo situation as much as possible by culturing them on porous 
membranes. Although this technique has been used before in more physiological 
studies, it has not been used in renal toxicological studies. In the present 
investigations monolayers of LLC-PKi- and rat renal cortical cells have been used. 
The cells were cultured either conventionally on a solid support, or on a porous 
support so that apical (luminal) and basolateral (serosal) membranes are 
accessible. 
36 
2.2 MONOLAYERS OF LLC-PKi CELLS 
Very few kidney cell lines are of a proximal tubular origin. Sofar the LLC-PKi 
cell line is the best characterized . It originated in 1958 and was derived from a 
juvenile male Hampshire pig (Hull et al, 1976). In culture the cells maintain their 
typical epithelial pattern and have numerous microvilli. When a culture reaches 
confluency , domes arise (Fig.2.1A). At those places the monolayer detaches from 
the substrate, and fluid accumulates between the cell layer and the substrate. 
Formation of these domes, enabled by junctional complexes (Fig.2.1B), was the 
f i rst indication of the presence of transport systems in this cell line. Although 
some characteristics can be associated with other parts of the nephron, most 
characteristics indicate that the probable site of origin is the proximale tubule 
(Table 2.1 ). The reason of these functional dissociations is not known. Its 
possible that as a result of the repeated culturing cells may express or lose 
several functions. However, a more likely explanation is that the LLC-PKi cell line 
exists of several cell types. Wohlwend et al (1986) demonstrated such functional 
an morphological heterogeneity. Cells different in their response to calcitonin and 
in their ability to form domes, were cloned into three subpopulations. Another 
clone ( L L C - P K I A ) shows a 250% increase in sodiumhydrogen exchange activity 
(Viniegra and Rabito, 1988). 
Figure 2.1 Scanning (A) and transmission (B) electron micrograph of LLC-PKi monolayers. 
Reaching confluency LLC-PKi monolayers form domes (D) enabled by apical junctional complexes 
( jc). Note the numerous microvil l i (mv) . (A, x 1520; B, x 6,300). 
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Table 2.1 Processes and enzymes identified in the LLC-PKl cell line. 
CHARACTERISTIC KIDNEY LOCATION REFERENCES 
Alkaline phosphatase PT 
Amino acid t ransport System A PT and DT 
Amino acid transport System ASC PT and DT 
Amino acid transport System L PT and DT 
cAMP respons to calcitonin and MTAL 
vasopressin 
Calcium transport PT 
1,25-Dihydroxyvitamin D3 receptor PT 
mediated 24-hydroxylase activity 
Electrical resistance 200-400 O.cm 2 DT 
Y-Glutamyltranspeptidase PT 
Leucine aminopeptidase PT 
a-Methyl-D-glucoside transport PT 
Oxidative 11ß-hydroxysteroid PT 
dehydrogenase 
Phosphate transport PT 
Sodium-hydrogen antiport PT 
Gstraunthaler et al , 1985 
Rabito and Karish, 1982 
Rabito and Karish, 1982 
Sepü Iveda and Pearson, 1982 
Rabito and Karish, 1982 
Sepiilveda and Pearson, 1982 
Golding et al , 1978 
Sakhrani and Fine,1983 
Parys et a l , 1986 
Colston and Feldman,1982 
Sakhrani and Fine,1983 
Perantoni and 8erman,1979 
Perantoni and Berman.1979 
Mullin et a l , 1980 
Rabito and Ausiello.1980 
Korbmacher et a l , 1989 
Rabito, 1983 
Biber et a l , 1983 
Moran et a l . 1986 
DT, Distal tubule; MTAL, Medullary Thick Ascending Limb; PT, Proximal Tubule 
LLC-PKl cells were cultured in Williams Medium E supplemented with 10% fetal 
calf serum (GIBCO, Glasgow, Scotland), penicillin (50 lU/ml , Gist-Brocades, Delft, 
The Netherlands) , and streptomycin (100 mg/ l , Gist-Brocades) in culture flasks 
(Costar, Badhoevedorp, The Netherlands) at 37 ° C in a humidified atmosphere 
containing 5% CO
 2 . Stock cultures, seeded at 0.8-1.0x10 A cells/cm 2 , were 
subcultured every 3-4 days by trypsinization with 0.25% trypsin (Difco, Detroit, 
Ml) and 0.05% EDTA (Merck. Darmstadt, FRG). LLC-PKi cells turned out to be 
rather insensitive to trypsinization. The best results were obtained when cells 
were subcultured before the stage the domes had appeared. Cells were rinsed 
with Hanks' Balanced Salt Solution without Ca 2 + and Mg 2 + (HBSS), and 4 ml of 
the trypsinizing solution was added to a flask of 75 cm 2 . The trypsinization was 
followed microscopically at room temperature. Before the cells became detached 
the trypsinizing solution was gently removed , and subsequently the cells were 
incubated at 37 ° C until all cells were detached. Experiments were performed 
with cells at passage 193-220. 
Experiments where only apical exposure was of importance were conducted 
with monolayers in 24-well tissue culture plates (Costar Mark II) . On day 0, cells 
were seeded at 1.5x10 5 cel ls/well , and on day 3 the monolayers were ready for 
use. At this time numerous domes had formed. 
To enable seperate exposure from either apical or basolateral side, 
monolayers were cultured on porous supports of tissue culture transwell inserts 
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Figure 2.2 LLC-PKt cells cultured on porous membranes of transwell inserts. The porous 
membrane of the transwell (A,B) is the only possibility for exchange between the apical (upper) 
and basolateral (lower) compartment. LLC-PKi cells were seeded on day 0 at 0.8x10 6 
ce l ls / inser t . Af ter 1 day (C) a few places were not fully covered and pores (p) are visible. Within 
3 days (DÏ a confluent monolayer had formed. Microvilli are especially visible on cells not fully 
expanded. (C, x 1520; D, x 800) . 
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(Costar). Cells were seeded on day 0 at 0.8-1.0x106 cel ls/ insert. Already within 
three days the monolayers were confluent (Fig. 2.2 ) (Mertens et al, 1989). 
2.3 MONOLAYERS OF RAT RENAL CORTICAL CELLS 
Renal cortical cells were isolated according to a modified method of Jones et 
al (1979) and cultured according to Bruggeman et al (1989) . Female Wistar rats 
(170-190 g, Centre for Laboratory Animals of the Agricultural Univerity 
Wageningen) were injected i.p. with sodium pentobarbital and heparin (6 mg/100g 
and 250 IU/100g, respectively). The abdomen was opened and the aorta and vena 
cave were separated from the surrounding tissue caudal and rostral of the renal 
arteries and veins. An arterial clamp was placed on the aorta rostral of the renal 
arteries. A catheter (I.D. 0.95x51 mm; Terumo Corporation, Tokyo) was inserted 
into the aorta, caudal from the renal arteries, and secured with a Buldog vascular 
clamp. The kidneys were perfused in situ with a Hanks1 Balanced Salt Solution 
without Ca 2 + and Mg 2 + (HBSS), containing 20 mM HEPES and 0.8 mM EDTA 
(flow-rate 10 ml/min, Qilson Minipuls 2). The buffer was oxygenated (95% O
 2 • 
5% CO 2 ) a nd kept at 37 ° C. A vein in the abdomen was cut. Within 1 min from 
the start of the perfusion the kidneys started to become pale. Perfusion was 
continued for 10-20 min. 
Kidneys were excised following perfusion, decapsulated, and the papillae were 
removed. The cortex was minced into 1-2 mm pieces and incubated in 0.125% 
trypsin- 0.05% EDTA in HBSS at 37 ° C in a gently shaking water bath for 
20-30 min. At 5 min intervals pieces were drawn through a 10-ml pipette, to help 
to dissociate the cells. The suspension was centrifuged (400 g, 3 min) and the 
pellet was resuspended in a solution of 12.5 mg collagenase (Clostridium 
histolyticum; Boeringer, Mannheim, FRG), 0.8 mg DNase (Grade I I ; Boehringer, 
Mannheim) , and 31.5 mg CaCI
 2 in 50 ml of HBSS and placed in a gently shaking 
water bath for 10-30 min. At 5-min intervals the suspension was drawn through a 
5-ml pipette. The suspension was centrifuged (4-00 g, 3 min) and the cells were 
resuspended in 80 ml of Williams Medium E supplemented with 10% fetal calf 
serum , penicillin (50 lU/ml) , and streptomycin (100 u,g/ml). The cells were 
counted in a haemocytometer and cell viability was determined by trypan blue 
exclusion. The isolation yielded a suspension of 6-10x10 6 single cells per kidney 
with a viability of more than 85%. In addition, cell clumps and some small tubule 
fragments were present in the suspension. Of this suspension 0.5 ml /well was 
plated in a 24-well tissue culture plate or 2 ml/insert in a tissue culture transwell 
plate. These concentrations were optimal for obtaining a confluent monolayer 
within 3-5 days (Fig. 2.3A and 2.4). Colonies mostly derived from attached cell 
clumps. This was also observed in other studies (Kedinger et al, 1987; Yang et al, 
1987). Most of the cells in the culture were identified as proximal tubular cells . 
Histochemical detection of fQlutamyltranspeptidase (Rutenburg et al, 1969) 
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Figure 2.3 Primary culture of rat renal cortical cells. A phase-contrast micrograph of a 
4-days culture monolayer (A), and a transmission electron micrograph of parts of two adjacent 
proximal tubular cells (B). The size of the mitochondria (M) and the electron 
transparancy of the nucleoplasma (N) are similar to those in proximal tubular cells in vivo 
(Mansbach. 1973). (A. x 160; B, x 13.200). 
Figure 2.4 Scanning electron micrographs of a 4-day old primary culture of rat renal cortical 
cells on porous membranes. . Microvill i on fully expanded cells differ in number and length from 
those on the cell clump (CO f rom which the former derive. (A, x 320; B, x 1080). 
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showed bright red areas demonstrating the presence of the proximal tubular 
brushborder enzyme (not shown). Transmission electron microscopy (Fig. 2.3B) 
revealed, a relative electron transparancy of the nucleoplasma and number, and 
size of mitochondria , similar to those in proximal tubular cells in vivo (Mannsbach, 
1973) . Since no special purification preceeded the culture, cells of different 
origin (distal tubular, connective tissue) were present too. 
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PART II 
INVENTARISATION OF MONOLAYERS OF RENAL CORTICAL CELLS 
FOR STUDYING MECHANISMS OF NEPHROTOXICITY OF 
GLUTATHIONE CONJUGATED HALOALKENES 
AND THEIR DERIVATIVES 
45 
CHAPTER 3 
Differential toxicity as a result of apical and basolateral exposure of LLC-PKi 
monolayers with S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and 
N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine 
Mortens J.J.W.M., Weijnen J.G.J, van Doorn W., Spenkelink A, Temmink J.H.M., 
and van Bladeren P.J. (1988) Chem.-Biol. Interactions. 65, 283-293. 
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Differential toxicity as a result of apical and basolateral treatment of LLC-PKi 
monolayers with S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and N-acetyl-S-
(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine 
SUMMARY 
Monolayers of LLC-PKl cel ls , a cell line with features typical of 
proximal tubular epithelial cel ls , were treated at the apical and 
basolateral side with S-(l,2,3,4,4-pentachlorobutadienyl) glutathione 
(PCBD-GSH) and N-acetyl-S-(l,2,3,4,4-pentachlorobutadienyl)-L-
cysteine (PCBD-NAC). 
Apical treatment with PCBD-GSH O20 u.M) resulted in cytotoxicity , 
which could be inhibited by acivicin and aminooxyacetic acid (AOAA), 
inhibitors of fglutamyltrarspeptidase (YGT) and ß-lyase respectively. 
In contrast apical treatment with PCBD-NAC was only toxic at high 
concentrations O850 (iM), and this effect could hardly be inhibited by 
AOAA. 
Basolateral treatment of confluent LLC-PKl monolayers , grown on 
porous membranes, with PCBD-GSH gave a much smaller respons than 
apical treatment, consistent with the fact that yGT is predominantly 
present at the apical side. Basolateral treatment even with high 
concentrations of PCBD-NAC (1.1 mil) did not show an increase in 
cytotoxicity when compared to the effect after apical treatment. 
These results suggest the absence of an organic anion transporter, 
by which these conjugates in vivo are transported into the cells from 
the basolateral side. This supposition was substantiated in a study of 
transcellular transport of the model ions tetraethylammonium (TEA) 
and para-aminohippurate (PAH) , in LLC-PKl monolayers , grown as 
Indicated above. No active PAH transport could be demonstrated , 
whereas an active TEA transport was present. 
The absence of an organic anion transporter limits the usefulness of 
LLC-PKl cel ls for the study of nephrotoxicity of compounds , like 
PCBD-NAC, needing this transport to enter the cel ls . However, the 
finding of an active basolateral organic cation transporter, together 
with the presence of yGT, dipeptidase and ß-lyase, makes this system 
especially interesting for testing all compounds that use this 
transporter or these enzymes in order to elicit toxicity. 
ABBREVIATIONS 
AOAA, aminooxyacetic acid; DCV-CYS, S-(1,2-dichlorovinyl)-L-cysteine; DCV-GSH. S- (1 ,2-d i -
chlorovinyOglutathione; EBSS, Earle's Balanced Salt Solution; EDTA, ethylenediaminetetraacetic 
acid; FCS. fetal calf serum; yGT, f-glutamyltranspept idase; GSH, glutathione; HBSS. Hanks' 
Balanced Salt Solution; HCBD. hexachlorobutadiene; HEPES, N-2-hydroxyethylpiperazine-N'-2-
ethanesulphonic acid; HPLC, high performance liquid chromatography; LDH, lactate dehydrogenase; 
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PAH, para-aminohippurate; PCBD-CYS. S-(1,2,3,4-,4--pentachlorobutadienyl)-L-cysteine; 
PCBD-NAC. N-acetyl-S-(1,2,3,4-.4-pentachlorobutadienyl)-L-cysteine; PCBD-GSH, S-(1.2.3,4,4-
pentachlorobutadienyOglutathione; TEA, tetraethylammonium; WE, Williams Medium E. 
INTRODUCTION 
The kidney is a rather heterogeneous organ containing numerous cell types. 
For investigations on mechanisms of nephrotoxicity, a stable in vitro system of 
homogeneous cells, representative for the site of action of the nephrotoxicant, is 
of considerable importance . As such a model the LLC-PKi cell line has been used 
by several authors (Hori et al, 1984; Saito et al, 1986; Troyer et al, 1986; Stevens 
et al, 1986). This cell line is derived from a normal Hampshire pig kidney (Hull et 
al, 1976); it expresses a number of features typical of the proximal tubular 
epithelium, while also maintaining the polarity typical of epithelial cells. It exhibits 
high activities of proximal brush border membrane enzymes , e.g. y-glutamyl-
transpeptidase (yGT) (Perantoni and Berman, 1979; Rabito et al, 1984) and 
possesses a number of the membrane transport systems found in vivo (Rabito and 
Ausiello, 1980; Mullin et al, 1980; Misfeldt and Sanders, 1981; Rabito and Karish, 
1982; Rabito and Karish, 1983; Sepülveda and Pearson. 1982; Rabito, 1983; Biber 
et al, 1983). 
Recently a number of glutathione (GSH) conjugates have been reported to be 
nephrotoxic. Although GSH conjugation is generally accepted as one of the major 
pathways of detoxification, GSH- and/or cysteine conjugates of e.g. tr ichloro-
ethylene (Hassal et al, 1983), chlorotrifluoroethene (Dohn et al, 1985), hexachloro-
butadiene (HCBD) (Jaffe et al, 1983; Nash et al, 1984), and 2-bromohydroquinone 
(Monks et al, 1985) have been found to be responsible for the nephrotoxicity of 
these compounds. Their major site of action is the proximal tubulus. The initial 
step in the metabolic activation is thought to be the hydrolysis of the GSH 
conjugate by yGT at the apical membrane. After subsequent removal of the glycine 
by a dipeptidase, the corresponding cysteine conjugate is not acetylated by 
N-acetyltransferase, to give the mercapturic acid, but converted by a ß-lyase, to 
a reactive thiol which is thought to be responsible for the ultimate toxic effect 
(Elfarra and Anders. 1984), (Fig. 3.1). 
On the other hand, basolateral transport systems such as organic anion 
transporters may play a decisive factor in the nephrotoxicity of these compounds. 
The N-acetylcysteine conjugate of e.g. HCBD (N-acetyl-S-(1,2,3,4,4-pentachloro-
butadienyl)-L-cysteine (PCBD-NAC) has been reported to be nephrotoxic (Nash 
et al, 1984). This conjugate apparently can be transported into the cell through the 
basolateral membrane by an organic anion transporter , since PCBD-NAC 
accumulation in renal cortical slices is inhibited by probenecid (Lock et al, 1986). 
The mercapturic acid may either leave the cell at the apical (luminal) side into the 
tubular lumen . or may be deacetylated yielding the cysteine conjugate which again 
can be metabolized to the reactive thiol (Fig. 3.1). 
- 49 -
\glomerular filtration] 
RENAL PROXIMAL TUBULAR CELL 
R-NAC 
excreted 
in urine 
apical 
R-OSH 
R-CYS 
R-NAC 
basolateral 
Figure 3.1 Schematic representation of renal glutathione conjugate metabolism. 
Glutathione conjugates (R-GSH). either directly f rom the glomerular f i l t ra te or 
indirectly af ter probenecid sensitive basolateral transport through the epithelial cell 
to the f i l t ra te , enter the proximal tubular lumen (1). They are metabolized by Y G T (2) 
and a dipeptidase (3) to the corresponding cysteine conjugates (R-CYS). which enter 
the cell at the apical side. Basolaterally a probenecid sensitive transport of R-CYS 
(4) and the mercapturic acid (R-NAC) (5) has been postulated. R-NAC can be 
excreted into the urine or be deacetylated (6) to R-CYS. This derivative can be 
acetylated by N-acetyltransferase (7) or metabolized by ß-lyase (8) to a reactive 
thiol , resulting in toxic i ty. 
Basolateral transport systems may also play a role in the access to the 
proximal tubular cell of cysteine conjugates and of the glutathione conjugates 
themselves: Probenecid sensitive uptake of S-(1,2-dichlorovinyl)glutathione 
(DCV-QSH) (Lash and Jones, 1985), and probenecid inhibition of S-(1.2-dichloro-
vinyl)-L-cysteine (DCV-CYS) toxicity (Lash and Anders, 1986), have been reported 
in basolateral vesicles as well as in isolated kidney cells . 
In the present study the LLC-PK1 cells were grown on porous membranes in 
transwell cell culture chambers. Using this system the role of apical and 
basolateral transport systems in the toxicity elicited by the GSH and (^-acetyl-
cysteine conjugates of HCBD was studied. For a complete picture organic anion 
and cation transport was also investigated with the model ions para-amino-
hippurate (PAH) and tetraethylammonium (TEA). 
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MATERIALS AND METHODS 
Chemicals 
CGIycyl-1- 1 4 C]PAH, spec. act. 42.7 mCi/mmol and C1- 1 * C]TEA. spec. act. 
4.8 mCi/mmol were purchased from New England Nuclear, Boston, MA, USA. 
Glutathione , HCBD , Aminooxyacetic acid (AOAA) and quinine were obtained from 
Janssen, Beerse, Belgium. Acivicin was a gift from Dr. Wendell Wieringa from The 
Upjohn Company, Kalamazoo, Michigan, USA. Probenecid was bought from Sigma, 
St Louis, MO , USA. Sodium pyruvate was obtained from BDH Chemicals Ltd, 
Poole, England and NADH from Boehringer, Mannheim, FRG. Triethylamine was 
purchased from Merck-Schuchardt, Hohenbrunn, FRG. All other reagents, when 
not specified, were obtained from commercial sources and were of the highest 
purity available. 
Syntheses 
S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-glutathione (PCBD-GSH) was 
synthesized by adding 3.32 g hexachloro-1,3-butadiene to a solution of 1 g 
glutathione in 100 ml of dry methanol to which was added 5 ml of triethylamine. 
The reaction mixture was stirred for 6 days, the solvent evaporated in vacuo, and 
the residue dissolved in 50 ml of 0.5 M NaHCO
 3 . The aqueous phase was 
extracted repeatedly with diethylether and then adjusted to pH 3.5 with 1% H3PO4.. 
The precipitate formed was collected by centrifugation, and washed several times 
by stirring with water/ethanol (95:5 v/v) followed by centrifugation. Drying in 
vacuo (KOH) yielded 399 mg (23.1%) of a yellow material (mp. 186-190 ° C; l i t . 
Nash et al, 1984: 186-187 ° C). The identity of the product was confirmed by field 
desorption mass spectrometry on a MS 902 equipped with a VG-ZAB console 
(signal at emitter current 24-30 mA (only 3 5 Cl-peak is given), m/e 530 (MH + ) 
(Tunek et al, 1980). The purity was checked by thin layer chromatography (TLC) 
(n-propanol/acetic acid/H
 2 O: 16 /3 /5 ; Rf 0.54; visualization after spraying with 
ninhydrin). 
PCBD-NAC was synthesized according to Nash et al (1984). Purification of the 
crude product was achieved by high performance liquid chromatography (HPLC) 
using a reversed phase preparative column (250x12 mm, Lichrosorb 10RP-18) 
(Chrompack, Middelburg, The Netherlands) eluted isocratically with 
methanol/water (1% acetic acid) (80:20 v/v) at a flow rate of 5 ml/min. Purity 
exceeded 98% as judged by HPLC using a reversed phase analytical column 
(150x4.6 mm; Lichrosorb 5RP-18) (Chrompack, Middelburg, The Netherlands) and 
methanol/water (1% acetic acid) (70:30 v/v) as mobile phase at a flow rate of 
1 ml/min . The UV-spectrum (methanol) was determined with a Beekman DU-8 
spectrophotometer (Beekman Instruments Inc. Fullerton, USA) and showed X max 
at 283 nm. The identity was further confirmed by nuclear magnetic resonance 
analysis and mass spectral analysis (only 3 5 Cl-peaks are given) using both field 
desorption mass spectrometry (signal at emitter current 24-30 mA, m/e 
385 (M + )) and electron impact mass spectrometry (70 eV, m/e 385 (M + , 1%), 
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350 (M+-Cl, 1%), 340 (M + -COOH, 3%). 305 (M +-COOH-CI. 3%). 298 
(M+-COOH-COH g . 5%). 255 (C 4. Cl
 5 S + , 9%). 220 (C 4 CI 4 S + , 100%). 
Cell strain and culture 
Epithelial pig kidney cells (LLC-PKi) (Flow, Irvine, ScotlancDwere grown in 
William's Medium E (WEHFlow, Irvine, Scotland), supplemented with 10% fetal calf 
serum (FCS) (GIBCO. Glasgow, Scotland ), 100 IU of penicillin, and 100 mg/ l of 
streptomycin (Gist-Brocades , Delft, The Netherlands ) in culture flasks (Costar, 
Badhoevedorp, The Netherlands) at 37 ° C in a humidified atmosphere, containing 
5% CO
 2 . Stock cultures, seeded at 0.8-1.0 x10 * cel ls/cm 2 , were subcultured 
every 3 to 4 days by trypsinization with 0.25% trypsin (Dlfco, Detroit, Mich. USA ) 
and 0.05% EDTA (Merck, Darmstadt, FRG ), after being rinsed with Hanks' 
Balanced Salt Solution (HBSS). Experiments were performed with cells at passage 
193-220. 
Cytotoxicity assay 
For experiments where monolayers were exposed only at the apical side cells 
were seeded into 24-well tissue culture plates (Costar) at 3.5x105 cel ls/well . 
Within 2-3 days the monolayers were confluent and dome formation occurred. At 
the third day after seeding, the wells were rinsed with HBSS and the test 
compounds were added dissolved in 1.0 ml WE without FCS and antibiotics. The 
concentration of the test compounds was afterwards checked by a UV-scan, 
X max= 280-284 nm and E = 1 0 5 0 0 (Reichert and Schütz, 1986). Whenever enzyme 
inhibitors were used, the cells were preincubated for half an hour with the 
inhibitors before the test compounds were added (for concentrations see the 
figure legends). After overnight incubation ( 16 hours) , 400 (il samples of the 
media were taken from each well and centrifuged. Lactate dehydrogenase activity 
(LDH) was measured (Mitchell et al, 1980) in 100 (il of supernatant . The maximal 
release (Rmax) of LDH was obtained by scraping control cells with a pipet tip in 
1 ml of 0.5% tri ton X-100 in 0.1 M phosphate buffer, and measuring the LDH 
activity in the supernatant after sonication (5 min.) and centrifugation. Each 
experiment was performed in triplicate. Toxicity data are presented as percentage 
of Rmax and as the mean + / - S.D. for at least three experiments. 
In experiments where apical treatment was compared with basolateral 
treatment, the cells were grown in transwell cell culture chambers (Costar) with 
an effective porous membrane area of 4.7 cm 2 . Cells were seeded at 0.8x10 6 
cells/membrane and the medium was renewed after 3-4 days. At the 6 t h or 7 t h 
day after seeding the cells were used for an experiment. Confluency was checked 
by scanning electron microscopy (not shown). After the cells were carefully rinsed 
with WE the membranes were returned to the wells, filled with 2.6 ml of WE, with 
or without the test compounds dissolved. Then the apical compartment was filled 
with 1.5 ml of WE, with or without test compounds dissolved. Using these volumes, 
an equal level of medium in both compartments was achieved. After overnight 
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incubation , the medium from the apical and basolateral compartments were added 
together and a 400 ul sample was taken. LDH activity was measured in the 
supernatant of the sample after centrifugation. 
Transport assay 
The transcellular transport experiments were performed with cells grown in 
transwell culture chambers as described above. After rinsing with Earle's 
Balanced Salt Solution (EBSS), without phenol red and supplemented with 2.4 mM 
HEPES (pH 7.5), the porous membranes were incubated in the same solution. 
Hydrostatic pressure was prevented by keeping the solution at either side at the 
same level . Before (20 min.) and during the experiment cultures were kept at 
37 ° C in a humidified atmosphere containing 5% CO 2 • The experiment was 
started by adding a solution of 1 4 C-PAH (42.7 mCi/mmol) or 1 * C-TEA 
(4.8 mCi/mmol) in EBSS (-phenol red, + 2.4 mM HEPES ) such that a final 
concentration of 6 uM and 25 uM respectively was reached, concentrations near 
the optimal concentration used with kidney tubules (Hassall et al, 1983). At 
different times 100 ul samples were taken at the transcellular compartment. Each 
volume of solution removed from a compartment was restored with an identical 
volume of the corresponding non-radioactive solution. 
RESULTS 
Toxicity as a result of apical treatment of LLC-PKi monolayers with HCBD 
conjugates 
When confluent monolayers of LLC-PK1 cells in multiwells are used, only the 
apical side of the cell is accessible. Overnight incubation of such LLC-PK1 
monolayers with PCBD-GSH resulted in a dose related cytotoxicity starting at 
20 uM, measured by LDH release (Fig.3.2A). Inhibitors of enzymes of the 
mercapturic acid pathway were used to determine the specificity of the toxic 
effect. As expected, inhibition of Y ~ G T (acivicin) and ß-lyase (AOAA) prevents the 
toxicity . In figure 3.2B , the results are shown obtained when LLC-PK1 monolayers 
were treated with PCBD-NAC . No toxicity could be observed at concentrations up 
to 850 u,M PCBD-NAC . The toxicity observed at higher concentrations was only 
slightly inhibited by AOAA. 
Apical versus basolateral treatment of LLC-PKi monolayers with PCBD-GSH and 
PCBD-NAC 
Basolateral exposure of the LLC-PKi cells was achieved by growing 
monolayers on porous membranes using a transwell cell culture chambers. After 
apical or basolateral treatment with PCBD-GSH , a large difference in toxicity, 
was observed, which disappeared as a result of acivicin (Fig. 3.3). 
However , basolateral incubation with PCBD-NAC did not result in a higher 
toxicity than apical incubation, as would be expected if a PCBD-NAC transporter 
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Figure 3.2 Effect of PCBD-GSH (A) and PCBD-NAC (B) on LLC-PKl monolayers. Confluent 
monolayers of LLC-PKl cells were treated apically for 16 h in the absence ( • # ) o r presence 
of inhibitors of -rGT (acivicin, 0.5 mM; O O) or ß-lyase (AOAA, 0.5 mM; A A) . Note 
the difference in the scale of the abscissa. Each point represents the mean of at least three 
experiments. 
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Figure 3.3 Apical versus basolateral treatment of LLC-PKl 
monolayers with PCBD-GSH and PCBD-NAC. LLC-PKi 
monolayers were grown in transwell cell culture chambers 
(see Methods) were treated apically (E2) or basolaterally ( • ) 
for 16 h. Acivicin was used at a concentration of 0.5 mM and 
added only at the apical side. Each bar represents the mean 
(±S.O.) of three membranes of one experiment typical for at 
least three. 
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at the basolateral side would be involved . Even when we increased the 
concent ra t ion up to 1.1 mM , no d i f fe rences in tox ic e f fec ts were observed. These 
resu l ts suggest the absence of an organic anion t r anspo r te r in LLC-PKi cel ls by 
which these conjugates are t ranspor ted into the cell across the basolateral 
membrane in vivo. 
Transepithelial organic cation (TEA) and anion (PAH) transport 
The ex is tence of both organic cat ion and anion t r a n s p o r t systems was 
invest igated using radioact ive TEA and PAH. Figure 3.4 shows very clearly that 
TEA is t ranspor ted f r o m the basolateral side to the apical s ide. Both quinine 
(0.1 mM) , a potent compet i t ive inhibi tor of organic cat ion t r a n s p o r t , and ouabain 
(0.1 mM) , which ac ts by inhibit ing the Na +,K + - ATPase, were able to inhibit th is 
t r a n s p o r t . In con t ras t no probenicid sensi t ive PAH t ranspo r t was observed. 
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Figura 3.4 Transepithelial organic cation (TEA) and anion (PAH) transport. 
Monolayers were grown in transwell cell culture chambers (see Methods). 
Transport was measured f rom the apical to the basolateral side, and f rom 
the basolateral to the apical side, in the absence ( • • ) or presence of 
inhibitors: ouabain, 0.1 mM (O O ) ; quinine, 0.1 mM (A A) or 
probenecid, 1.0 mM (D D ) . Note the scale difference in the ordinate. Each 
point represents the mean (±S.D.) of three membranes and the line was 
calculated by regression analysis of all points. 
55 -
DISCUSSION 
Organic anion transporters may play an important role in the nephrotoxicity of 
GSH conjugates and their metabolites. Probenecid, a well-known inhibitor of 
organic anion transport, has been reported to inhibit the nephrotoxicity of 
PCBD-GSH, PCBD-CYS, PCBD-NAC (Lock and Ishmael, 1985) and S-(2-chloro-
ethyl)-DL~cysteine (Elfarra et al, 1985) in vivo, as well as the renal cortex slice 
accumulation of PCBD-NAC (Lock et al, 1986) in vitro. Experiments with freshly 
isolated rat kidney cells show the same effect of probenecid; the cytotoxicity of 
S-(1,2-dichlorovinyl)-L-cysteine (Lash and Anders, 1986) as well as the uptake of 
S-(1,2-dichlorovinyl)glutathione (Lash and Jones, 1985) was inhibited. 
Since the organic anion transporter is situated at the basolateral side of the 
proximal tubular epithelium (see Fig.3.1), in the present study the cytotoxicity of 
the model compounds PCBD-GSH and PCBD-NAC as a result of either apical or 
basolateral treatment of LLC-PKi monolayers was compared. 
LLC-PKi monolayers in culture plates only allow apical treatment . In this 
system PCBD-GSH elicited a toxic effect, that could be inhibited by acivicin , 
consistent with the fact that fGT is present in the apical membrane. Apical 
treatment with PCBD-NAC resulted in a small toxic effect. The slight effect of 
AOAA indicates that the toxicity is essentially not due to the reactive metabolite 
formed via the ß-lyase pathway. Most likely at these high concentrations some 
general cytotoxic effect occurs, which has nothing to do with nephrotoxicity. 
These results are in agreement with the finding of Stevens et al (1986) that 
N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in a similar system also has low toxicity 
and confirms the finding that these substances are transported into the cell by an 
organic anion transporter (Lock et al, 1986). In order to further substantiate this 
we extended the test system and cultured monolayers of LLC-PKi cells on porous 
membranes in a transwell system which allows selective basolateral treatment. 
Apical incubation with PCBD-GSH resulted in a much larger toxic effect than 
basolateral incubation, showing that 1) f ^ T is indeed predominantly present in the 
apical membrane and 2) transport of the GSH conjugate from the basolateral side 
through the cell followed by conversion via fQT on the apical side does not occur. 
However , basolateral treatment with PCBD-NAC did not result in an increase 
in the toxic respons compared to apical treatment, as would be expected if a baso-
lateral transporter were present . Since the monolayers on the porous membranes 
are slightly less sensitive to PCBD-GSH than the monolayers in the multiwells, the 
effect of PCBD-NAC was studied up to a concentration of 1.1 mM, but still no 
increase in toxicity due to basolateral treatment was detected. The absence of an 
increase in toxicity by basolateral treatment with PCBD-NAC may have two 
explanations. Either the LLC-PKi cell is not capable of deacetylating PCBD-NAC, 
or it does not have a transport system by which PCBD-NAC can enter the cell. The 
absence of a transport system seemed the most likely explanation and was further 
investigated by measuring transcellular transport of radiolabeled PAH. 
Indeed no probenecid sensitive transepithelial PAH transport was found. This 
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is in agreement with a recent report by Rabito (1986) who did not find any 
probenecid sensitive accumulation of PAH. In contrast, an active transcellular 
transport from the basolateral side to the apical side, of the cation TEA, was 
clearly present. 
In conclusion, LLC-PKi monolayers are a suitable model for testing glutathione 
conjugates such as PCBD-GSH. The role of a number of important enzymes of the 
mercapturic acid pathway as yGT and ß-lyase. can then be studied. Because of the 
absence of an organic anion transporter no meaningful toxicity studies can be 
carried out with these cells when basolateral uptake via this organic anion 
transporter is a prerequisite for their toxic effect. 
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CHAPTER 4 
Cytotoxicity of S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine after apical and 
basolateral exposure of LLC-PKi monolayers. Involvement of an amino acid 
transport system 
Martens J.J.W.M., Keukens E.A.J., Appel M., Spenkelink A., Temmink J.H.M., and 
van Bladeren P.J. (1990) Chem.-Biol. Interactions, 75, 119-130. 
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Cytotoxicity of S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine after apical and 
basolateral exposure of LLC-PKi monolayers. Involvement of an amino acid 
transport system 
SUMMARY 
Glutathione conjugation and subsequent formation of cysteine 
conjugates are key steps In the nephrotoxicity of halogenated alkenes. 
In this metabolic activation several organs are involved. However little 
is known about the transporters responsible for the uptake of cysteine 
conjugates. Recent evidence suggest that amino acid transporters play a 
role In this uptake. 
Monolayers of LLC-PKi cel ls , a kidney cell line, were exposed to 
S-(l,2,3,4,4-pentachlorobutadlenyl)-L-cysteine (PCBD-CYS). Cyto-
toxicity was used as a parameter for PCBD-CYS uptake. Basolateral 
exposure (1 h : 400 iiM and 16 h : 2S iiM) to PCBD-CYS resulted in a 
much higher aminooxyacetic acid inhibitable cytotoxicity than apical 
exposure, suggesting a preferential basolateral uptake of PCBD-CYS. 
Exposure to PCBD-CYS In the absence of sodium did not result in a 
decrease of the cytotoxicity, suggesting a sodium independency of the 
PCBD-CYS uptake. Amino acids and amino acid analogues were used as 
diagnostic compounds in the further identification of the PCBD-CYS 
transporter. In cis-lnhibition experiments monolayers were 
co-incubated with PCBD-CYS and these diagnostic compounds during 
one hour. System L substrates such as 2-aminoblcyclo[2.2.11heptane-2-
carboxylic acid (BCH) and cycloleucine did not inhibit cytotoxicity. 
D-Tryptophan, a model Inhibitor of System T, caused a strong 
inhibition. System L has, in contrast to System T, a high sensitivity to 
trans-stimulation. Pre-loading the monolayers with the diagnostic 
compounds should cause an increase in cytotoxicity when System L Is 
Involved. Neither System L substrates such as BCH and cycloleucine nor 
D-tryptophan Increased cytotoxicity. 
These results suggest a preferential basolateral uptake of 
PCBD-CYS in LLC-PKi monolayers and involvement of an amino acid 
transporter with characteristics of System T. 
ABBREVIATIONS 
AIB. a-aminoisobutyric acid; AOAA. aminooxyacetic acid; BCH, 2-aminoblcycloC2,2.1]heptane-
2-carboxylic acid: SCO, 3-aminobicycloC3.2,1]octane-3-carboxylic acid; CYS. cysteine; DCV-CYS. 
S-(1,2-dichlorovinyl)-L-cysteine; EBSS. Earle's Balanced Salt Solution; yQT. Y-glutamyl-
transpeptidase; GSH, glutathione; HBSS. Hanks' Balanced Salt Solution; HCBD, hexachloro-
butadiene; LDH, lactate dehydrogenase; MeAIB. o-(methylamino)isobutyric acid; PCBD-CYS, 
S-(1,2.3.4.4-pentachlorobutadlenyl)-L-cysteine; PCBD-NAC. N-acetyl-S-(1,2.3.4.4-pentachloro-
butadienyU-lcysteine; SBC, S-benzyl-L-cysteine; SEC, S-ethyl-L-cysteine; SMC, S-methy l -L-
cysteine; WE, Williams Medium E. 
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INTRODUCTION 
Several halogenated alkenes have been reported to elicit a specific proximal 
tubular nephrotoxicity (Kociba et al, 1977; Odum and Green, 1984). Responsible for 
this effect is a cysteine(CYS)-conjugate that is activated via ß-elimination by 
ß-lyase, an enzyme which is present in the renal proximal tubular epithelium. The 
CYS-conjugate is formed after a complex series of metabolic steps, involving 
several organs. The initial reaction is a glutathione (GSH) conjugation of the halo-
genated alkenes in the liver. The next steps are enzymatic conversion by yg lu tamy l -
transpeptidase (fGT) and a dipeptidase leading to the CYS-conjugate. These steps 
can occur either intrarenally, after the GSH-conjugate has reached the brush 
border in the proximal tubulus, or extrarenally, in the bile duct and/or intestine. In 
the latter case the CYS-conjugate is absorbed from the intestine and can reach 
the kidney as it is, or after acetylation into the corresponding N-acetyl-cysteine 
conjugate in the liver. Deacetylation in the kidney then results in the reformation of 
the CYS-conjugate (for review see: Anders et al, 1988; Lock, 1988). 
Due to the structure and function of the proximal tubule, conjugates can reach 
the epithelial cell from either the luminal or serosal side. It is evident that cellular 
uptake systems for these different conjugates in either membrane play an 
important role in the nephrotoxicity of halogenated alkenes. For the 
N-acetyl-cysteine conjugate of hexachlorobutadiene (HCBD) Lock et al (1985:1986) 
demonstrated involvement of an organic anion transporter in the renal uptake, 
probably located in the anti-luminal membrane. Less is known about the renal 
uptake of CYS-conjugates. Lash and Anders (1986) postulated involvement of an 
organic anion transporter in the uptake of S-(1,2-dichlorovinyl)-L-cysteine 
(DCV-CYS). Recently, Schaeffer and Stevens (1987a) found that DCV-CYS could 
be taken up in LLC-PKi monolayers via an amino acid transporter. The LLC-PKi 
cell line (Hull et al, 1976) is a convenient cell model for studying transport aspects 
of CYS-conjugates. It possesses a number of characteristics typical of proximal 
tubular epithelium, among them the enzymes, necessary for the activation of GSH-
and CYS-conjugates (Stevens et al, 1986; Mertens et al, 1988) and several amino 
acid transporters (Rabito and Karish, 1982; Rabito and Karish, 1983; Sepülveda 
and Pearson, 1982). It maintains the epithelial polarity, when cultured on a solid or 
porous support. In their investigations Schaeffer and Stevens (1987a) used 
LLC-PKi monolayers on a solid support . This makes access of the CYS-conjugate 
to the basolateral membrane virtually impossible, thus obviating appraisal of the 
relative importance of apical versus basolateral uptake routes. Using a porous 
support for LLC-PKi cells allows the investigation of apical and basolateral uptake 
processes (Mertens et al, 1988) and should give information about the relative role 
of amino acid transporters of both membrane systems in the cytotoxicity of 
CYS-conjugates in these cells. 
The terminology of amino acid transporters has been proposed by Christensen 
and co-workers (Oxender and Christensen, 1963; Christensen et al, 1967; 
Vadgama and Christensen, 1985; Christensen, 1984). Within the group of neutral 
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amino acid transporters transport systems are distinguished by their sodium 
dependence, substrate specificity and exchange properties. System L is a sodium 
independent transport system that preferentially transports zwitterionic amino 
acids with branched and apolar side chains, like cycloleucine and 2-aminobi-
cyclo[2,2,1]heptane-2-carboxylic acid (BCH). It has a high sensitivity to 
trans-stimulation of substrate uptake, i.e. enhanced uptake of a substrate as a 
result of fast exchange with a previously loaded intracellular analogous substrate. 
System T resembles System L, it is also sodium independent, but has a preference 
for aromatic and bicyclic amino acids. It shows some sensitivity to 
trans-stimulation of substrate uptake and has D-trytophan as a model substrate. 
System ASC is a sodium dependent transporter with preference for zwitterionic 
amino acids with preferentially three to five carbon in a chain, like oc-aminoiso-
butyric acid (AIB). It excludes N-methylated amino acids , like a-(methylamino)-
isobutyric acid (MeAlB) and shows minor sensitivity to trans-stimulation. System 
asc is similar to ASC in substrate specificity, but differs from it by its 
sodium-independence, which is indicated by the use of the lower-case letters. It 
has valine as model substrate. System A is also a sodium dependent transporter 
of zwitterionic amino acids, but it accepts N-methylated amino acids like MeAlB 
and is sensitive to trans-inhibition: exchange inhibited by a pre-loaded analogous 
substrate. 
In the present study we investigated in LLC-PKi monolayers the uptake of 
S-(1,2,3,4-,4-pentachlorobutadienyl)-L-cysteine (PCBD-CYS) at the apical and the 
basolateral membrane. Experiments of Schaeffer and Stevens (1987) demonstrate 
unequivocally that cytotoxicity data give reliable information about uptake. We 
therefore used cytotoxicity as a parameter for uptake. Furthermore the influence 
of amino acids and amino acid analogues on the cytotoxicity was studied. The 
results indicate preferential basolateral uptake and involvement of a sodium 
independent amino acid transporter with characteristics of System T in the 
cytotoxicity of PCBD-CYS . 
MATERIALS AND METHODS 
Chemicals 
S-ethyl-L-cysteine (SEC), S-methyl-L-cysteine (SMC), S-benzyl-L-cysteine 
(SBC), BCH, AIB and D-tryptophan were purchased from Janssen Chimica (Beerse, 
Belgium). Aminooxyacetic acid (AOAA), MeAlB and cycloleucine were bought from 
Aldrich-Chemie (Steinheim, FRG), histidine and valine from Merck (Darmstadt, 
FRG). 
Syntheses 
PCBD-CYS was synthesized by hydrolysis of N-acetyl-S-(1,2,3,4,4-penta-
chlorobutadienyl)-L-cysteine, which was synthesized as described before 
(Mertens et al, 1988). Field desorption mass spectrometry on a MS 902 equipped 
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with a VG-ZAB console (signal at emitter current 24-30 mA) showed a 5 chlorine 
pattern at m/e 343 (M * ) confirming the identity of PCBD-CYS. Purity exceeded 
98% as judged by HPLC. 
Cell culture 
Epithelial pig kidney cells (LLC-PKi) (Flow, Irvine, Scotland) were grown in 
culture flasks (Costar, Badhoevedorp, The Netherlands) at 37°C in a humidified 
atmosphere containing 5% CO
 2 • The medium was William's Medium E (WE) (Flow) 
supplemented with 10% fetal calf serum (GIBCO, Glasgow, Scotland), penicillin 
(50 lU/ml) , and streptomycin (100 mg/l) (Gist-Brocades, Delft, The Netherlands). 
Subconfluent cultures were subcultured every 3 to 4 days . Cells were rinsed with 
Ca 2 + - and Mg 2 + - f ree Hanks' Balanced Salt Solution (HBSS) and trypsinized with 
0.25% trypsin (Difco, Detroit, Mich. USA) and 0.05% EDTA (Merck). Experiments 
were performed with cells at passage 193-220. 
Cytotoxicity assay 
LLC-PKi monolayers were obtained by seeding 24-well tissue culture plates 
(Costar) with 3.5x105 cells/well or porous membranes of transwell cell culture 
chambers(Costar. no 3412) with 1.0x106 cells/membrane on day 0. Experiments 
were conducted at the third day after seeding. At this time numerous domes had 
formed in the monolayers in the culture plates. This culture period also was long 
enough to produce tightly confluent monolayers on the porous membranes as 
evidenced by scanning electron microscopy. In addition, the tightness was checked 
with the inhibitable transcellular transport of radiolabeled tetraethylammonium as 
described before (Mertens et al, 1988). Monolayers were washed with Earle's 
Balanced Salt Solution ( 10 mM NaHCO
 3 , 20 mM HEPES , pH 7.4) (EBSS), and 
treated with PCBD-CYS in EBSS during 1 or 16 h . Cytotoxicity was determined 
immediately after the 16 h exposure or after a subsequent overnight stay in EBSS 
in the experiments with 1 h exposure. LDH-leakage was used as a parameter for 
cytotoxicity (Mertens et al, 1988). 
Experimental procedure 
To see whether and which amino acid transporter is involved in the uptake and 
subsequent cytotoxicity of PCBD-CYS in LLC-PKi monolayers, we conducted the 
following experiments: 
Sodium dependence was investigated by exposing LLC-PKi monolayers during 
one hour to PCBD-CYS either in EBSS in which the sodium was replaced by 
equimolar amounts of choline (EBSS-Na +) or in EBSS in the presence of ouabain 
(5 u.M and 1 mM). The monolayers were left overnight in EBSS before cytotoxicity 
was determined. 
To see whether cis-inhibition occurred, monolayers were exposed during one 
hour to PCBD-CYS in EBSS in the presence of 10 mM of several different amino 
acids or amino acid analogues, which were used as diagnostic compounds. Only 
S-benzyl-L-cysteine (SBC) was used at lower concentrations due to its lower 
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solubility. The concentration of PCBD-CYS chosen was high enough to produce a 
strong toxic effect in the control cultures, enabling registration of inhibition of the 
toxicity as a result of the co-incubation with the diagnostic compound. 
Trans-stimulation was determined by exposing monolayers overnight to 
PCBD-CYS after pre-loading the cells for one hour with 10 mM of the diagnostic 
compound. In this case the concentration of PCBD-CYS chosen was low enough to 
produce a small toxic effect in the control, enabling detection of a stimulation of 
the toxicity. Higher concentrations resulted in a high toxicity which was not 
inhibited by the use of the amino acid transporter substrates, indicating that 
metabolism by ß-lyase was not influenced. 
In the experiments where sodium dependence and cis-inhibition were 
investigated, we chose for a short term exposure of one hour. Long term exposure 
(e.g. 16 h) may obscure competitive inhibition of uptake because, this inhibition will 
probably only delay for a limited time , the reaching of a maximum and the ensuing 
toxic effects. Furthermore trans-stimulatory effects could mask cis-inhibition as 
Schaeffer and Stevens suggested (1987a). 
RESULTS 
Cytotoxicity after apical or basolateral exposure 
Apical exposure of confluent LLC-PKi monolayers in 24-well tissue culture 
plates to PCBD-CYS resulted in a cytotoxicity that could be inhibited by AOAA, a 
ß-lyase inhibitor (Fig.4.1). 
Monolayers in transwell cell culture chambers were exposed separately from 
the apical or basolateral side. As shown in figure 4.2, basolateral exposure gives a 
higher AOAA inhibitable toxicity than apical exposure, suggesting a preferential 
basolateral uptake of PCBD-CYS. Note the difference in sensitivity to apical 
exposure between monolayers in 24-well tissue culture plates and those on the 
porous membranes of the transwells (Mertens et al, 1988). 
Sodium dependence 
No sodium dependence could be demonstrated for the cytotoxicity of 
PCBD-CYS. One hour exposure to PCBD-CYS in EBSS without sodium or EBSS 
containing ouabain, an inhibitor of Na+ ,K+-ATPase, did not result in decreased cyto-
toxicity (Table 4.1). On the contrary, ouabain increased the cytotoxicity of 
PCBD-CYS. The sodium independence was found for both apical and basolateral 
exposure. 
Cis-inhibition 
As shown in table 4.2, the use of AIB and MeAlB, model substrates for 
discriminating between Systems A and ASC, did not result in a decrease of the 
cytotoxicity in the cis-inhibition experiments. Neither did cis-inhibition occur when 
substrates were used of System asc, like valine, or System L, Jike cycloleucine and 
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Figure 4.1 Cytotoxicity of LLC-PKi monolayers as a result of PC8D-CYS 
exposure. LLC-PKi monolayers in 24-well tissue culture plates were exposed 
to PCBD-CYS during 1 h (O — O ) or 16 h ( • • ) . AOAA was used at a 
concentration of 0.5 mM ( o . • ) LDH-leakage was used as parameter and 
was measured after 16 h (see materials & methods). Results are the mean 
(± S.D.) of 2-5 experiments in t r ip l icate. 
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Figure 4.2 Cytotoxicity of PCBD-CYS after apical or basolateral exposure 
of LLC-PKi monolayers. LLC-PKi monolayers on porous membranes of 
transwell cell culture chambers were exposed during 1 or 16 h to PCBD-CYS 
either apically VE&) or basolaterally ( • ) . AOAA was used at a concentration 
of 0.5 mM and added to both sides. LDH-leakage was used as parameter . 
Each bar represents the mean (± S.D.) of 2-6 experiments in t r ip l icate. 
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Table 4.1 Na*-dependence of PCBD-CYS toxicity. LLC-PKi monolayers in 24-well tissue 
culture plates (apical) or on porous membranes of transwell cell culture chambers (basolateral) 
were exposed to PCBD-CYS during 1 h , under the indicated conditions. LDH-leakage data are the 
mean (± S.D.) of two experiments in t r ip l icate. 
Z LDH-release 
CONDITION APICAL 
0 uM 150 uM 
BASOLATERAL 
0 uM 250 (iM 
Control 
Ouabain 5 
1 
E B S S - N a * 
uM 
mM 
6.3 
7.4 
7.3 
7.8 
± 0.6 
± 2.1 
t 1.4 
± 2.1 
46.7 
62.6 
65.8 
46.1 
± 15.1 
± 19.2 
± 7.4 
± 6.3 
5.9 
4.2 
9.8 
5.6 
± 2.0 58.5 ± 4.4 
± 0.1 78.7 ± 4.8 
± 0.3 78.6 ± 2.4 
± 0.4 51.4 t 3.3 
Table 4.2 Inhibitory effect of various amino acid transporter substrates on the cytotoxicity 
of PCBD-CYS . LLC-PKi monolayers were exposed apically (24-well tissue culture plates) with 
0.2 mM or basolaterally (transwell cell culture chamber) with 0.4 mM PCBD-CYS In the presence 
of 10 mM diagnostic compound during 1 h. LDH-leakage data of co-incubated cells were expressed 
as frequency of LDH-leakage data of control cel ls. Percentage are the mean (± S.D.) of n 
experiments in t r ip l icate. Aster iks indicate when inhibition was statist ically significant 
(Wllcoxon, p<0.05) in each experiment. 
DIAGNOSTIC 
COMPOUND APICAL 
Percentage of control 
n BASOLATERAL 
none 
SMC 
SEC 
SBC 2 
AIB 
MeAlB 
cycloleucine 
BCH 
hlstidine 
D-tryptophan 
valine 
100 
77 
77 
99 
115 
107 
101 
96 
69 
78 
89 
(79X 
± 
± 
± 
t 
± 
± 
± 
± 
± 
± 
±20)1 
7.8» 
9.4» 
8.5 
14.5 
31.2 
21.8 
16.0 
17.0* 
7.2* 
5.5 
10 
5 
5 
3 
3 
3 
4 
2 
7 
6 
3 
100 ( 
75 
75 
104 
117 
118 
136 
123 
68 
86 
120 
60J 
± 
± 
± 
± 
± 
± 
dt 
± 
± 
1 
±23)1 
3 0 . 7 * 
2 3 . 6 * 
14.8 
19.8 
23.1 
16.0 
26.6 
18.8* 
18.2* 
41.0 
12 
4 
4 
2 
2 
4 
2 
4 
9 
8 
3 
1 ) LDH-release 
2 ) 4 mM 
BCH. A decrease in cytotoxicity did occur when histidine, SMC, SEC and the 
System T inhibitor D-tryptophan were used. No significant inhibition was visible 
with SBC. No clear cut differences could be seen between apical or basolateral 
exposure. 
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Trans-stimulation 
Preloading the cells with amino acid transporter substrates resulted in a 
substantial stimulation of the cytotoxicity after apical or basolateral exposure to 
PCBD-CYS with SBC only (Table 3 ). Basolateral preloading with AIB also seemed 
to stimulate the PCBD-CYS toxicity, but the stimulation was not statistically 
significant. 
Table 4.3 Stimulatory effect of various amino acid transporter substrates on the cytotoxicity 
of PCBD-CYS. Af ter pre-loading with 10 mM diagnostic compound for 1 h. LLC-PK1 monolayers 
were exposed apically (24-wel l t issue culture plates) or basolaterally to 20 nM PCBD-CYS during 
16 h. LDH-leakage data of pre-loaded cells were expressed as frequency of LDH-leakage data of 
control cel ls. Percentages are the mean (± S.D.) of n experiments in t r ip l icate. Asteriks indicate 
when trans-st imulat ion was statist ical ly significant (Wilcoxon, p<0.05) in each experiment. 
DIAGNOSTIC 
COMPOUND 
Percentage of control 
APICAL BASOLATERAL 
none 
SMC 
SEC 
SBC 2 
AIB 
MeAlB 
cycloleucine 
BCH 
hlstidine 
D-tryptophan 
valine 
100 
119 
124 
178 
111 
123 
95 
129 
108 
110 
111 
(20% 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
±8)1 
9 
2 
16* 
8 
35 
6 
37 
14 
16 
30 
10 
4 
3 
5 
3 
5 
3 
6 
5 
4 
4 
100 
92 
118 
248 
164 
101 
101 
85 
109 
131 
88 
(14% 
± 
± 
± 
± 
± 
± 
1 
± 
± 
1 
±6)1 
32 
3 
103* 
18 
28 
14 
44 
34 
75 
28 
6 
3 
2 
6 
2 
3 
3 
3 
3 
3 
2 
1
 ) LDH-release 
2 ) 8 mM 
DISCUSSION 
As was demonstrated before , LLC-PK1 monolayers grown on porous 
membranes of transwell cell culture chambers allow separate exposure of the 
apical or basolateral side of the cell. Whereas apical treatment with PCBD-GSH 
was found to result in a higher toxicity than basolateral treatment (Mertens et al, 
1988), the opposite is the case after exposure to PCBD-CYS, suggesting a 
preferential basolateral uptake of the cysteine conjugate. 
Lock and co-workers demonstrated that the organic anion transporter is also 
the transporter of PCBD-NAC. Probenecid inhibited the accumulation of the 
radiolabeled PCBD-NAC in cortical slices (Lock et al, 1986) and the toxicity of the 
PCBD-NAC (Lock and Ishmael, 1985). This organic anion transporter has been 
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p o s t u l a t e d by L a s h and A n d e r s ( 1 9 8 6 ) t o be o f i m p o r t a n c e in t h e t r a n s p o r t o f 
c y s t e i n e - c o n j u g a t e s a l s o . They s h o w e d i n h i b i t i o n o f t h e t o x i c i t y o f D C V - C Y S by 
p r o b e n e c i d in a s u s p e n s i o n o f i s o l a t e d k i dney c e l l s . S i n c e an o r g a n i c a n i o n 
t r a n s p o r t e r is a b s e n t in t h e L L C - P K i c e l l l i ne ( M e r t e n s e t a l , 1 9 8 8 ; R a b i t o , 1 9 8 6 ) , 
C Y S - c o n j u g a t e s have t o e n t e r t h i s ce l l by a n o t h e r r o u t e t o b e c o m e t o x i c . A m i n o 
a c i d t r a n s p o r t e r s w o u l d s e e m l i ke l y c a n d i d a t e s . 
In o u r e x p e r i m e n t s w e no t on ly s t u d i e d a m i n o a c i d t r a n s p o r t s y s t e m s a l r e a d y 
d e s c r i b e d in t h e L L C - P K i c e l l t ine ( R a b i t o and K a r i s h , 1 9 8 2 ; S e p ü l v e d a a n d 
P e a r s o n , 1 9 8 2 ) , b u t a l s o S y s t e m a s c and S y s t e m T ( V a d g a m a and C h r i s t e n s e n , 
1 9 8 5 ; R o s e n b e r g e t a l , 1 9 8 0 ) , w h i c h t o o u r k n o w l e d g e have n o t b e e n i n v e s t i g a t e d in 
t h i s c e l l l ine b e f o r e . T h e s o d i u m i n d e p e n d e n c e o f t h e c y t o t o x i c i t y e x c l u d e s t h e 
i n v o l v e m e n t o f S y s t e m A a n d S y s t e m A S C ( S e e a l s o T a b l e 4 . 4 ) . T h i s i s f u r t h e r 
s u p p o r t e d by t h e i n a b i l i t y t o i n h i b i t t h e c y t o t o x i c i t y o f P C B D - C Y S in m o n o l a y e r s 
c o - i n c u b a t e d w i t h A I B o r M e A l B . O f t h e s o d i u m i n d e p e n d e n t a m i n o a c i d 
t r a n s p o r t e r s , t h e S y s t e m a s c s e e m s t o p lay no r o l e in t h e t r a n s p o r t o f P C B D - C Y S , 
s i n c e t h e s p e c i f i c s u b s t r a t e v a l i n e ( V a d g a m a and C h r i s t e n s e n , 1 9 8 5 ) has no e f f e c t 
on t h e c y t o t o x i c i t y . 
S y s t e m T is an a m i n o a c i d t r a n s p o r t e r w h i c h has o v e r l a p p i n g s u b s t r a t e 
s p e c i f i c i t y w i t h S y s t e m L. S y s t e m L is c h a r a c t e r i z e d by a h i gh s e n s i t i v i t y t o 
t r a n s - s t i m u l a t i o n , a s o d i u m i n d e p e n d e n c e and a w e a k pH d e p e n d e n c e . S y s t e m T is 
a l s o s o d i u m a n d pH i n d e p e n d e n t , i t a p p a r e n t l y p r e f e r s a m o n g t h e c l a s s i c a l 
S y s t e m L s u b s t r a t e s t h o s e w i t h a b e n z e n e r i n g in t h e a m i n o a c i d s t r u c t u r e 
( R o s e n b e r g e t a l , 1 9 8 0 ) , b u t i t has a l o w e r s e n s i t i v i t y t o t r a n s - s t i m u l a t i o n 
Table 4.4 Some characterist ics of amino acid t ransport systems, (references: Vadgama and 
Christensen, 1985; Christensen, 1984; Rosenberg et a l , 1980; and Gazzola et a l , 1980). 
System Na*-dependence Substrate Exchange properties 
A 
ASC 
Zwitterionic amino acids. MeAIB is a 
model substrate. 
Zwit ter ionic amino acids with 
preferentialy three to five carbon in a 
chain. Excludes N-methylated amino 
acids. 
Zwit ter ionic amino acids with 
preferential ly branched and apolar side 
chains. BCH is a model substrate. 
Same as ASC. A favourable substrate is 
valine. 
Prefers among the classical System L 
substrates aromatic and blcyclic amino 
acids. D-tryptophan is a model 
substrate 
Trans-inhibit ion 
Trans-st imulation 
Strong 
Trans-st imulat ion 
Trans-st imulation 
but questionable 
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(Vadgama and Christensen, 1985) . Vadgama and Christensen found that 
substrates as BCH and BCO, which had been used as specific System L 
substrates, also are transported in part via System T (Vadgama and Christensen, 
1985). Apart from the difference in sensitivity to trans-stimulation, the use of 
D-tryptophan makes it possible to distinguish System T from System L. This amino 
acid is an inhibitor of System T, but does not inhibit System L (Rosenberg et al, 
1980). 
On the basis of our results we propose that System T is involved in the uptake 
of PCBD-CYS in LLC-PKi cells. Firstly, in our cis-inhibition experiments 
D-tryptophan induced inhibition of cytotoxicity. In contrast BCH and cycloleucine, 
which are primarily substrates for System L , did not show any inhibitory effect. 
Secondly, histidine also induced strong inhibition of cytotoxicity. Although it has 
been suggested that histidine shares System L and T, the inhibitory action of 
histidine on System L is very weak (Vadgama and Christensen et al, 1985; 
Rosenberg, 1982). Finally, if System L were responsible for the uptake of 
PCBD-CYS, a strong stimulation of toxicity should occur after pre-loading the 
LLC-PKi monolayers with System L substrates. However, neither BCH nor 
cycloleucine showed any stimulation. 
When we compare our results with those of Schaeffer and Stevens (1987a), 
there are some apparent discrepancies. In the trans-stimulation experiments they 
demonstrated an inversely proportional relationship of the ability of S-cysteine 
conjugates to trans-stimulate the uptake and toxicity of DCV-CYS to their 
hydrophobicity (SMC>SEC>SBC). Histidine and BCH also showed a substantial 
trans-stimulation. However in the results presented here, using PCBD-CYS, only 
SBC showed a strong trans-stimulation. Comparing the cis-inhibition experiments 
is only partly possible due to the differences in the protocol. Schaeffer and 
Stevens (1987a) found a strong stimulation of DCV-CYS cytotoxicity due to 
histidine, where they expected an inhibition. They suggested that in their protocol 
trans-stimulatory effects could mask cis-inhibition . Nonetheless a strong 
trans-stimulator as SMC and to a lesser extent BCH, did cause a substantial 
cis-inhibition in the DCV-CYS cytotoxicity. To prevent a possible masking effect 
we shortened the exposure time from 14 to 1 h . However in our experiments BCH 
and SBC were not inhibitory. Neither were they in previous experiments where we 
used a longer exposure period of 16 h (results not shown). Thus, these differences 
between our results and those of Schaeffer and Stevens (1987a) indicate that 
different amino acid transporters are responsible for the uptake of DCV-CYS and 
PCBD-CYS, possibly due to differences in molecular size. 
In the LLC-PKi cell line System T has not yet been described , but other amino 
acid transporters like System A, ASC and L are only or primarily present in the 
basolateral membrane (Rabito and Karish, 1982). This seems to hold for the 
PCBD-CYS transporter also: basolateral exposure of LLC-PKi monolayers to 
PCBD-CYS leads to a higher LDH-release than apical exposure . However the 
trans-stimulated and cis-inhibited uptake was similar at either side. This apparant 
discrepancy is currently under investigation. 
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How impor tant the renal uptake of CYS-conjugates via amino acid 
t r anspo r t e r s in vivo is , remains unclear . Schaef fer and Stevens (1987b), using 
membrane vesicles of ra t kidney cor tex , found a Na + - s t imu la ted apical DCV-CYS 
uptake that was not inhibited by BCH. However Lash and Anders (1989), using 
f reshly isolated ra t renal proximal tubular ce l ls , found a Na * -dependent and a 
Na + - independent DCV-CYS uptake, inhibitable by respect ively probenecid or AIB 
and BCH, suggest ing a DCV-CYS uptake by an organic anion t r anspo r t e r and amino 
acid t r a n s p o r t e r s . Recent resu l ts of Zhang and Stevens (1989) quest ion the role 
of an organic anion t r anspo r te r in the DCV-CYS uptake. They showed in proximal 
tubules an inhibit ion in uptake by probenecid only when using the N - a c e t y l - S - ( 1 , 2 -
d ich lo rov iny l ) -L - cysteine , and not in the uptake of DCV-CYS. Fur ther 
invest igat ions using pr imary cu l tu res might help to solve th is m a t t e r . 
In conclus ion, our resu l ts show a cytotox ic i ty of PCBD-CYS in LLC-PKi 
monolayers , indicate a pre ferent ia l basolateral uptake and suggest involvement of 
an amino acid t r anspo r t e r w i th cha rac te r i s t i cs of System T . 
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CHAPTER 5 
The effect of S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and its derivatives on 
primary cultures of rat renal cortical cells 
Mortens J.J.W.M.. Bruggeman I.M., Spenkelink A., Temmink J.H.M., and 
van Bladeren P.J. 
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The affect of S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and its derivative* on 
primary cultures of rat renal cortical cells 
SUMMARY 
Specific metabolic processes are necessary in the nephrotoxicity of 
several haloalkenes. Although renal uptake of metabolites is a 
prerequisite for their toxicity, l ittle is known about the relative 
importance of organic anion and amino acid transporters in this process. 
Apical exposure of monolayers of rat renal cortical cells during 16 h 
to S-(l,2,3,4,4-pentachlorobutadienyl)glutathione (PCBD-GSHH20 uM), 
S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine (PCBD-CYS) (20 uM), and 
N-acetyl-S-(l,2,3,4,4-pentachlorobutadienyl (PCBD-NAC) (200 uM) 
caused a specific cytotoxicity. This toxicity could be decreased by 
inhibition of the extracellular y-glutamyltranspeptidase (fGT) and/or 
the intracellular pyridoxal phosphate-dependent ß-lyase using 0.3 mM 
acivicin or amlnooxyacetic acid (0.S mM) respectively, indicating the 
essential role of these enzymes. 
Culturing the monolayers on porous substrates enabled exposure of 
cel ls from the basolateral side. The presence of an organic anion and 
cation transporter in those monolayers was demonstrated by a 
probenecid-sensltive para-aminohlppuric acid and a quinine-sensitive 
tetraethylammonlura accumulation. In spite of the accessibility of the 
basolateral membrane, and the presence of the organic anion 
transporter, cytotoxicity of PCBD-CYS and PCBD-NAC could neither be 
inhibited by probenecid (0.S mM) nor by the amino acid transporter 
substrates (10 mM) hlstidine and D-tryptophan. 
These results indicate that the renal cellular uptake of conjugates 
is not the rate-limiting step in the mechanism of toxicity. 
ABBREVIATIONS 
AOAA, aminooxyacetic acid; CYS. cysteine; DCV-CYS, S-(1,2-dichlorovinyl)-L-cysteine; 
DCV-NAC, N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine; EBSS, Ear les Balanced Salt Solution; EDTA, 
ethylenediaminetetraacetic acid; yGT, Y-glutamyltranspeptidase; GSH. glutathione; HBSS, Hanks' 
Balanced Salt Solution; HCBD. hexachlorobutadiene; HEPES, N-2-hydroxyethylpiperazine-N'-2-
ethanesulphonic acid; LDH. lactate dehydrogenase; NAC, N-acetylcysteine; PAH, para-amino-
hippuric acid; PCBD-CYS, S-(1,2.3,4,4-pentachlorobutadienyl)-L-cysteine; PCBD-GSH, 
S-(1,2,3,4,4-pentachlorobutadienyl)glutathione; PCBD-NAC, N-acetyl-S-(1,2.3,4,4-pentachloro-
butadienyl)-L-cysteine; TEA, tetraethylammonium; WE, Williams Medium E . 
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INTRODUCTION 
The nephrotoxicity of halogenated alkenes is a resultant of specific metabolic 
and transport processes in several organs . The f i rst step is a conjugation with 
glutathione (GSH), a detoxification step which sometimes is the initial step in an 
activation route (van Bladeren, 1988). Metabolism by Y_glu t a myl t ranspeptidase 
(YQT) and a dipeptidase results in the formation of a cysteine (CYS)-conjugate 
which can be acetylated to give a N-acetylcysteine (NAC)-conjugate. In the renal 
proximal tubular cell the pyridoxal phosphate-dependent ß-lyase transforms the 
CYS-conjugate, formed either after intracellular deacetylation of the 
NAC-conjugate or extracellular metabolism of the GSH-conjugate, into a reactive 
thiol, leading to cytotoxicity (Anders et al, 1988; Lock, 1988). 
Although several transport systems have been postulated to be responsible 
for the uptake of NAC-, and CYS-conjugates, little is known about the relative 
importance of those transporters for the nephrotoxicity. The transporter of 
NAC-conjugates is probably an organic anion transporter. Probenecid is often 
used as an inhibitor of this organic anion transport. The uptake of 
N-acetyl-S-(1,2,3,4.4-pentachlorobutadienyl)-L-cysteine (PCBD-NAC) in rat renal 
slices was probenecid sensitive (Lock et al, 1986), whereas a probenecid sensitive 
toxicity has only been demonstrated in vivo (Lock and Ishmael, 1985). Other 
NAC-conjugates are apparently transported by the same transporter. The uptake 
of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine (DCV-NAC) was probenecid sensitive 
in rat kidney proximal tubules (Zhang and Stevens, 1989) and in rabbit renal slices. 
The toxic effects of this compound in slices were also probenecid sensitive 
(Wolfgang et al, 1989). In the uptake of CYS-conjugates recent evidence indicates 
the involvement of amino acid transport systems. The toxicity of S-(1.2,3,4,4-
pentachlorobutadienyl)-L-cysteine (PCBD-CYS) (Mertens et al, 1990) and S-(1,2-di-
chlorovinyl)-L-cysteine (DCV-CYS) (Schaeffer and Stevens, 1987a) in LLC-PKi 
monolayers could be inhibited by amino acid transporter substrates. Influence of 
these substrates on the uptake of DCV-CYS has been demonstrated in LLC—PKi 
cells (Schaeffer and Stevens, 1987a), rabbit renal slices (Wolfgang et al, 1989), 
and rat kidney cortex membrane vesicles (Schaeffer and Stevens, 1987b). 
Since LLC-PKi monolayers lack a probenecid sensitive organic anion 
transporter (Mertens et al, 1988; Rabito, 1986) primary cultures of rat renal 
cortical cells have been used in the present study to investigate the toxicity of a 
series of conjugates derived from hexachlorobutadiene (HCBD) and the relative 
importance of various uptake systems for their toxic effects. 
MATERIALS AND METHODS 
Chemicals 
Probenecid was obtained from Sigma (St Louis, MO); acivicin from The Upjohn 
Company (Kalamazoo, Ml); aminooxyacetic acid (AOAA) from Aldrich-Chemie 
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(Steinheim, FRG); D-tryptophan, and quinine from Janssen Chimica (Beerse, 
Belgium); histidine from Merck (Darmstadt, FRG); and para-Cg/ycyM-CHamino-
hippuric acid (PAH) (50 mCi/mmol), and C1-14C]tetraethylammonium (TEA) 
(4.8 mCi/mmol) from New England Nuclear (Boston, MA). 
Synthases 
S-(1,2,3.4,4-pentachlorobutadienyl)-L-glutathione (PCBD-GSH), PCBD-NAC, 
PCBD-CYS were synthesized as described previously (Mertens et al, 1988; 
Mertens et al, 1990). 
Cell isolation and culture 
The renal cortical cells were isolated according to Bruggeman et al (1989) 
with slight modifications. The kidneys were perfused in situ with a Hanks' 
Balanced Salt Solution without Ca 2 + and Mg z* (HBSS) containing 20 mM HEPES 
and 0.8 mM EDTA. After excision of the kidneys the cortex was removed, minced 
into 1-2 mm pieces, and incubated in 0.125% trypsin-0.05% EDTA in HBSS at 
37°C in a gently shaking water bath for 20-30 min . After centrifugation (400 g, 
3 min) the pellet was resuspended in a solution of 12.5 mg coilagenase 
(Clostridium histolyticum; Boehringer, Mannheim, FRG), 0.8 mg DNase (Grade I I ; 
Boehringer, Mannheim), and 31.5 mg CaCI
 2 in 50 ml of HBSS and placed in a 
shaking water bath for 10-30 min. During both incubations , the suspension was 
drawn through a pipette of 10 and 5 ml, respectively at 5-min intervals . After a 
second centrifugation the pellet was resuspended in 80 ml of Williams Medium E 
(WEHFlow Laboratories, Irvine, Scotland), supplemented with 10% fetal calf serum 
(GIBCO, Glasgow, Scotland), penicillin and streptomycin (50 lU/ml and 100 ng/ml 
respectively; Gist Brocades, Delft, The Netherlands ). Cultures were started on 
day 0 by pipetting 0.5 ml of the suspension per well in a 24-well tissue culture 
plate or 2 ml/ insert in a tissue culture transwell plate (3412; Costar, 
Badhoevedorp, The Netherlands). On day 4 the primary cultures were ready for 
use in the experiments (Bruggeman et al, 1989). 
Organic ion transport 
Both organic anion transport and organic cation transport was measured using 
radiolabeled PAH and TEA respectively as model ions . On day 5 the cultures on 
the porous membranes were gently rinsed with Earles Balanced Salt Solution with 
10 mM NaHCO
 3 and 20 mM HEPES, pH7.4 (EBSS). The inserts were transferred 
to a culture plate with 25 uM PAH or TEA (sp. act. 4.8 mCi/mmol) in EBSS with 
or without 0.5 mM probenecid or 0.1 mM quinine, an inhibitor of the organic cation 
transport. At different times the medium in the apical compartment was added to 
the one of the basolateral compartment, and the inserts were rinsed with a cold 
solution (200 mM LiCI, 20 mM Tris, 20 mM HEPES, pH 7.4) . 100 til Samples of 
incubation medium, and the membranes of the inserts were transferred to 
scintillation vials. Before radioactivity was determined the inserts were solubilized 
for 1.5 h with soluene-350 (Packard, Brussels, Belgium) at 55 °C in a shaking 
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water bath. The uptake was expressed as a f i l ter- to-medium ratio (F/M). 
Cytotoxicity assay 
On day 4 cultures were rinsed with EBSS and exposed to the conjugates 
dissolved in EBSS. When acivicin was used the cells were pre-incubated for 15 min 
with this TfGT-inhibitor. A short-time exposure period was followed by an 
overnight incubation in WE before cytotoxicity was determined by measuring 
lactate dehydrogenase (LDH) leakage (Mertens et al, 1988) . Exposure of primary 
cultures on porous substrates was conducted two-sided, apically as well as 
basolaterally. 
RESULTS 
Apical exposure to conjugates 
Primary cultures of rat renal cortical cells were sensitive to all three 
conjugates. After an overnight apical exposure to 20 tiM of PCBD-GSH or 
PCBD-CYS cytotoxicity was evident. Exposure to PCBD-NAC also resulted in cyto-
toxicity, but higher concentrations were necessary to elicit the same effect 
(Fig.5.1). Inhibition of the brushborder enzyme yGT by the irreversible inhibitor 
acivicin (0.3 mM) inhibited the cytotoxicity of PCBD-GSH (Fig.5.2). As expected, 
the cytotoxicity of PCBD-CYS was not affected. Inhibition of the pyridoxal 
phosphate-dependent ß-lyase by the competitive inhibitor AOAA (0.5 mM) inhibited 
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Figure 5.1 Apical exposure of monolayers of rat renal cortical cells 
to PCBD-GSH, PCBD-CYS and PCBD-NAC. Monolayers of rat renal cort ical 
cells in 24-well tissue culture plates were exposed to PCBD-GSH. PCBD-CYS 
or PCBD-NAC dissolved in EBSS. After 16 h LDH-retease was determined. 
Results are the mean (±S.D.) of at least three experiments in t r ip l icate. 
77 -
100 
a 
50 
CONTROL PCBD-GSH 
20 nM 
PCBD-CYS 
20 |^ M 
i , m 
PCBO-NAC 
200 nM 
Figure 5.2 Effect of inhibitors of yGT and ß-lyase on the toxicity after apical 
exposure of primary cultures of rat renal cortical cells to PCBD-GSH, PCBD-CYS, 
and PCBD-NAC. Monolayers of rat renal cort ical cells in 24-well tissue culture 
plates were exposed to PCBD-GSH, PCBD-CYS or PCBD-NAC dissolved in EBSS in 
the absence ( • ) or presence of 0.3 mM acivicin ( ^ ) or 0.5 mM AOAA (DID). After 
16 h LDH-release was determined. Bars represent the mean (± S.D.) of at least 
two experiments in t r ip l icate. 
the cytotoxicity of all three conjugates, but could not completely prevent the 
cytotoxicity of PCBD-NAC. 
Organic anion and cation transport 
The presence of the organic ion transporters was demonstrated by an 
intracellular accumulation of both the radiolabeled PAH and TEA, in monolayers on 
porous supports (Fig.5.3). The accumulation of PAH could be inhibited for 40% 
(after 60 min) by an initial basolateral concentration of 0.5 mM probenecid. 
Quinine (0.1 mM) caused an inhibition of 52% of the TEA fi lter to medium ratio 
(after 60 min). 
Investigating the presence of these organic transporters by measuring 
transcellular transport from the basolateral side to the apical side, as we did 
previously in LLC-PKi monolayers (Mertens et al, 1988), proved to be impossible. 
Comparison in the same experiment of transcellular TEA transport in LLC-PKi 
monolayers and in primary cultures on porous membranes, revealed an apparent 
17-fold higher transcellular TEA transport in the primary culture than in the 
LLC-PKi monolayer within 30 min. Since inhibition with quinine only occurred in the 
LLC-PKi monolayers, transcellular transport in the primary cultures was 
apparently mainly a result of leakage (data not shown). 
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Figure 5.3 Accumulation of PAH and TEA in monolayers of rat renal 
cortical cells on porous membranes. Cultures were incubated basolaterally 
with 25 |»M radiolabeled PAH or TEA (see methods) with (O) or without ( • ) 
inhibitor. Probenecid (0.5 mM) was used as inhibitor of PAH transport and 
quinine (0.1 mM) was used as inhibitor of TEA transport . Each point 
represents the mean (± S.O.) of at least three incubations . Values are 
significantly di f ferent at * p<0.1, * * p<0.05. or * * * p<0.01 (Wilcoxon-Mann-
Whitney). 
Cytotoxicity in the presence of transporter substrates 
PCBD-NAC has been postulated to be transported into the renal proximal 
tubular cell by an organic anion transporter. However, 0.1 mM probenecid resulted 
in an increase of PCBD-NAC toxicity after an overnight apical exposure of primary 
cultures in 24-well tissue culture plates (Fig. 5.4). PCBD-NAC (0.5 mM) toxicity 
after a short exposure (0.5 or 1.0 h) of primary cultures on porous substrates, 
with the accessibility of a basolateral organic anion transporter, could not be 
inhibited by 0.5 mM probenecid (Fig.5.5). This lack of inhibition of toxicity was also 
found for 0.3 mM PCBD-NAC, the lowest concentration with an exposure time of 
1 h that still caused a cytotoxic effect. 
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Figure 5.4 Influence of probenecid on the 
toxicity after apical exposure of monolayers 
of rat renal cortical cells to PCBD-NAC. 
Cultures of rat renal cort ical cells In 24-wel l 
t issue culture plates were exposed apically 
to PC8D-NAC with or without 0.1 mM 
probenecid. After 16 h LDH-release was 
determined. Bars represent the mean 
(± S.D.) of two experiments in t r ip l icate. 
Aster iks indicate statist ically significant 
differences in both experiments tp<0.05, 
Wilcoxon-Mann-Whitney). 
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Figure 5.5 Absence of an effect 
of probenecid on the toxicity after 
simultaneous apical and basolateral 
exposure of monolayers of rat renal 
cortical cells to PCBD-NAC. Cultures 
of rat renal cort ical cells on porous 
substrates were simultaneously 
exposed f rom apical and basolateral 
sides with or without 0.5 mM 
probenecid during 0.5 or 1.0 h. Af ter a 
subsequent Incubation without the 
conjugate in W E , LDH-release was 
determined. Bars represent the mean 
( iS.D.) of at least four Incubations. 
Exposure of monolayers on porous supports during 1 h to PCBD-CYS resulted 
in a cytotoxicity (46% LDH-leakage) at a concentration of 25 (iM already. Neither 
probenecid (0.5 mM) nor the amino acid transporter substrates (10 mM) histidine 
and D-tryptophan caused any inhibition of cytotoxicity (data not shown). 
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DISCUSSION 
Nephrotoxicity of PCBD-GSH and its derivatives is the resultant of a complex 
metabolic pathway and several transport processes. The primary cultures in the 
present study, obtained by a rapid and simple isolation and culture procedure of 
rat renal cortical cells (Bruggeman et al, 1989), have a sufficient level of the 
essential enzymes and uptake systems to elicit a specific cytotoxicity of these 
conjugates. The presence and involvement of yOU and ß-lyase could be 
demonstrated by a decrease in cytotoxicity after the inhibition of these enzymes. 
A transport system generally accepted to be of importance in the 
nephrotoxicity of HCBD is a basolateral probenecid-sensitive transporter, 
presumably an organic anion transporter. Lock and co-workers (Lock and Ismael, 
1985; Lock et al, 1986) demonstrated inhibition of nephrotoxicity and accumulation 
of PCBD-NAC in cortical slices by the organic anion probenecid. The presence of 
both organic anion (PAH) and cation (TEA ) transporters in the primary cultures 
used in the present study, could be demonstrated by measuring intracellular 
accumulation of the radiolabel, inhibited by probenecid and quinine respectively. In 
studies with LLC-PKi monolayers , involvement of amino acid transport systems in 
cytotoxicity of haloalkene cysteine conjugates could be demonstrated using 
cytotoxicity as a parameter (Schaeffer and Stevens, 1987a; Mertens et al, 1990). 
However, in the present study, cytotoxicity due to a two-sided (apical and 
basolateral) exposure of monolayers to PCBD-CYS and PCBD-NAC could not be 
inhibited by transporter substrates . The reasons for this may be manifold. In 
contrast to LLC-PKi monolayers, metabolism instead of cellular uptake may well 
be the rate-limiting step in the toxicity of PCBD-NAC and PCBD-CYS in these 
primary cultures. In addition, the total amount of conjugate metabolized by ß-lyase 
may be influenced by apical carrier-mediated diffusion of conjugates out of the 
cell during and after the exposure period. The balance between acetylation and 
deacetylation seems to be of prime importance for toxic ef fects. 
N-acetyl-S-tetrafluoroethyl-L-cysteine and N-acetyl-S-(2-chloro-
1,1,2-trifluoroethyl)-L-cysteine were deacetylated to a larger extent and thus 
more cytotoxic than N-acetyl-S-(1,1,-difluoro-2,2-dichloroethyl)-L-cysteine and 
N-acetyl-S-(1,1.-difluoro-2,2-dibromoethyl)-L-cysteine in freshly isolated rat 
renal proximal tubular cells (Boogaard et al, 1989). Zhang and Stevens (1989) 
observed in isolated rat renal proximal tubules that after 20 min still 40% of the 
DCV-NAC taken up was present intracellularly. Studies with the isolated perfused 
rat kidney revealed an excretion of PCBD-NAC after perfusion with PCBD-CYS, 
demonstrating that not all PCBD-CYS is metabolized by ß-lyase, but also is 
acetylated into PCBD-NAC and transported ex.tracellularly (Schrenk et al, 1988). 
Exposure of rat kidney proximal tubules to radiolabeled DCV-CYS resulted in 
covalently bound fragments to cellular molecules, and in freely soluble label. Of 
the latter about 27% was present as DCV-NAC after 5 min (Zhang and Stevens, 
1989). Also in freshly isolated rat renal proximal tubular cells S-(1,1-dichloro-2,2-
difluoroethyl)-L-cysteine and S-(1,1-difluoro-2,2-dibromoethyl)-L-cysteine were 
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partly acetylated into the corresponding mercapturates (Boogaard et al, 1989). 
Thus a short period of time of partly inhibited uptake of PCBD-NAC or PCBD-CYS 
does not necessarily lead to a decreased cytotoxicity. 
Several authors have reported a decreased in vitro toxicity caused by 
probenecid (Boogaard et al, 1989; Lash and Anders, 1986; Wolfgang et al, 1989). 
Although probenecid is commonly used as an inhibitor of organic anion transport, 
it is a rather unspecific inhibitor and has also been demonstrated to influence 
metabolism. It has been reported to inhibit glycine conjugation of p-aminobenzoic 
acid and ^-aminosalicylate (Beyer et al, 1950), acetylation of sulfanilamide and 
choline (Kuriaki and Marumo, 1959), and protein synthesis (Wack et al, 1982). 
Probenecid itself can also be metabolized; it can be oxidized and glucuronidated. 
When rats were dosed with probenecid, only less than 1% of the excreted amount 
in the urine was unchanged parent compound (Emanuelsson and Paalzow, 1989). 
Thus the reported probenecid sensitivity of toxicity could well be caused by an 
influence on metabolism. In the present experiments in fact an increase in toxicity 
after an overnight exposure to PCBD-NAC in the presence of probenecid was 
observed, illustrating the variability in the effects of this compound. The in vivo 
inhibition by probenecid of the nephrotoxicity of HCBD, PCBD-GSH. PCBD-CYS, 
and PCBD-NAC (Lock and Ishmael, 1985) might well be a result of a combination 
of effects on hepatic metabolism, hepatic transport systems, renal transport 
systems, and renal metabolism. 
In conclusion, the present study demonstrates the presence of the essential 
enzymes and uptake systems in primary cultures of rat renal cortical cells for a 
specific toxicity of PCBD-GSH and its derivatives. The absence of an inhibition of 
toxicity by transporter substrates indicates that the rate-limiting step in the 
mechanism is not the uptake, but may lie thereafter in the metabolism. Further 
studies will be necessary to identify this rate-limiting step and to investigate the 
exact effect of probenecid. 
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Inhibition of Y-glutamyltranspeptidase potentiates the nephrotoxicity of glutathione 
conjugated chlorohydroquinones 
SUMMARY 
Administration of either 2,S-dichloro-3-(glutathion-S-yl)-l ,4-benzo-
quinone (DC-(GSyl)BQ) or 2,5,6-trichloro-3-(glutathlon-S-yl)-l ,4-benzo-
qulnone (TC-(GSyl)BQ) to male Sprague-Dawley rats caused dose 
dependant (50-200 (imol/kg; i.v.) renal proximal tubular necrosis as 
evidenced by elevations in blood urea nitrogen (BUN), urinary lactate 
dehydrogenase (LDH) , Y~glutamyltranspeptidase (fGT) and glucose 
values as well as histological alterations. Administration of the 
corresponding hydroquinone conjugates (DC-(GSyl)HQ and 
TC-(GSyl)HQ), prepared by reducing the quinones with a threefold 
molar excess of ascorbic acid, resulted in a substantial increase in 
nephrotoxicity. Surprisingly, and in contrast to other glutathione (GSH) 
conjugated hydroquinones (Monks et al, 1988b, Lau et al, 1988a ) , the 
nephrotoxicity of both DC-(GSyl)HQ and TC-(GSyl)HQ was potentiated 
when rats were pretreated with acivicin, an irreversible inhibitor of -fGl. 
Neither qulnone-GSH nor hydroquinone-GSH conjugates caused any 
effect on liver histology or serum glutamate-pyruvate transaminase 
levels . 
The results suggest that coadministration of ascorbic acid with 
DC-(GSyl)BQ or TC-(GSyl)BQ decreases their interactions with 
extra-renal nucleophiles Including plasma proteins, and thus increases 
the concentration of the conjugates delivered to the kidney, and hence 
toxicity. Furthermore the ability of fGT inhibition to potentiate the 
nephrotoxicity of DC-(GSyl)HQ and TC-(GSyl)HQ suggests that 
different renal transport mechanisms may be Involved in the proximal 
tubular accumulation of GSH conjugated hydroquinones, and/or that 
metabolism by ?GT can constitute a detoxication reaction for some of 
these conjugates. 
A B B R E V I A T I O N S 
BUN, blood urea nitrogen; 2 -Br -HQ. 2-bromohydroquinone; 2-Br-(diGSyl)HQ. 2-bromo-(d i -
glutathion-S-yl)hydroquinone; 2-Br-(GSyl)HQ, 2-bromo-(glutathion-S-yl)hydroquinone; DCBQ, 
2.5-dichloro-1,4-benzoquinone; DC-(GSyl)BQ, 2,5-dichloro-3-(glutathion-S-yl)-1.4-benzoquinone; 
DC-(GSyl)HQ. 2,5-dichloro-3-(glutathion-S-yl)-1.4-hydroquinone; DMSO, dimethyl sulfoxide; Y G T . 
•j—glutamyltranspeptidase; GSH, glutathione; HPLC, high performance liquid chromatography; IM, 
inner medulla; i.p., intraperi toneal; i.V.. intravenous; LDH. lactate dehydrogenase; OSOM, outer 
str ipe of the outer medulla; PBS. phosphate buffered saline; SGPT, serum glutamate pyruvate 
transaminase; TC-(GSyl)BQ, 2.5,6-t r ichloro-3-(glutathion-S-yl) -1,4-benzoquinone; TC-(GSyl)HQ, 
2.5,6-t r ichloro-3-(glutathion-S-yl) -1,4-hydroquinone; TeCBQ, tetrachloro-1,4-benzoquinone; 
(triGSyl)HQ, 2,3,5-(tr iglutathion-S-yl)hydroquinone. 
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INTRODUCTION 
Several halogenated benzenes have been reported to cause nephrotoxicity 
(Reid, 1973; Chu et al, 1983). The mechanism underlying this effect has only been 
investigated in detail for bromobenzene: o-Bromophenol, a major metabolite of 
bromobenzene in rats, caused a more severe necrosis of the proximal tubule than 
bromobenzene itself (Lau et al, 1984a). The data suggested that o-bromophenol, 
or a metabolite thereof, was formed in the liver and subsequently transported to 
the kidney. 2-Bromohydroquinone (2-Br-HQ) was subsequently identified as a 
major in vivo and in vitro metabolite of o-bromophenol which could reproduce the 
renal proximal tubular necrosis caused by both bromobenzene and o-bromophenol 
(Lau et al, 1984b). However, the dose of 2-Br-HQ (0.80 mmol/kg; i.p.) required to 
cause toxicity was less than 10% of that required by bromobenzene. Further 
studies revealed the in vitro (Monks et al, 1985) and in vivo (Lau and Monks, 1990) 
formation of several mono- and di-substituted glutathione (GSH) conjugates of 
bromohydroquinone and that 2-Br-(diglutathion-S-yl)HQ (2-Br-(diGSyl)HQ) was a 
very potent nephrotoxicant . The corresponding mono-substituted GSH conjugates 
were considerably less toxic than the di-substituted analog. (Monks et al, 1985, 
1988a). A similar correlation between toxicity and extent of GSH substitution was 
also found for GSH conjugated hydroquinones which lacked a halogen atom 
(Lau et al, 1988a). 
GSH conjugation, as a rule a detoxication pathway, is for several classes of 
compounds an activation route (van Bladeren, 1988). GSH conjugation of 
haloalkenes results, after subsequent extracellular metabolism by y-glutamyl-
transpeptidase (fGT) and a dipeptidase , in the formation of cysteine conjugates . 
Intracellular^ these are converted by cysteine conjugate ß-lyase into a reactive 
thiol, which can rearrange to form a thioacylating intermediate such as a 
thioketene and/or a thionoacyl halide (Dekant et al, 1987, 1988; Commandeur et al, 
1989). The covalent binding of these intermediates to cellular macromolecules 
probably leads to nephrotoxicity (Anders et al, 1988; Lock , 1988). The f irst step in 
this activation pathway, the metabolism by yGT, also appears to be of importance 
in the nephrotoxicity of GSH conjugated hydroquinones, since inhibition of fGT 
with acivicin (L-(otS,5S)-ot-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, 
AT-125) protected rats from both 2-Br-di(GSyl)HQ (Monks et al, 1988a) and 
2,3,5-(triglutathion-S-yl)hydroquinone ((triGSyl)HQ) (Lau et al, 1988a) mediated 
nephrotoxicity. 
At present, no chlorinated GSH conjugated benzo- or hydroquinones have been 
studied. In the present study we therefore investigated the toxicity of 
2,5-dichloro-3-(glutathion-S-yl)benzoquinone (DC-(GSyl)BQ) , 2,5,6-tr ichloro-3-
(glutathion-S-yl)benzoquinone (TC-(GSyl)BQ) and the corresponding hydroquinones. 
The results show a selective nephrotoxicity which , surprisingly, was potentiated 
by the acivicin mediated inhibition of yGT. 
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MATERIALS AND METHODS 
Chemicals 
GSH was obtained from Janssen (Beerse, Belgium). 2,5-Dichloro-1,4-benzo-
quinone (DCBQ) was purchased from Kodak (Rochester, NY, USA) and 
2,3,5,6-tetrachloro-1,4-benzoquinone (TeCBQ) from Merck-Schuchardt 
(Hohenbrunn, FRG). Acivicin was a gift from the National Cancer Institute. All 
other chemicals were of the highest grade commercially available. 
Synthesis of GSH conjugates 
Quinone GSH conjugates were synthesized according to van Ommen et al 
(1988) with slight modifications. To a solution of 1.2 mmol TeCBQ in 0.4 I of 
methanol, a solution of 0.12 mmol GSH in 12 ml of destilled water was added 
dropwise with constant st irr ing. The reaction mixture was evaporated in vacuo, 
the residue was collected in water and ethyl acetate, and the aqueous phase was 
extracted repeatedly with ethyl acetate. After evaporating the remaining ethyl 
acetate, the aqueous phase was frozen in dry ice/acetone and lyophilized. Minor 
impurities appeared to be more water soluble than the major product. They were 
removed by washing the product with water. After centrifugation the supernatant 
was discarded and the remaining pellet was frozen and lyophilized. Purity of the 
product dissolved in DMSO exceeded 95% as determined by high performance 
liquid chromatography (HPLC ) (Shimadzu LC-6A ) using a Whatman ODS-3 
reversed phase analytical column and a linear gradient of methanol/1 % acetic acid 
in distilled water (10:90 to 100:0) at a flow rate of 1 ml/min, over 60 min and 
monitored at 254 nm. The retention time of the product was 26.4 min.The 
UV-spectrum (200-600 nm) (Shimadzu UV-160) of the compound dissolved in 
distilled water showed five maxima at 472; 321; 287; 248 and 204 nm. Field 
desorption mass spectrometry on a MS 902 equipped with a VG-ZAB console 
showed a signal (m/e 518 (M + +3)) at emitter current 26-30 mA (only 3 5 Cl-peak 
is given), which is in agreement with the protonated 2,5.6-trichloro-1,4-benzo-
quinone GSH conjugate. 
The 2,5,6-trichloro-3-(glutathion-S-yl)hydroquinone (TC-(GSyl)HQ) was 
prepared by reducing TC-(GSyl)BQ , dissolved in dimethyl sulfoxide (DMSO), using 
a threefold molar excess of ascorbic acid , dissolved in phosphate buffered saline 
(PBS) , immediately prior to administration to rats. The extent of reduction was 
determined by HPLC . Authentic TC-(GSyl)BQ had a retention time of 26.4 min 
which completely disappeared upon addition of ascorbic acid with the concomitant 
appearance of a new peak with a retention time of 25.0 min . 
Synthesis of the DC-(GSyl)BQ was essentially the same as described above. 
A GSH solution in distilled water (0.34 mmol in 12 ml) was added dropwise to a 
solution of 3.4 mmol DCBQ in 0.4 I of methanol. After extraction with ethyl 
acetate the aqueous phase was frozen in dry ice/acetone and lyophilized. The 
purity of the product, dissolved in water, exceeded 95 % as determined by HPLC 
under the conditions as described above. The retention time of the product was 
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22.4 min. The UV-spectrum revealed maxima at 465; 278; 248 and 204 nm. Field 
desorption mass spectrometry showed a signal (m/e 484(M + +3)) at emitter 
current 28-32 mA, corresponding to the protonated form of DC-(GSyl)BQ. 
The dichlorohydroquinone glutathione conjugate (DC-(GSyl)HQ) was prepared 
by dissolving DC-(GSyl)BQ with a threefold molar excess of ascorbic acid in PBS 
immediately prior to administration to rats. The HPLC peak at retention time 
22.4 min which corresponded to authentic DC-(GSyl)BQ, completely disappeared 
with the concomitant appearance of a new peak at 21.8 min. The UV spectrum of 
this product was also consistent with the conversion of a quinone to a 
hydroquinone. 
Determination of oxidation potentials 
DC-(GSyl)BQ and TC-(GSyl)BQ (0.5 mM) were dissolved in a mixture of 
DMSO: methanol (1:9; v:v) and diluted to a concentration of 5 tiM with the HPLC 
mobile phase (see below). Oxidation potentials were determined by HPLC 
(Shimadzu LC-6A) with electrochemical (coulometric respons) detection 
(ESA Coulochem Model 5100A). The detector was equipped with two porous 
graphite test electrodes in series. An aliquot of each sample (10 | i l ; 50 pmol) was 
injected onto a Partisil 5 ODS-3 reversed phase analytical column (Whatman) and 
eluted with a mixture of 60% citric acid (12.5 mM)/ ammonium acetate (25 mM) 
and 40% methanol (pH 4.0) containing 20 mg/L EDTA, at a flow rate of 1 ml/min. 
A potential of -0.6 volts was applied to the f irst test electrode to effect reduction 
of the injected quinones. The applied potential at the second test electrode was 
varied from -0.2 to +0.3 volts. Peak areas were measured at each potential and 
expressed as a % of the maximum response obtained. 
Animals 
Male Sprague-Dawley rats (Harlan Sprague-Dawley, Houston, TX; 115-140 g) 
were used for all experiments and were allowed food and water ad libitum. 
Toxicity studies 
Each rat received a freshly prepared solution of the GSH-benzoquinones 
dissolved in DMSO. DC-(GSyl)HQ and TC-(GSyl)HQ were dissolved in PBS and 
DMSO/PBS (1/1) respectively. Conjugates (100 (il/100 g) were injected 
intravenously (i.v.) in the tai l . 
Inhibition of yGT was achieved by an intraperitoneal (i.p.) injection of acivicin 
in PBS (10 mg/kg; 200 (il/100 g) one hour before the i.v. injection with the 
conjugates (Monks et al, 1988a). Rats were housed in metabolism cages and urine 
was collected and kept in the dark at 4°C individual. After 19 h the volume of the 
urine was determined and urine was filtered using PD-10 columns (Sephadex, 
G25M, Pharmacia). A sample of 2.5 ml of urine was brought on the column and 
eluted with 3.5 ml of saline. The filtered urine was used for determination of 
lactate dehydrogenase (LDH) activity by measuring the decrease in NADH 
(0.23 mM) at 340 nm in the presence of pyruvate (0.6 mM). Urinary glucose and 
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•fGT-activity were determined with Sigma Kit Glucose 15-UV, and a Sigma Kit 545, 
respectively. By orbital puncture 400 nl of blood were collected. Blood urea 
nitrogen (BUN) was measured with Sigma Kit 535A . Liver damage was assessed 
by measuring serum glutamate pyruvate transaminase (SGPT) in plasma according 
to Sigma Kit 505. Rats were euthanized by cervical dislocation, liver and kidneys 
were removed, and thin slices were placed in phosphate buffered formalin. 
Sections for histological study of liver and kidney were made and stained with 
eosin and hematoxylin . 
Statistical analysis 
All data are expressed as the mean ± standard error. Significance in 
differences was determined by the Wilcoxon-Mann-Whitney test. 
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Figure 6.1 Dose-dependent nephrotoxicity of TC-(GSyl)BQ in male 
Sprague-Dawley rats. Rats were injected (100 t i l /100 g) i.v. with 
TC-(GSyl)BQ dissolved in DMSO. Control animals received only DMSO. 
Data of BUN and urinary Y<3T, LDH, and glucose are given as the 
average ± S.E. (n=2-13). Values are significantly di f ferent from control 
values at : * p<0.025 or * * p<0.005. Values marked b are significantly 
dif ferent f rom those marked a at p<0.005 (Wilcoxon-Mann-Whitney). 
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RESULTS 
Nephrotoxicity of DC-(GSyl)BQ and TC-(GSyl)BQ 
Administration of either DC-(GSyl)BQ or TC-(GSyl)BQ to male 
Sprague-Dawley rats caused a dose-dependant increase in BUN concentrations 
and increases in the urinary excretion of yGT, LDH and glucose (Figs. 6.1 and 6.2). 
Of the two conjugates studied, TC-(GSyl)BQ appeared to be more toxic than 
DC-(GSyl)BQ since the former caused enzymuria and glucosuria at a dose of 
100 nmol/kg, whereas doses of 150-200 nmol/kg were required to cause similar 
increases in these parameters by DC-(GSyl)BQ (p<0.1). 
Histological examination of kidney slices from TO(GSyl)BQ and DC-(GSyl)BQ 
treated animals also support the contention that the former conjugate is the more 
potent nephrotoxicant. For example, animals treated with either 50 or 100 (imol/kg 
DC-(GSyl)BQ showed little evidence of injury. Injury at these doses was limited to 
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Figure 6.2 Dose-dependent nephrotoxicity of DC-(GSyl)8Q in male Sprague-Dawley 
rats. Rats were injected (100 nl/100 g) i.v. with DC-(GSyl)BQ dissolved in DMSO. 
Control animals received only DMSO. Data of BUN and urinary yGT, LDH. and glucose 
are given as the average ± S.E. (n=4-8). Values are significantly different from control 
values at: * p<0.025 or ** p<0.005. Values are significantly different from those 
marked a at: b p<0.1; c p<0.025 or <* p<0.005 (Wilcoxon-Mann- Whitney). 
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individual cell death and necrosis, apparant as eosinophilic cells with pyknotic 
nuclei, scattered throughout the outer stripe of the outer medulla (OSOM) 
(Figs. 6.3 and 6.4). In contrast, animals treated with 100 (xmol/kg TC-(GSyl)BQ 
Figure 6.3 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
100 (imol/kg DC-(GSyl)BQ. Tubular injury is limited to single cell death and necrosis, as indicated 
by the dark staining (eosinophilic) cells with pyknotic nuclei, throughout the OSOM (arrowheads). 
Paraffin section stained with hematoxylin and eosin (x72). 
94 -
displayed injury ranging f r o m focal necros is at the junct ion of the cor t i ca l S 3 
(S 3 C) and the medullary S 3 (S 3 M) segment at the base of the medullary rays 
(MR), to more extensive injury forming a r im of necrosis at the junct ion of the 
cor tex and the OSOM (Fig. 6 .5 ) . Single cell death and necrosis was also evident 
throughout the OSOM. Sublethally injured cells of the S 3 segment appeared highly 
ves icu lated. At 150 ( imo l /kg DC-(GSyl)BQ proximal tubular injury was l imited to 
the S 3 M segment . The injury ranged f rom individual cell death and necros is 
involving the proximal por t ion of the S 3 M at the top of the OSOM, to a somewhat 
more severe injury which included focal tubular necrosis at the junct ion of S 3 C 
and S 3 M at the base of the MR. At 200 j imo l / kg DC-(GSyl)BQ, individual cell 
death and necros is progressed to involve much of the OSOM, wi th small foc i of 
tubular necrosis evident at the junct ion of the S 3 C and S 3 M at the base of the 
MR (Fig. 6 .6 ) . Sublethally injured cel ls in the OSOM showed evidence of cytosol ic 
ves icu lat ion. Treatment of the animals wi th 200 nmo l / kg TC-(GSyl)BQ caused a 
to ta l loss of the OSOM wi th involvement of the lower por t ion of the MR 
Figure 6.4- Higher magnification of the OSOM following the administration of 100 |imol/kg 
DC-(GSyl)BQ.Showing evidence of single cell death and necrosis affecting cells of the proximal 
tubule (arrowheads). Paraff in section stained with hematoxylin and eosin (x184). 
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Figure 6.7 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
200 umol/kg TC-(GSyl)BQ. Widespread proximal tubular necrosis is evident throughout the S
 3 M 
segment in the OSOM («). Paraff in section stained with hematoxylin and eosin (x64). 
Figure 6.5 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
100 umol/kg TC-(GSyl)BQ. Proximal tubular necrosis can be observed involving the S
 3 segment 
at the junction of the medullary ray and the OSOM (*). Paraffin section stained with hematoxylin 
and eosin (x64). 
Figure 6.6 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
200 umol/kg DC-(GSyl)BQ. Necrosis is apparent primarily affecting the S
 3 segment of the 
proximal tubule at the junction of the medullary ray and the OSOM (»). Paraffin section stained 
with hematoxylin and eosin (x64). 
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(S 3 C segmentMFig. 6 .7) . The cor t i ca l proximal tubules (S , and S
 2 ) and lower 
nephron segments appeared unaf fected in both DC-(GSyl)BQ and TC-(GSyl)BQ 
t rea ted r a t s . The morphology observed in all DMSO t rea ted cont ro l animals was 
Figure 6.8 Normal histology of the renal cortex (C) and OSOM (O) from a control animal. Paraffin 
section stained with hematoxylin and eosin (x64). 
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normal fo r immersion f ixed ra t kidney (Fig. 6 .8 ) . Thus based upon both biochemical 
and histological c r i t e r i a , TC-(GSyl )BQ is a more potent nephrotox icant than 
DC-(GSyl )BQ. 
Effects of ascorbic acid on DC-(GSyl)BQ and TC-(GSyl)BQ-mediated 
nephrotoxicity 
Coadmin is t ra t ion of ascorbic acid wi th ei ther DC-(GSyl)BQ (200 (xmol/kg) or 
TC-(GSyl)BQ (100 and 200 nmo l / kg ) clearly potent ia ted the nephrotox ic i ty of both 
compounds. Thus when the conjugates were adminis tered in the reduced , 
hydroquinone f o r m , BUN concent ra t ions were more than double those observed in 
animals t rea ted wi th the quinone-GSH conjugates (Figs. 6.9 and 6 .10) . This 
protoco l also ampl i f ied the ur inary excre t ion of glucose (DC-(GSy l )HQ, 
200 [ i m o l / k g , ; Fig. 6 . 9 ) . However, w i th TC- (GSy l )HQ, ur inary glucose excre t ion 
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Figure 6.9 The effect of ascorbic acid and acivicin on the nephrotoxicity of 
DC-(GSyl)BQ. Male Sprague-Dawley rats were injected I.p. with acivicin In 
PBS (10 mg /kg ; 200 t i l /100 g) 1 h prior to DC-(GSyl)BQ dosing. DC-(QSyl)BQ 
(200 umol/kg) was injected i.v. either alone ( • ) or after reduction with 
ascorbic acid (0.6 mmol/kg) (E53). Control animals received DMSO O ) or 
acivicin and ascorbic acid dissolved in PBS (ES). Further experimental groups 
received DC-(GSyl)BQ plus acivicin ( • ) or plus a combination of acivicin and 
ascorbic acid (KB). Data of BUN and urinary glucose, fGT, and LDH are given 
as the average ± S.E. (n=3-8) . Values are significantly di f ferent when 
compared to rats which received DC-(GSyl)BQ alone at: * p<0.1, * * p<0.05 or 
* * * p<0.025. Values are significantly di f ferent f rom a at : b p<0.1 or c 
p<0.025 (Wilcoxon-Mann-Whltney). 
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was equal (100 [xmol/kg) or even lower (200 ( imo l / kg ) than in the quinone t rea ted 
animals, which probably re f lec ts a decrease in g lomerular f i l t ra t ion ra tes 
concomitant w i th the severe tox ic i ty . As noted in previous studies (Lau and Monks, 
1990) the ur inary excre t ion of yQT appears to be the most sensit ive indicator of 
proximal tubular necrosis caused by qu ino l /qu inone- th ioe thers . Thus the ur inary 
excre t ion of yGT was not increased by coadmin is t ra t ion of the quinone conjugates 
wi th ascorbic acid (Figs. 6.9 and 6.10) . This is probably because the doses of 
DC-(GSyl)HQ and TC-(GSyl)HQ used in this study cause a maximal excre t ion of 
this brush border enzyme into ur ine. Indeed, when TC-(GSy l )HQ, at a dose of 
200 (xmol /kg, was admin is te red , the appearance of yGT in urine actually 
decreased. This occur red despite the severe necrosis observed histological ly 
(see below). The decrease in yGT act iv i ty may be a consequence of the abil i ty of 
qu inone- th ioethers to apparently inhibit this enzyme (Hill et a l , 1990). 
Admin is t ra t ion of DC-(GSyl)HQ and TC-(GSylHQ did also cause s ta t is t ica l ly 
s igni f icant potent ia t ion of the ur inary excre t ion of LDH (Figs. 6.9 and 6 .10) . 
Histological examinat ion of kidney sl ices f r om animals coadminis tered 
ascorb ic acid conf i rmed the potent iat ing e f f ec t s of this p ro toco l . In DC-(GSyl)HQ 
(200 ( imol /kg) and TC-(GSyl)HQ (100 ( imol /kg) t rea ted animals extensive proximal 
tubular cell necros is was observed, involving all of the OSOM and the MR 
(Figs. 6.11 and 6 . 1 3 ) . Tubular necrosis was also found to involve the cor t i ca l 
proximal tubules. This injury appeared to pr imar i ly involve the S 2 segment in that 
all of the neck segments (S-|) were normal (DC-(GSyl)HQ (Fig. 6.12), 
TC- (GSy l )HQ)(F ig . 6.14) or at worse sublethally (TC-(GSyl)HQ) i n ju red . Tubular 
casts were observed in the cor tex and IM. At 200 v imol /kg TC-(GSy l )HQ, the 
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Figure 6.10 The effect of ascorbic acid and acivicin on the nephrotoxicity of TC-(GSyl)BQ. Male 
Sprague-Dawley rats were injected i.p. with acivicin in PBS (10 mg /kg ; 200 (i l/100 g) 1 h prior to 
TC-(GSyl)BQ dosing. TC-(GSyl)BQ was injected i.v. either alone ( • ) or after reduction with 
ascorbic acid (0.6 mmol/kg) (E53). Animals which received TC-(QSyl)BQ in combination with 
ascorbic acid and acivicin are indicated as E89.Data of BUN and urinary glucose, Y G T , and LDH are 
given as the average ± S.E. (n=2-13). Values are significantly di f ferent when compared to rats 
which received TC-(GSyl)BQ alone at: * p<0.1, * * p<0.05 , * * * p<0.025 or * * * * p<0.005. Values 
are significantly di f ferent f rom a at : b p<0.1 (Wilcoxon-Mann-Whitney). 
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extensive necrosis involved nearly the entire proximal tubule. Large casts and 
cystic spaces were observed in the cortex. The tubular casts containing necrotic 
debris were found to extend down into the IM. The lower nephron segments still 
Figure 6.11 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
200 umol/kg DC-(GSyl)BQ after reduction with 600 umol/kg ascorbic acid. Widespread necrosis 
involving the proximal tubule throughout the cortex and the OSOM. Hyaline casts, frequently 
containing calcified debris, are evident (arrowheads). Cells of the lower uriniferous tubule 
(including ascending thick l imb, distal tubule and collecting duct) appear unaffected. Paraffin 
section stained with hematoxylin and eosin (x64) . 
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appeared unaffected. 
Figure 6.12 Higher magnification of the renal cortex following the administration of 200(imol/kg 
DC-(GSy!)BQ after reduction with 600 umol/kg ascorbic acid. Note the necrotic proximal tubules 
surrounding the glomeruli (G). The cort ical injury appears to primarily af fect the cells of the S
 2 
segment; all of the neck (S , ) segments (arrowhead) appear normal. Hyaline casts containing 
calcif ied debris are also present («). Paraffin section stained with hematoxylin and eosin (x180). 
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Figure 6.13 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
100 (imol/kg TC-(GSyl)BQ after reduction with 300 umol/kg ascorbic acid. Proximal tubular 
necrosis is evident involving the S
 3 segment throughout the OSOM and medullary ray. Many of the 
cort ical tubules surrounding the glomeruli are also af fected. Hyaline casts (arrowheads) are also 
evident in this animal. Paraffin section stained with hematoxylin and eosin (x64). 
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Figure 6.14 Higher magnification of the renal cortex following the administration of 100 (imol/kg 
TC-(GSyl)BQ after reduction with 300 umol/kg ascorbic acid. Many of the proximal tubules 
around the glomeruli (G) are necrotic (»). The cortical injury appears to primarily affect the cells 
of the S 2 segment; all of the neck (S ^ ) segments (arrowhead) appear normal. Paraffin section 
stained with hematoxylin and eosin (x180). 
Effects of acivicin on DC-(GSyl)BQ and TC-(GSyl)BQ-mediated nephrotoxicity 
Urinary glucose excretion was greater in animals pretreated with acivicin, an 
irreversible inhibitor of yGT, prior to DC-(GSyl)BQ (200 timol/kg) administration 
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than in animals treated with DC-(GSyl)BQ alone (Fig. 6.9 ). BUN concentrations 
and urinary LDH values were unaffected and yGT could not be measured due to 
inhibition by acivicin. Interestingly, the pattern of injury seen in these animals was 
different to that seen in animals treated with DC-(GSyl)BQ alone. Tubular necrosis 
with calcification was observed, involving the terminal portion of the S 3 M 
segment at the junction of the OSOM and the inner stripe of the outer medulla. 
The more proximal S 3 M and S 3 C segment in the MR appeared less severely 
injured, with individual cell necrosis and cytosolic vesiculation in the sublethally 
injured cells. Some casts were evident in the cortex, although the cortical 
proximal tubule cells appeared to be unaffected. The cells of the lower nephron 
remained unaffected. Thus, acivicin pretreatment clearly did not protect these 
animals from DC-(GSyl)BQ mediated nephrotoxicity. 
Pretreatment of DC-(GSyl)BQ/ascorbate treated animals with acivicin actually 
potentiated the nephrotoxicity of the reduced conjugate, as evidenced by further 
increases in BUN concentrations (Fig. 6.9) and by macroscopic and histological 
examination of kidney slices. In addition, the decrease in glucose excretion 
previously observed with severely toxic doses of TC-(GSyl)HQ, was now seen in 
DC-(GSyl)HQ treated animals (Fig. 6.9). Histological examination revealed an 
extensive proximal tubule cell injury, similar to that described for the 
DC-(GSyl)HQ treated group. Moreover, calcification of necrotic tubule cells and 
cast material was widespread. Even the S 1 segment showed severe injury with 
massive cytosolic vesiculation. Perhaps surprisingly, the lower nephron segments 
still appeared unaffected. There was clearly no evidence for protection from 
DC-(GSyl)HQ mediated nephrotoxicity with acivicin , rather, acivicin treated 
animals displayed a greater degree of overall injury. 
Pretreatment of TC-(GSyl)HQ treated animals with acivicin resulted in higher 
BUN concentrations than in either TC-(GSyl)BQ or TC-(GSyl)HQ treated animals 
without acivicin, at both the 100 (imol/kg and 200 u.mol/kg dose levels (Fig.6.10). 
Moreover, at the higher dose, the glucosuria induced by TC-(GSyl)HQ was further 
reduced by pretreatment with acivicin. The effects of acivicin on TC-(GSyl)HQ 
induced urinary excretion of LDH were equivocal. At 100 nmol/kg TC-(GSyl)HQ, the 
injury ranged from involvement of the proximal tubule in the OSOM and MR (S 3 M 
and S 3 C), with no apparent involvement of the cortical tubules, to more extensive 
injury including focal to extensive necrosis of the cortex. The pattern of injury 
seen at 200 u.mol/kg TC-(GSyl)HQ was similar in animals with or without acivicin 
pretreatment (Fig. 6.15). Injury appears maximal at this dose. Again, therefore, 
there was no evidence for protection with acivicin. Conversely, the increases in 
BUN and decrease in urinary glucose, and the pathological observations at 
100 u.mol/kg TC-(GSyl)HQ, are indicative of potentiation by acivicin. 
Neither treatment with DC-(GSyl)BQ/HQ nor TC-(GSyl)BQ/HQ caused any 
hepatocellular alterations as evidenced by SGPT values (control, 46.9 ± 12.7 
units/ l i ter; 200 (imol/kg DC-(GSyl)BQ/ascorbic acid/acivicin, 54.9 ± 8.6 
units/ l i ter; 200 u.mol/kg TC-(GSyl)BQ/ascorbic acid/acivicin, 34.8 ± 4.8 
units/ l i ter) or histological examination (not shown). 
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Figure 6.15 The renal cortex (C) and OSOM (O) 19 hours following the administration of 
200 umol/kg TC-(GSyl)BQ after reduction with 600 (imol/kg acorbic acid and pretreatment of the 
animals with 10 mg/kg acivicin. Cell injury and necrosis are apparent involving all segments of the 
proximal tubule. Hyaline casts, often containing calcified debris, are evident throughout the cortex 
and OSOM (arrowheads). Cells of the lower uriniferous tubule (including ascending thick limb, 
distal tubule and collecting duct) appear unaffected. Paraffin section stained with hematoxylin and 
eosin (x72). 
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Figure 6.16 Hydrodynamic voltammograms of DC-(GSyl)HQ and 
TC-(GSyl)HQ. Oxidation potentials were determined by HPLC with 
electrochemical detection equipped with two porous graphite 
electrodes in series. A potential of -0 .6 V was applied to the f i rs t 
electrode to af fect reduction of the injected quinones. The applied 
potential at the second electrode was varied f rom - 0 . 2 to +0.3 V. 
Peak areas were measured at each potential and expressed as % of 
the maximum response obtained. Under the used conditions 
(see methods), DC-(GSyl)BQ and TC-(GSyl)BQ were eluted with 
retention times of 4.8 and 8.4 min and the corresponding hydro-
quinones exhibited half-wave potentials (E1/2) of +19 mV and 
-89 mV respectively. 
Electrochemistry of DC-(GSyl)BQ and TC-(GSyl)BQ 
Hydrodynamic voltammograms of the reduced, hydroquinone forms of 
DC-(GSyl)BQ and TC-(GSyl)BQ are illustrated in figure 6.16 . Reduction of 
DC-(GSyl)BQ and TC-(GSyl)BQ was achieved electrochemically, subsequent to 
their separation by HPLC, by applying a potential of -0.6 V to the f irst of two 
porous graphite electrodes connected in series. The half-wave oxidation potentials 
of the reduced conjugates, in protonic media at pH 4.0, were +19 mV and -89 mV 
respectively. Consequently, the reduced thrichloro- conjugate will be more readily 
oxidized than the dichloro-analog. 
DISCUSSION 
In the present study we have shown that both DC-(GSylBQ and TC-(GSyl)BQ 
are renal proximal tubule cell toxicants. Coadministration of these compounds with 
ascorbic acid, which effectively produces the corresponding hydroquinone-GSH 
conjugates increased the nephrotoxicity. Quinones can readily react with a variety 
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of cellular and extracellular nucleophiles. It is possible therefore, that a 
significant fraction of the DC-(GSyl)BQ and TC-(GSyl)BQ administered to rats 
reacts with nucleophilic sites on plasma proteins or other extrarenal 
macromolecules, substantially reducing the effective dose delivered to the kidneys. 
Reducing the quinone with ascorbic acid decreases the extra-renal removal of the 
conjugates and increases delivery to the kidney, thus a greater toxicity ensues. 
Based upon both biochemical and histological cr i ter ia, TC-(GSyl)BQ and its 
corresponding hydroquinone, were more potent nephrotoxicants than either 
DC-(GSyl)BQ or its hydroquinone analog. Consistent with these findings, the 
TC-(GSyl)HQ conjugate exhibited a lower oxidation potential than the DC-(GSyl)HQ 
conjugate (Fig. 6.16).The additional chlorine atom in TC-(GSyl)HQ clearly facilitates 
its ready oxidation. We have previously shown that oxidation, rather than 
metabolism to reactive thiols catalysed by cysteine conjugate ß-lyase, plays an 
important role in the nephrotoxicity of several benzoquinol-thiol conjugates 
(Monks et al, 1988 a,b; Lau et al, 1988a). The present data are consistent with 
these findings. The site and mechanism of oxidation of the DC-(GSyl)HQ and 
TC-(GSyl)HQ conjugates are unknown but warrant further investigation. 
The renal specific toxicity of both 2-Br-(diGSyl)HQ and 2,3,5-(triGSyl)HQ 
appears to be a consequence of the high activity of YGT within the membrane of 
proximal tubule cells. The activity of yGT appears to be necessary for the 
accumulation of these conjugates into renal cells (Lau et al, 1988b) and also, 
perhaps for the activation of the conjugates by facilitating oxidation (Monks and 
Lau, 1990). Thus, pretreatment of rats with acivicin to inhibit yGT, protected the 
animals from both 2-Br-(diGSyl)HQ- and 2,3,5-(triGSyl)HQ-mediated 
nephrotoxicity (Monks et al, 1988a; Lau et al, 1988a). Interestingly however, 
acivicin pretreatment failed to protect rats from either DC-(GSyl)HQ- or 
TC-(GSyl)HQ-mediated nephrotoxicity. Rather, acivicin actually potentiated the 
toxic effects of these compounds. This observation suggests that , at least for the 
present conjugates, metabolism via yGT may lead to detoxication. Support for this 
interpretation is provided by recent studies on the YGT catalyzed metabolism of 
2-Br-3-(GSyl)HQ (Monks et al, 1990). The products of this reaction, the 
cystein-S-ylglycine and cystein-S-yl conjugates, undergo an oxidative cyclization 
reaction that results in 1,4-benzothiazine formation. This is, in effect, an 
intramolecular detoxication reaction, since it results in removal of the reactive 
quinone function from the molecule. This same reaction appears to be occurring 
with both DC-(GSyl)HQ and TC-(GSyl)HQ. We observed the appearance of a 
characteristic green precipitate in urine of rats treated with both these 
conjugates, indicative of benzothiazine formation. Interestingly, pretreatment of 
animals with acivicin, and thus inhibition of yGT, prevented the appearance of the 
green precipitate in urine. 
The reasons for the differential effects of acivicin on quinol/quinone-GSH 
conjugate-mediated nephrotoxicity are unclear, but are probably related to the 
relative rates at which the products of the yGT catalyzed reaction undergo 
cyclization (detoxication) and macromolecular alkylation (toxication). The ability of 
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both DC-(GSyl)HQ and TC-(GSyl)HQ to cause severe proximal tubular necrosis, 
under conditions where yGT activity is almost completely inhibited, also raises 
several questions. For example, since it is generally accepted that the activity of 
brush border fGT is required for the transport of GSH (as its corresponding 
constituent amino acids) and its S-conjugates, from the tubular lumen into 
proximal tubule cells, how do DC-(GSyl)HQ and TC-(GSyl)HQ gain access to these 
cells? In addition, the peritubular extraction of GSH and S-conjugates via the 
basolateral membrane is also a significant physiological process (Curthoys, 1990), 
and might also contribute to the renal uptake of quinol-GSH conjugates. Such 
uptake may be mediated either by YGT which is associated with the basolateral 
membrane (Abbott et al, 1984; Rankin et al, 1985) or via an electrogenic, 
Na^-dependent transport system. Indeed it has been suggested that the 
Na+-dependent, probenecid sensitive, transport system exists for the transport 
of GSH-conjugates (Lash and Jones, 1985). Although probenecid offered only slight 
protection against 2-Br-(diGSyl)HQ (Monks et al, 1988a) and failed to protect rats 
from 2,3,5-(triGSyl)HQ-mediated nephrotoxicity (Lau et al, 1988a), it is possible 
that this system contributes significantly to the transport of DC-(GSyl)HQ and 
TC-(GSyl)HQ. The relative importance of each of these pathways to the renal 
uptake of quinol-GSH conjugates is unclear and requires further study. 
Alternatively, it is possible that quinone-GSH conjugates express their toxicity 
extracellularly. In this case, transport across a membrane would be unneccessary. 
This scenario would also implicate the membrane as a principal target of these 
compounds. The observation that the presence of yGT in urine is a sensitive 
indicator of the toxicity of these compounds supports the brush border membrane 
as a potential target. The extremely high reactivity of the quinone conjugates with 
protein thiols would be in line with this suggestion (van Ommen et al, 1988). An 
extracellular mode of action of these compounds would also have to explain the 
tissue selectivity of these conjugates. The physiological function of the kidney may 
provide the rationale behind the specificity of these compounds. The cells of the 
kidney are constantly exposed to higher concentrations of chemicals than cells of 
most other organs, as a consequence of its normal function of f i l t rat ion, 
reabsorption and excretion. 
In conclusion we have demonstrated that the nephrotoxicity of DC-(GSyl)BQ 
and TC-(GSyl)BQ can be potentiated by reduction of these conjugates with 
ascorbic acid, presumably due to an increased delivery of the reduced conjugates 
to the kidney. The unexpected increase in nephrotoxicity after inhibition of YGT 
activity suggests that different renal transport mechanism may be involved in the 
proximal tubular accumulation of GSH conjugated hydroquinones, and/or that 
metabolism by yGT can constitute a detoxication reaction for some of these 
conjugates. 
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In vitro cytotoxicity of nephrotoxic glutathione conjugated halohydroquinones. 
Influence of aqueous stability, and Y-glutamyltranspeptidase 
SUMMARY 
The effects of several nephrotoxic glutathione(GSH) conjugated 
halogenated hydroqulnones were studied in monolayer cultures of 
LLC-PKi cel ls . Half-lives of the halogenated glutathion-S-yl hydro-
qulnone ((GSyl)HQ) conjugates in aqueous solutions ranged from 19 to 
88 min at pH 7.4. When oxygen was excluded however, 2-bromo-6-(gluta-
thion-S-yl)hydroqulnone (2-Br-6-(GSyl)HQ) was stable. At pH 5.8, the 
(GSyl)HQ conjugates were all relatively stable even in the presence of 
oxygen. The toxicities of 2-chloro-(diglutathion-S-yl)hydroquinone 
(2-Cl-(diGSyl)HQ ), 2-Br-6-(GSyl)HQ and 2-bromo-(diglutathion-S-yl)-
hydroquinone (2-Br-(dlGSyl)HQ ) to LLC-PKl cells were all decreased at 
pH 5.8 as compared to pH 7.4. In contrast, 2,5-dichloro-3-(glutathion-S-
yDhydroqulnone (DC-(GSyl)HQ) and 2,5,6-trichloro-3-(glutathion-S-yl)-
hydroquinone (TC-(GSyl)HQ ) were equally toxic at either pH. 
Acivicin, an irreversible inhibitor of Y-glutamyltranspeptidase (yGT), 
had no effect on the cytotoxicity of any of the compounds studied. 
However, addition of exogenous yGT to the medium caused a decrease in 
the toxicltly of 2-Br-6-(GSyl)HQ, DC-(GSyl)HQ, and TC-(GSyl)HQ, 
possibly as a consequence of either 1,4-benzothiazlne formation and/or 
due to the formation of extracellular quinone-GSH-protein adducts. In 
the absence of YGT activity, breakdown products arising from 
2-Br-(GSyl)HQ were toxic to LLC-PKl cel ls , whereas those arising from 
DC-(GSyl)HQ or TC-(GSyl)HQ were without toxic effect. 
The cytotoxicity of halohydroquinone-GSH conjugates is thus 
caused by a process which also results in the breakdown of the 
conjugate, presumably via oxidation. The most likely explanation for the 
contrasting effects of YGT is that, on the one hand, yGT initiates detoxi-
catlon via 1,4-benzothiazine formation and/or polymerization, and on 
the other hand , targets the toxic glutathione conjugate to the 
membrane, thus enhancing the toxic effect. 
ABBREVIATIONS 
2-Br-6-(GSyl)HQ . 2-Bromo-6-(glutathion-S-yl)hydroquinone ; 2-Br-(dlGSyl)HQ , 2-Bromo-
(diglutathion-S-yl)hydroquinone; 2-CI-(diGSyl)HQ . 2-Chloro(diglutathion-S-yl)hydroquinone: 
CYS(GLY). cysteinyl(glycine); DC-(GSyl)BQ , 2.5-Dichloro-3-(glutathion-S-yl)benzoquinone; 
DC-(GSyl)HQ . 2,5-Dichloro-3-(glutathion-S-yl)hydroquinone; EBSS. Earle's Balanced Salt 
Solution; Y G T . Y-glutamyltranspeptidase; GSH. glutathione; HEPES. N-2-hydroxyethylpiperazine-
N'-2-ethanesulphonic acid; HPLC. high performance liquid chromatography; LDH, lactate dehydro-
genase; PCBD-GSH, 1,2,3,4-,4-pentachlorobutadienyl-glutathione; TC-(GSyl)BQ . 2 .5 ,6-Tr ich loro-
3-(glutathion-S-yl)benzoquinone; TC-(GSyl)HQ , 2,5,6-Tr ichloro-3-(glutathion-S-yl)hydroquinone; 
(triGSyl)HQ . (tr iglutathion-S-yl)hydroquinone; WE, Williams Medium E. 
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INTRODUCTION 
Glutathione (GSH) conjugates are dualistic compounds. Their formation often 
results in detoxication and excretion of the parent compound. However, for an 
increasing number of xenobiotics. GSH conjugation can result in the formation of 
reactive metabolites and ensuing toxicity (van Bladeren, 1988). Although GSH 
conjugation of haloalkenes occurs in the liver, the target of these toxic conjugates 
very often is the proximal tubular epithelium of the kidney. Once formed within the 
liver, GSH conjugates can be released both into bile and plasma (Wahlländer and 
Sies, 1979). Biliary and/or intestinal metabolism results in the formation of 
cysteine conjugates which can be transferred to the kidney, either directly or 
following acetylation in the intestine or liver. Cysteine conjugates can also 
originate from the GSH conjugates at the proximal tubular epithelium through the 
activity of the brushborder enzymes , y-glutamyltranspeptidase (yGT) and 
dipeptidases, and intracellular^ after deacetylation of mercapturic acids. Further 
metabolism by cysteine conjugate ß-lyase can result in the formation of a reactive 
thiol, and subsequent nephrotoxicity (Lock, 1988 ; Anders et al, 1988). 
Several GSH-conjugated hydroquinones are potent nephrotoxicants. For 
example, 2-bromo-(glutathion-S-yl)hydroquinone (2-Br-(GSyl)HQ; 50 (imol/kg), 
and to a greater extent, 2-bromo-(diglutathion-S-yl)hydroquinone 
(2-Br-(diGSyl)HQ ; 10-30 (tmol/kg) caused a severe necrosis of renal proximal 
tubules (Monks et al, 1985, and 1988a). The same effect was also caused by 
GSH-conjugated hydroquinones lacking the halogen atom, albeit at slightly higher 
doses (Lau et al, 1988) . In contrast to the pathway of haloalkene mediated nephro-
toxicity, metabolism by ß-lyase does not appear to play a role in the nephrotoxicity 
of hydroquinone-GSH conjugates, since pretreatment of animals with aminooxy-
acetic acid, an inhibitor of ß-lyase, had only a negligible effect on the nephro-
toxicity of both 2-Br-(diGSyl)HQ (Monks et al, 1988a) and tri(GSyl)HQ (Lau et al, 
1988). However, inhibition of yßl by acivicin , an irreversible inhibitor, caused a 
decrease in the nephrotoxicity of 2-Br-(diGSyl)HQ (Monks et al, 1988a) and 
(triglutathion-S-yl)hydroquinone ((triGSyl)HQ) (Lau et al, 1988). We have also 
recently shown that 2,5-dichloro-3-(glutathion-S-yl)benzoquinone (DC-(GSyl)BQ), 
2,5,6-trichloro-3-(glutathion-S-yl)benzoquinone (TC-(GSyl)BQ), and the 
corresponding hydroquinones cause renal proximal tubular necrosis in rats (Monks 
et al, 1990a; Mertens et al, 1990). In contrast to 2-Br-dl(Gsyl)HQ and tri(GSyl)HQ 
however, inhibition of yGT resulted in an increase in nephrotoxicity . In view of the 
paradoxical effects of acivicin on the in vivo nephrotoxicity of halohydroquinone-
GSH conjugates we therefore investigated the role of fGT on the cytotoxicity of 
these conjugates, in the LLC-PKi cell line. The LLC-PKi cell line maintains several 
characteristics of the proximal kidney tubule epithelia, including a brushborder and 
substantial -yGT activity. Moreover, this cell line has been shown to respond to 
other nephrotoxic GSH and cysteine conjugates (Stevens et al, 1986; Mertens et 
al, 1988). Preliminary experiments with this cell model also indicated that several 
of the (GSyl)HQ conjugates were unstable under the conditions employed. The 
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study was therefore extended to investigate the effects of aqueous stability on the 
cytotoxicity of the halohydroquinone-GSH conjugates. 
MATERIALS AND METHODS 
Chemicals 
Glutathione was purchased from Janssen (Beerse, Belgium). 2-Chlorohydro-
quinone (90% pure) was from Aldrich Chemie (Brussel, Belgium). Acivicin was a 
product from the Upjohn Company (Kalamazoo, Ml), and YGT was obtained from 
Sigma (St. Louis, MO). 
Synthesis of GSH-conjugates 
2-Br-6-(GSyl)HQ and 2-Br-(diGSyl)HQ were synthesized as previously 
described (Monks et al, 1985). DC-(GSyl)BQ and TC-(GSyl)BQ were synthesized 
according to Mertens et al (1990) and the corresponding hydroquinones obtained 
by reducing the quinones in the presence of a threefold molar excess of ascorbic 
acid (Mertens et al,1990). 1,2.3,4,4-pentachlorobutadienylglutathione (PCBD-GSH) 
was synthesized according to Mertens et al (1988). 
For the synthesis of 2-chloro-(diglutathion-S-yl)hydroquinone (2-CI-(diGSyl)-
HQ) , 2-chlorohydroquinone was twice recrystallized from chloroform after 
treatment with activated carbon. The resulting white/beige crystals had a melting 
point of 101-103°C. To a solution of 2.5 g of the 2-chlorohydroquinone in 15 ml of 
distilled water, 1.25 ml of 1 N sulfuric acid and 1.05 g of KBr03 in 10 ml of distilled 
water was added. The mixture was stirred at 60-65°C for 20 min . After 15 min a 
red oil and a yellow liquid had appeared. The yellow liquid was transferred to ice 
water and yellow crystals (2-chlorobenzoquinone) formed. The latter were dried 
with NaOH under vacuum (m.pt. 53.5 -55 .5°C) . 
2-Chlorobenzoquinone (1.3 mmol) was dissolved in 100 ml of methanol and a 
solution of 0.13 mmol GSH in 5 ml of water was added dropwise with constant 
st irr ing. The reaction mixture was evaporated under vacuum and redissolved in 
water and ethyl acetate. The aqueous phase was extracted repeatedly with ethyl 
acetate, and evaporated until approximately 30 ml of solution remained. An 
additional 0.13 mmol GSH in 5 ml of water was added dropwise. The solvent was 
evaporated and the residue stored under nitrogen at 4°C. 
For purification , the product was dissolved in water and an aliquot injected 
onto a Zorbax ODS 9.4 mm i.d. x 25 cm reversed phase semipreparative column, 
eluted with methanol/1% acetic acid in water (10:90) at a flow rate of 4 ml/min, 
and the eluate monitored at 254 nm. Two major peaks were collected from several 
injections of the crude mixture. The one eluting f i rst was not further identified, 
the second one contained the required conjugate. After removing the methanol by 
evaporation the aqueous solution was frozen in dry ice/acetone and lyophilized. 
Purity exceeded 95% as determined by HPLC using a reversed phase analytical 
column (LiChrosorb 5RP18, 150x4.6 mm, Chrompack, Middelburg,The Netherlands) 
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and a linear gradient of methanol/1% acetic acid in water (10:90 to 100:0) at a flow 
rate of 1 ml/min , over 60 min. The eluate was monitored at 310 nm. The peak had 
a k'of 3.1 . 
The identity of the conjugate was established by UV- and NMR-spectroscopy. 
The UV-spectrum ( Beekman DU-8) showed a maximum at 336 nm and was similar 
to that reported for 2-Br-(diGSyl)HQ (Monks et al, 1985). The 1 H-NMR spectrum 
(Bruker CXP-300 in D 2 0 ) showed the appropriate signals for a diglutathion-S-yl 
substituted monohalogenated hydroquinone (i.e., the aromatic proton at 
8. 7.05 ppm; Cys a, 4.52-4.45 and 4.29-4.26 ppm; Gly « and Glu a, 3.80 and 
3.76-3.73 ppm; Cys ß, 3.40-3.33 and 3.24 -3.20 ppm; Glu f . 2.49-2.45 ppm and 
Glu ß, 2.15-2.07 ppm (Monks et al, 1985)). 
Stability experiments 
The aqueous stability of the conjugates was determined by analytical HPLC 
using the conditions described above. Conjugates (0.5 mM) were dissolved in water 
and kept in the dark under argon . At time zero, an aliquot was diluted (1:1) with a 
modified Earle's Balanced Salt Solution (containing twice the concentrations of the 
ingredients plus 20 mM NaHC03 , 40 mM HEPES) (EBSSx2) pH 7.4 or pH 5.8. 
Ascorbic acid (1.5 mM) was dissolved in EBSS x2 . The solutions were incubated at 
37°C and 5% C 0 2 in a humidified atmosphere. At different times a sample (20 (jtl> 
was taken and injected on the HPLC. Peak heights were related to the peak height 
of a sample diluted 1:1 with water at time zero . 
The influence of oxygen on the stability was also investigated for 
2-Br-6-(GSyl)HQ (0.25 mM). Argon or air was bubbled through the solution, after 
thirty minutes a sample was taken and injected on the HPLC. 
Cell strain and culture 
Epithelial pig kidney cells (LLC-PKi) (Flow, Irvine, Scotland) were cultured as 
described previously (Mertens et al, 1988). Cells were used in experiments 
between passage 193 and 230. 
Cytotoxicity assay 
Compounds were dissolved as described above. LLC-PKi monolayers cultured 
in 24-well tissue culture plates (Costar, Mark I I ; 3.5x105 cells/well) were 
exposed on day 3 to the compounds in 1 ml of EBSS at pH 5.8 or pH 7.4 for 2 h. 
After the exposure period EBSS was removed and the monolayers were cultured in 
Williams Medium E (WE) for 16 h. Lactate dehydrogenase (LDH) leakage was used 
as a parameter for cytotoxicity (Mertens et al, 1988) by measuring both the intra-
and extracellular enzyme activity. 
Statistical analyses 
Statistical analyses were performed by the Wilcoxon-Mann- Whitney test. 
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Figure 7.1 Cytotoxicity of halogenated quinoid GSH conjugates. LLC-PK1 monolayers were 
exposed for 2 h to GSH conjugates in EBSS (pH 7.4) (See Methods) . Af ter a subsequent 
overnight incubation in WE. LDH-leakage was determined. Values represent the mean ±S.D. 
of at least three experiments in t r ip l icate. 
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RESULTS 
Cytotoxicity of (QSyl)hydroquinones at pH 7.4 
Exposure of LLC-PKi monolayers to QSH conjugated hydroquinones resulted in 
cytotoxicity as presented in figure 7.1 . In contrast to in vivo data, 2-Br-6-(GSyl)-
HQ was more toxic than 2-Br-(diGSyl)HQ (at 0.5 mM, p<0.1). Of the (diGSyl)mono-
halohydroquinones 2-CI-(diGSyl)HQ was the most toxic (at 0.25 mM, p<0.05). The 
cytotoxicity of dichloro and trichloro GSH conjugates were tested both in the 
oxidized (quinone) and reduced (hydroquinone) forms. As quinones they were not 
toxic at concentrations up to 0.5 mM; however, as hydroquinones, toxicity was 
observed at concentrations as low as 60 u.M. The LLC-PKi monolayers were 
slightly more sensitive to DC-(GSyl)HQ than to TC-(GSyl)HQ (at 0.125 mM, 
p<0.025), again, in contrast to observations in vivo. Pretreatment of LLC-PKi 
monolayers for 30 min with acivicin (0.5 mM) caused a 70 % inhibition of fGT 
activity. However, such a treatment did not protect the cells from halohydro-
quinone-GSH conjugate-mediated cytotoxicity (data not shown). 
Stability of the (GSyl ) hydroquinones 
From pilot studies it was clear that GSH-conjugated hydroquinones were 
unstable under standard in vitro incubation conditions. We therefore studied the 
stability of the compounds in more detail. In EBSS at pH 7.4 the half-life of the 
GSH conjugates varied between 4 and 80 min (Table 7.1). Of the mono-halogenated 
(GSyl)hydroquinones, 2-Br-(diGSyl)HQ ( t l / 2 72 min) was more stable than 
2-CI-(diGSyl)HQ U1/2 52 min), while 2-Br-6-(GSyl)HQ was the least stable ( t l / 2 
19 min). The difference in stability was also apparent at pH 5.8. Both brominated 
(GSyl)hydroquinones were stable throughout the 120 min testing period, whereas 
Table 7.1 Stability of halogenated quinoid GSH conjugates. Conjugates dissolved in water 
(0.5 mM) were diluted (1:1) with EBSSx2 (pH 5.8 or 7.4), and incubated at 37°C in a humidified 
atmosphere with 55! CO
 2 . At di f ferent times samples were injected on HPLC (see Methods). 
T i / 2 (min) 
Conjugate 
pH 7.4 pH 5.8 
2-Br-6-(GSyl)HQ 19 00 a 
2-Br-(diGSyl)HQ 72 00 
2-CI-(diGSyl)HQ 52 620 
DC-(GSyl)HQ* 47 00 
DC-(GSyl)BQ 5 
TC-(GSyl)HQ* 77 00 
TC-(GSyl)BQ 4 
*in the presence of ascorbic acid 
ano decrease in concentration throughout the 120 min testing period. 
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Figure 7.2 Oxygen dependence of the stability of 2-Br-6-(GSyl)HQ. 2-Br-6-(GSyl)HQ dissolved 
in water (0.5 mM) was diluted (1:1) with EBSS x2 (pH 7.4). After the solution was bubbled with air 
or argon during 30 min a sample was injected on HPLC (see Methods). 
2-CI-(diGSyl)HQ showed a slight decrease in concentration resulting in a half-l ife 
of 620 min. Stabilities of the d i - and trihalogenated (QSyl)hydroquinones were 
similar: t i / 2 47 and 77 min for DC-(QSyl)HQ and TC-(GSyl)HQ respectively at 
pH 7.4, and an absence of a decrease in concentration at pH 5.8 ( t i / 2 00 ). In 
contrast to the hydroquinones, the concentrations of the d i - and trihalogenated 
(GSyl)quinone conjugates decreased very rapidly at pH 7.4 . Both DC-(GSyl)BQ and 
TC-(GSyl)BQ had a half-l ife of approximately 5 min. 
The instability of the reduced conjugates is probably a consequence of the 
ease with which they autoxidize. since the exclusion of oxygen from the media 
completely prevented the alteration in the HPLC-pattern for 2-Br-6-(GSyl)HQ due 
to thirty minutes of aerobic incubation (Fig.7.2). 
Cytotoxicity at pH 5.8 
Because of the relative stability of the hydroquinone GSH conjugates at pH 5.8 
we exposed LLC-PK1 monolayers at this pH. Preliminary experiments showed that 
LLC-PKi cells were not adversely affected when incubated for short periods of 
time, even at pH 5.5. As a positive control, PCBD-GSH was used. As shown in 
figure 7.3 , the metabolic and transport systems needed for PCBD-GSH to cause 
toxicity were still present and effective at pH 5.8. In fact, the toxicity was slightly 
higher at pH 5.8 than at pH 7.4. Inhibition of YQT by 0.5 mM acivicin protected the 
monolayers from the effects of PCBD-GSH . 
Exposure of LLC-PKi monolayers at pH 5.8 to (GSyl)hydroquinones (0.25 mM), 
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Figure 7.3 Cytotoxicity of PCBD-GSH at pHS.8 and pH 7.4. 
LLC-PK1 monolayers were exposed to PCBD-GSH in EBSS 
(pH 7.4 or 5.8) with O ) or without ( • ) 0.5 mM acivicin for 
2 h . LDH-leakage was determined after a subsequent overnight 
incubation in WE. Data represent the mean ±S.D. of two 
experiments in t r ip l icate. 
which are stable under these conditions, resulted in cytotoxicity for the 
chlorinated (GSyl)hydroquinones only (Fig.7.4-). 2-Br-6-(GSyl)HQ and 2-Br-(diGSyD-
HQ were not cytotoxic under these conditions. Again addition of acivicin, to inhibit 
fGT, did not prevent the cytotoxic effects of the chlorinated (GSyl)hydroquinones 
(data not shown). 
Role of YGT 
As described above, acivicin did not affect the cytotoxicity of the (GSyl)hydro-
quinones, suggesting that yGT activity was not necessary for the expression of 
cytotoxicity. Addition of commercially obtained, exogenous YGT during the 
exposure to (GSyl)hydroquinones resulted in a dose related decrease in toxicity 
(Fig.7.5). However, preincubation of exogenous yGT with 1 mM acivicin for 45 min 
(which caused an 87% inhibition of the yGT activity as determined with 
L-Y-glutamyl-p-nitroanilide as the substrate) did not prevent the inhibitory effect 
of YGT on the cytotoxicity of DC-(GSyl)HQ and TC-(GSyl)HQ , and slightly 
increased the toxicity of 2-Br-6-(GSyl)HQ . This suggests that for 2-Br-6-(GSyl)-
HQ, the catalytic activity of the exogenous Y(3T plays a more Important role in its 
inhibitory effect than it does for the chlorinated conjugates , where yQJ may be 
providing a source of alternative nucleophiles. 
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Figure 7.4 Cytotoxicity of halogenated (GSyl)hydroquinones at pH5.8. 
LLC-PKi monolayers were exposed to 0.25 mM SSH conjugated chloro-
hydroquinones or 0.5 mM SSH conjugated bromohydroquinones in EBSS 
at pH 5.8 for 2 h . Af ter a subsequent overnight incubation in WE, 
LDH-leakage was determined. Data represent the mean ±S.D. of at 
least two experiments in t r ip l icate. 
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Figure 7.5 Cytotoxicity of DC-(GSyl)HQ, TC-(GSyl)HQ, and 2-Br-6-(GSyl)HQ in the presence 
of additional exogenous -(GJ. LLC-PKi monolayers were exposed to DC-(GSyl)HQ. 
TC-(GSyl)HQ. or 2-Br-6-(GSyl)HQ in EBSS at pH 7.4- for 2 h in the presence of either active 
or inactive exogenous fQJ. Exogenous yGT was inactivated by preincubating with acivicin for 
45 min. After preincubation , 0.5 ml of the fGl solution was added to the cells , followed by 
0.5 ml of medium containing the conjugate. The concentrations shown are the final 
concentrat ions. After a subsequent overnight incubation in WE. LDH-leakage was 
determined. Data represent the mean ±S.D. of two experiments in t r ip l icate. Asteriks 
indicate when the effect of acivicin was statist ical ly significant (p<0.05). 
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Stability vs toxicity 
For the mono-halogenated (GSyl)hydroquinones there was an inverse 
correlation between stability and toxicity. To investigate whether toxicity was 
caused by the parent compound or a breakdown product(s), LLC-PK1 monolayers 
were exposed for two hours to either the parent conjugates or their breakdown 
products. The latter were obtained by incubating the parent compounds in EBSS 
pH 7.4 at 37 °C for 3 h before adding them to the cells. Such a time period was 
sufficient to obtain a solution in which no parent compound remained (Table 7.1). 
Exposure of LLC-PKi monolayers to the breakdown product(s) derived from 
2-Br-6-(GSyl)HQ caused toxicity, at least equal to that caused by incubation with 
the parent compound (Fig. 7.6) indicating that the derivatives formed remain toxic. 
In contrast, no cytotoxicity was observed after exposure of the cells to the break-
down product(s) of the poly-halogenated GSH-conjugates DC-(GSyl)HQ and 
TC-(GSyl)HQ. 
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Figure 7.6 Cytotoxicity after exposure to 2-Br-6-(GSyl)HQ, 
DC-(GSyl)HQ, TC-(GSyl)HQ. or their breakdown products. 
LLC-PKi monolayers were exposed for 2 h to DOtGSyOHQ. 
TC-(GSyl)HQ. 2-Br-6- (GSyl )HQ. or their breakdown products. 
The lat ter were obtained by incubation of the compounds for 
three hour at 37 ° C in a humidified atmosphere containing 52! 
CO
 2 . Af ter a subsequent incubation in WE. LDH-leakage was 
determined. Data represent the mean (±S.D.) of two experiments 
in t r ip l icate. 
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DISCUSSION 
The nephrotoxicity of haloalkene GSH conjugates appears to be mediated by 
the combined activities of yQT and cysteine conjugate (J-lyase, which results in the 
formation of a reactive thiol(s) (Anders et al, 1988; Lock, 1988). The reactive thiol 
can rearrange to form a thioacylating intermediate, probably a thioketene and/or a 
thionoacyl halide (Dekant et al, 1987; 1988; Commandeur et al, 1989). However, for 
the nephrotoxicity of GSH conjugated hydroquinones, ß-lyase mediated metabolism 
appears to be of lesser importance. Oxidation resulting in the formation of the 
corresponding quinone conjugates, seems to play a major role in the nephrotoxicity 
of these compounds (Monks et al, 1988a, and 1988b). However, the exact 
mechanism of toxicity is unknown: Nephrotoxicity might be initiated by either 
quinone-mediated macromolecule arylation and/or via the formation of reactive 
oxygen species during the oxidation process(Fig. 7.7). 
Thus, although ß-lyase appears to play a minor, if any, role in quinol-GSH 
conjugate-mediated nephrotoxicity, fGT activity can effectively modulate the 
toxicity of these compounds. For example, the toxicity of 2-Br-(diGSyl)HQ and 
(triGSyl)HQ can be attenuated by inhibition of yQT by acivicin (Monks et al, 1988a; 
Lau et al, 1988). Conversely, acivicin potentiated the nephrotoxicity of DC-(GSyl)-
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Figure 7.7 Postulated reaction pathways for (GSyl)HQ conjugates resulting in toxicity or 
detoxication (See text ) . 
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HQ and TC-(GSyl)HQ (Monks et al, 1990a ; Mertens et al, 1990). The reason(s) for 
this paradoxical behavior is unclear but may be related to events subsequent to the 
yGT mediated removal of the Y_glutamyl moiety. Thus, after the fg lutamyl-moiety 
is removed by yGT, subsequent oxidative cyclization of the cysteinylglycine-
conjugate can result in 1,4-benzothiazine formation (Monks et al, 1990b). This 
reaction sequence seems to constitute a detoxication mechanism. Consistent with 
this view, the L-homocysteine-conjugates of 2-bromohydroquinone, which, as a 
consequence of the additional methylene group, should not undergo the cyclization 
reaction, are as nephrotoxic as the corresponding cysteine conjugates (Lau and 
Monks, 1990). Thus the YGT catalysed removal of the y g ^ t a m y l moiety can have 
the ultimate effect of removing the reactive quinone function from the molecule 
(Fig.7.7(2)). 
GSH-conjugated hydroquinones are sensitive to air-oxidation (Table 7.1; 
Fig. 7.2), and this is influenced by the pH and the nature of the ring substituents 
(Musso and Döpp, 1967). Upon oxidation the hydroquinones (Fig.7.7 (D) may form 
several breakdown products, among them, presumably, polymers with an intact 
GSH-moiety similar to those reported for GSH conjugates of acetaminophen 
(Potter et al, 1986). In addition, YGT may facilitate the oxidation process. Removal 
of the Y~glutamyl and glycine-moiety decreases the oxidation potential drastically: 
for example 2-Bromo-3-(cystein-S-yl)hydroquinone is more readily oxidized than 
2-Br-3-(GSyl)HQ (Lau and Monks, 1990; Monks and Lau, 1990). This decrease may 
be sufficient to permit oxidation of the cysteinyl(glycine) (CYS(GLY)) conjugates of 
dichlorohydroquinone and trichlorohydroquinone but, due to the differences in 
halogenation, insufficient to permit oxidation of 2-bromo-(cystein-S-ylglycine)HQ 
and 2-bromo-(dicystein-S-ylglycine)HQ at pH 5.8. Thus, the chlorohydroquinones 
remain toxic at pH 5.8, whereas the bromohydroquinones are not (Fig.7.4). 
Does the oxidation of these conjugates occur intracellular^ and/or extra-
cellularly? Will oxidation in either compartment lead to cytotoxicity or is toxicity 
initiated by preferential oxidation in a specific compartment? If extracellular 
oxidation was responsible for the in vitro toxicity of these conjugates then one 
might expect to see a decrease in toxicity after inhibition of Y G T . However, 
pretreatment of LLC-PKi cells with acivicin, at concentrations sufficient to cause 
an 70% inhibition of YGT activity, failed to protect the cells from halohydro-
quinone-GSH conjugate mediated cytotoxicity. It should be noted that the residual 
YGT activity may be sufficient to permit efficient processing of the 
GSH-conjugates. In addition, the lack of toxicity of DC-(GSyl)BQ and TC-(GSyl)BQ 
when added directly to LLC-PKi cells (Fig. 7.1) further suggests that the presence 
of the quinones extracellularly does not, per se, cause toxicity. This suggests an 
intracellular mechanism of toxicity, with the rate-limiting step distal to metabolism 
by Y G T . Of the CYS(GLY) conjugate formed, ä fraction may be accumulated intra-
cellular^ (Fig.7.7(3)) with the remaining fraction detoxified via extracellular 
autoxidation and subsequent 1,4-benzothiazine formation. Inhibition of YGT should 
cause a decrease in the formation of CYS(GLY) conjugates , and an increase in 
oxidation of the intact GSH conjugates (Fig.7.7 (D). The relative rates of these two 
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reactions will determine the consequences of •YGT inhibition for each compound. 
The addition of exogeneous yGT to the LLC-PKi cells decreased the toxicity of 
2-Br-(GSyl)HQ , TC-(GSyl)HQ and DO(GSyl)HQ (Fig. 7.5). When the activity of 
exogenously added Y G T was decreased 87% by pretreatment with acivicin prior to 
its addition to LLC-PKi monolayers, the cytotoxicity of DC-(GSyl)HQ and TC-(GSyl)-
HQ was the same as in the presence of exogenously added active yGT. In contrast, 
this protocol partially restored the cytotoxic effects of 2-Br-6-(GSyl)HQ (Fig.7.5). 
This suggests that the effect of exogenously added YGT on TC-(GSyl)HQ and 
DC-(GSyl)HQ may be a consequence of the availability of additional nucleophilic 
sites on the protein which scavenge any reactive quinone formed and thereby 
protects critical sites on cellular membranes from electrophilic attack.The 
extremely high reactivity of the quinone conjugates with protein thiols would be in 
line with this suggestion (van Ommen et al, 1988).In contrast it is clear that the 
enzymatic activity of exogenously added YGT is at least partially responsible for its 
ability to protect LLC-PKi cells from 2-Br-6-(GSyl)HQ cytotoxicity in vitro. 
Data from in vivo studies also support the contention that yGT can serve both 
a toxication and detoxication function with respect to the metabolism of halohydro-
quinone-GSH conjugates. Inhibition of Y G T in vivo caused an increase in nephro-
toxicity after administration of DC-(GSyl)HQ or TC-(GSyl)HQ (Monks et al, 1990a; 
Mertens et al, 1990), and a decrease of the nephrotoxicity of 2-Br-(diGSyl)HQ and 
(triGSyl)HQ (Monks et al, 1988a; Lau et al, 1988). Apparently, for the toxicity of 
these latter two conjugates, yGT is the rate-limiting factor in vivo, whereas for 
DC-(GSylHQ and TC-(GSyl)HQ the detoxication reaction is predominant, possibly 
due to the lower oxidation potential compared to 2-Br-(diGSyl)HQ and (triGSyl)HQ 
(Monks et al, 1988b; Lau et al, 1988; Mertens et al, 1990). Finally, Lau et al (1990) 
have shown that differences in species susceptibility to 2-Br-di(GSyl)HQ do not 
correlate with variability in fGT-activity. These data indicate that factors other 
than YGT are important determinants of quinol-GSH mediated nephrotoxicity. For 
example, difference in the relative rates of cysteine conjugate N-acetylation and 
deacetylation may contribute to the observed difference in species susceptibility 
to 2-Br-di(GSyl)HQ nephrotoxicity. In addition, differences in the direct alkylating 
ability of the mono- versus the d i - and trihalogenated quinones might contribute to 
substrate-specific differences in toxicity and are areas worthy of future 
investigation. 
In conclusion, the present study indicates that : 1) Oxidation of halogenated 
(GSyl)hydroquinones appears necessary for toxicity. 2) The dualistic effects of 
•yGT may be a consequence of its ability to initiate a detoxication sequence via 
1.4-benzothiazine formation and/or polymerization , and on the other hand by 
targetting the toxic glutathione conjugate to the membrane, thus enhancing the 
toxic effect. 3) The role of breakdown products in the toxicity of these compounds 
deserves further attention especially in the case of 2-Br-6-(GSyl)HQ. Further 
studies are necessary to elucidate the mechanism and site of oxidation of these 
compounds. 
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8.1 SUMMARY 
Presently in our society animal tests still form the main starting point for the 
assessment of the possible risks of chemicals with regard to human and animal 
health. For scientific, economic, and ethical reasons, attempts are undertaken 
continuously to develop cell models as alternatives to animal testing. However, the 
predictive value of in vitro test systems is often limited due to the unawareness 
about the mechanisms of toxicity and the complexity of organisms. As a 
consequence, a strategy increasingly used is one of studying mechanisms of 
toxicity evolving in rational cell models. Following this strategy, this thesis aims at 
contributing to the development of cell models as an alternative to animal testing. 
A usefull cell model for studying mechanisms of toxicity requires the presence 
of characteristics which may play a role in this toxicity in vivo, and the possibility 
to demonstrate their involvement. The organ of our choice was the kidney. Since 
very often the cortex, more in particular the proximal tubule, is affected by 
chemicals, cortical cells of different origin have been used: A renal cell line 
derived from a Hamshire pig (LLC-PKi) and primary cultures of rat renal cortical 
cells (Chapter 2). The applicability of these cells in a cell model was tested 
considering two major aspects of importance for nephrotoxicity: Firstly, the 
functional polarity of the proximal tubular cell, and secondly the presence of 
specific biotransformation processes and transport systems (Chapter 1). 
In vivo luminal (apical) as well as serosal (basolateral) exposure of the 
proximal tubular cell can occur. However, when monolayers are cultured in a 
conventional way, i.e. on a solid support, only the apical side is accessible for the 
compounds to be investigated. To overcome this problem a new system for nephro-
toxicological in vitro studies has been developed. Cells were cultured on porous 
substrates, which enables exposure of monolayers on either side (Chapter 2). 
The nephrotoxic effects of haloalkenes and halobenzenes seem to be mediated 
via the formation of glutathione conjugates (Chapter 1). In part II of this thesis a 
glutathione conjugate of hexachlorobutadiene and its derivatives are used as model 
compounds to investigate the possibilities of the cell systems described in 
chapter 2. LLC-PKi monolayers possess the most important characteristics 
necessary for cytotoxicity of S-(1,2,3,4-,4-pentachlorobutadienyl)glutathione 
(PCBD-GSH) to occur (Chapter 3). Via the use of acivicin, an irreversible inhibitor 
of Y~glutamyltranspeptidase (fGT), and aminooxyacetic acid, an inhibitor of 
ß-lyase, the importance of these enzymes in the activation of PCBD-GSH was 
demonstrated. After metabolism by yGT and dipeptidase S-(1,2,3,4,4-pentachloro-
butadienyl)-L-cysteine (PCBD-CYS) is formed extracellularly. This is taken up and 
converted by ß-lyase into a reactive thiol resulting in toxicity. In vivo and in the 
LLC-PKi cell line yGT is predominantly present on the luminal and apical membrane 
respectively. In agreement with this, apical exposure of LLC-PKi monolayers to 
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PCBD-GSH caused a stronger toxicity than basolateral exposure . In the 
nephrotoxicity of the corresponding mercapturate N-acetyl-S-(1,2,3,4,4-penta-
chlorobutadienyl)-L-cysteine (PCBD-NAC), which is deacetylated intracellular^ 
into PCBD-CYS, a serosally located probenecid sensitive organic anion transporter 
has been suggested to be of importance (Chapter 1). Apical exposure of LLC-PKi 
monolayers to PCBD-NAC caused hardly any toxicity; only at relatively high 
concentrations a toxic effect was detected. Surprisingly, basolateral exposure and 
consequently administration of the compound to the possible transporter, did not 
cause substantial toxicity either. Further investigations revealed that this is 
probably caused by the absence of an organic anion transporter in the LLC-PKi 
cell line: The model organic anion para-aminohippurate (PAH) was not transported 
by LLC-PKi cells. In contrast, LLC-PKi monolayers are in the possession of an 
organic cation transporter. A quinine and ouabaine inhibitable transcellular 
transport of the cation tetraethylammonium (TEA) was demonstrated (Chapter 3). 
The organic anion transporter was also postulated (Lash and Anders, 1986) to 
play a role in the cytotoxicity of cysteine conjugates . However, in spite of the 
demonstrated absence of an organic anion transporter , PCBD-CYS causes 
toxicity in the LLC-PKi monolayer. In contrast to PCBD-GSH, basolateral exposure 
to PCBD-CYS resulted in a stronger toxic effect than apical exposure (Chapter 4). 
A possible candidate for the transport of PCBD-CYS in LLC-PKi cells is an amino 
acid transporter. The inhibitory effect of D-tryptophan and histidine on the 
toxicity of PCBD-CYS strongly suggests the involvement of the amino acid 
transport System T (Chapter 4). 
Culturing primary cultures of rat renal cortical cells resulted in confluent 
monolayers (Chapter 2 and 5). However, investigating transcellular transport of 
organic ions in a similar way as with the LLC-PKi monolayers was not possible, 
because a non-leaking monolayer on a porous support was not obtained. This may 
be due to the diversity of the cell population in the culture, and the concomitant 
differences in junctional complexes necessary for complete sealing of the 
monolayer. The presence of both PAH and TEA transporters was demonstrated by 
measuring intracellular accumulation, which could be inhibited by probenecid and 
quinine respectively. Inhibition of fGT and/or ß-lyase decreased the toxic effect 
of PCBD-GSH, PCBD-CYS, and PCBD-NAC. In contrast to the experiments with 
LLC-PKi monolayers, no effect of amino acid transporter substrates or probenecid 
on the toxicity was observed. Apparently uptake of PCBD-CYS or PCBD-NAC in 
primary cultures of rat renal cortical cells is not the rate-limiting step in the 
toxicity. The probenecid sensitivity of toxicity observed by others thus must be 
caused by other mechanisms. 
In part I I I , glutathione conjugated halohydroquinones are the subject of 
investigation. These conjugates resemble the bromohydroquinone glutathione 
conjugates which are supposed to be responsible for the nephrotoxic effects of 
bromobenzene. The exact mechanism of nephrotoxicity is not known. In vivo 
experiments indicate that yGT is an important factor , as in the case of 
PCBD-GSH. However, ß-lyase mediated metabolism appears to be of lesser 
- 133 -
importance than oxidative metabolism resulting in quinone conjugates (Chapter 1). 
In a f i rst attempt to validate the in vitro test system and to see whether the 
mechanism of nephrotoxicity of glutathione conjugated bromohydroquinones is 
more generally valid, dichloro(glutathion-S-yl)hydroquinone (DC-(GSyl)HQ) and 
trichloro(glutathion-S-yl)hydroquinone (TC-(GSyl)HQ) were studied in vivo 
(Chapter 6). Administration (i.v.) of these compounds in the quinone form caused 
nephrotoxicity evidenced by elevations in blood urea nitrogen (BUN) , an increase 
in the urinary excretion of glucose, lactate dehydrogenase and YGT , and by the 
pathological changes in the kidney slices. Reducing the glutathione conjugated 
quinones with ascorbic acid caused a drastic increase in nephrotoxicity . This 
protocol may result in an increased delivery of DC-(GSyl)HQ and TC-(GSyl)HQ to 
the kidney , by preventing their interaction with nucleophilic sites on plasma 
proteins and/or with other extra-renal macromolecules. Surprisingly, inhibition of 
yGT increased the nephrotoxicity. 
Apparently yGT has a dual role in the nephrotoxicity of halogenated 
hydroquinone glutathione conjugates. This was further investigated in vitro in 
chapter 7. The LLC-PKi cell line was chosen, since the apical presence of fGT 
makes this cell line a very suitable model for this purpose. However, in contrast to 
the experiments with PCBD-GSH and its derivatives, the in vitro experiments did 
not completely clarify the mechanism of activation of halogenated hydroquinone-
glutathione conjugates. In a postulated scheme (Fig.7.7) the reactions that can 
occur with halogenated GSyl-HQ conjugates are summarized , and an explanation 
for the results obtained in vitro as well as in vivo is offered. The results indicate 
that -fGT is not the rate-limiting step in the toxicity. They suggest that yGT on the 
one hand initiates a detoxication by 1,4-benzothiazine formation and/or 
polymerization, and on the other hand activates by targetting the oxidation that 
causes the toxicity. In addition, without metabolism by yGT these compounds are 
not stable and can be detoxified via air-oxidation and presumably polymerization. 
Further studies will be necessary to elucidate the exact site and mechanism of 
oxidation. 
8.2. CONCLUDING REMARKS 
The studies described in this thesis demonstrate that exposing of monolayers 
on porous substrates closely resembles the in vivo luminal and serosal exposure of 
a renal proximal tubular cell. In the future this system offers the possibility to 
investigate and compare the relative importance of polarized functions of epithelial 
cells of different organs and origin. 
By using model compounds it could be demonstrated that the LLC-PKi cell may 
be a relatively simple model for determining a specific nephrotoxic potential of 
glutathione and cysteine conjugates. For this purpose, the absence of an organic 
anion transporter in the LLC-PKi cell line proved not to be a handicap. However, 
for investigating the nephrotoxic potential of other chemicals, the presence of an 
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organic anion transporter may be a prerequisite. Consequently, further 
characterization of other cell lines as the Opussum Kidney cell line (Koyama et al, 
1978) or the recently established human renal cell line (KRC/Y) (Yano et al. 1988) 
should focus on the presence of this transporter. 
Finally, the experiments on the role of yGT in the nephrotoxicity of glutathione 
conjugated halogenated hydroquinones underline once more the importance of 
in vivo validation. Differences of a more physical natures between in vivo and 
in vitro, as e.g. oxygen pressure and pH, may cause different or additional effects 
of compounds in vivo, which may be missed in vitro when these differences are not 
taken into account. 
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9.1. SAMENVATTING 
In onze huidige maatschappij vormen dierexperimenten nog steeds het 
belangrijkste uitgangspunt voor de vaststelling van mogelijke risico's van 
chemicaliën t.a.v. de gezondheid van mens en dier. Vanwege wetenschappelijke, 
economische en ethische redenen wordt er doorlopend getracht celmodellen te 
ontwikkelen ter vervanging van dierproeven. De voorspellende waarde echter van 
in vitro testsystemen is vaak beperkt door de onbekendheid van toxiciteits-
mechanismen en het complexe functioneren van organismen. Dientengevolge wordt 
steeds meer de strategie gevolgd: bestuderen van toxiciteitsmechanismen 
evoluerend in rationele celmodellen. Middels deze benadering probeert dit 
proefschrift een bijdrage te leveren in de ontwikkeling van celmodellen als een 
alternatief voor proefdierexperimenten. 
Een bruikbaar celmodel ter bestudering van toxiciteitsmechanismen dient te 
beschikken over eigenschappen die een rol kunnen spelen in de toxiciteit in vivo en 
over de mogelijkheid hun betrokkenheid te demonstreren. Het orgaan van onze 
keuze was de nier. Aangezien chemicaliën vooral de cortex, meer in het bijzonder 
de proximale tubulus beïnvloeden is er gebruik gemaakt van corticale niercellen van 
verschillende afkomst: Een niercellijn afkomstig van een Hampshire varken 
(LLC-PKi) en primaire kweken van corticale ratteniercellen (Hoofdstuk 2). De 
toepasbaarheid van deze cellen is in een celmodel getest waarbij rekening werd 
gehouden met twee aspecten van belang voor niertoxiciteit: Ten eerste, de 
functionele polariteit van de proximale tubuluscel en ten tweede, de aanwezigheid 
van specifieke biotransformatieprocessen en transportsystemen (Hoofdstuk 1). 
In vivo kan er zowel luminale (apicale) als serosale (basolaterale) blootstelling 
plaatsvinden. Wanneer echter cellen op conventionele wijze gekweekt worden, 
d.w.z. op een vaste ondergrond, is alleen de apicale zijde toegankelijk voor de te 
bestuderen stoffen. Om dit probleem op te lossen is een nieuw systeem voor 
niertoxicologische in vitro studies ontwikkeld. Cellen zijn gekweekt op een poreuze 
ondergrond , waardoor monolayers aan beide zijden kunnen worden blootgesteld 
(Hoofdstuk 2). 
De niertoxische effecten van haloalkenen en halobenzenen lijken veroorzaakt 
te worden via de vorming van glutathion-conjugaten (Hoofdstuk 1). In deel II van dit 
proefschrift zijn een glutathion-conjugaat van hexachloorbutadieen en zijn 
derivaten gebruikt als modelstoffen ter bestudering van de mogelijkheden van de in 
hoofdstuk 2 beschreven celsystemen. LLC-PKi monolayers bezitten de meest 
essentiële eigenschappen noodzakelijk voor het optreden van cytotoxiciteit van 
S-(1,2,3,4,4-pentachloorbutadiënyl)glutathion (PCBD-GSH) (Hoofdtuk 3). Door 
gebruik te maken van acivicin, een irreversibele remmer van y-glutamyl-
transpeptidase ( fGT), en van aminooxyazijnzuur, een remmer van (J-lyase, kon het 
belang van deze enzymen voor de activatie van PCBD-GSH worden aangetoond. Na 
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omzetting door yGT en dipeptidase ontstaat er extracellulair het 
S-(1,2,3,4,4-pentachloorbutadiënyl)~L-cysteine (PCBD-CYS). Dit wordt opgenomen 
en omgezet in een reactief thiol, resulterend in toxiciteit. In vivo en in de LLC-PKi 
cellijn is Y<3T voornamelijk aanwezig op het luminale/apicale membraan. In 
overeenstemming hiermee veroorzaakte apicale blootstelling van LLC-PK1 
monolayers aan PCBD-GSH een sterkere toxiciteit dan basolaterale blootstelling. 
Men neemt aan dat in de nephrotoxiciteit van het corresponderende 
mercaptuurzuur, het N-acetyl-S-(1,2,3,4,4-pentachloorbutadiënyl)-L-cysteïne 
(PCBD-NAC) dat intracellulair gedeacetyleerd wordt tot PCBD-CYS, een serosaal 
gelocaliseerde probenecide gevoelige organisch-aniontransporter van belang is 
(Hoofdstuk 1). Apicale blootstelling van LLC-PKi monolayers aan PCBD-NAC 
veroorzaakte nauwelijks toxiciteit; alleen t.g.v. relatief hoge concentraties werd er 
een toxisch effect waargenomen. Verwonderlijk was dat basolaterale blootstelling 
en dientengevolge toediening van de stof aan de mogelijke transporter, evenmin 
toxiciteit veroorzaakte. Verdere experimenten toonden aan dat dit waarschijnlijk 
veroorzaakt wordt door de afwezigheid van een organisch-aniontransporter in de 
LLC-PKi cellijn; het model organisch-anion para-aminohippuurzuur (PAH) werd niet 
getransporteerd door LLC-PKi cellen. Daarentegen bleken LLC-PKi monolayers wel 
in het bezit te zijn van een organisch-cationtransport; een door quinine en 
ouabaine rembaar transcellulair transport van het cation tetraethylammonium 
(TEA) kon worden aangetoond (Hoofdstuk 3). 
De organisch-aniontransporter zou ook een rol spelen in de cytotoxiciteit van 
cysteine-conjugaten (Lash en Anders, 1986). Echter, ondanks de aangetoonde 
afwezigheid van een organisch-aniontransporter bleek PCBD-CYS cytotoxisch te 
zijn voor de LLC-PKi monolayer. In tegenstelling tot PCBD-GSH, veroorzaakte 
basolaterale blootstelling aan PCBD-CYS een sterker toxisch effect dan apicale 
blootstelling (Hoofdstuk 4). Een mogelijke kandidaat voor het transport van 
PCBD-CYS door LLC-PK1 cellen is een aminozuurtransporter. Het remmende 
effect van D-tryptofaan en histidine op de toxiciteit van PCBD-CYS wijst sterk in 
de richting van een betrokkenheid van de aminozuurtransporter System T 
(Hoofdstuk 4). 
De kweek van corticale ratteniercellen resulteerde in confluente monolayers 
(Hoofdstuk 2 en 5). Echter, transcellulair transport van organische ionen 
onderzoeken op eenzelfde wijze als bij de LLC-PKi monolayers bleek niet mogelijk, 
omdat een niet-lekkende monolayer op een poreuze ondergrond niet verkregen 
werd. De oorzaak daarvan ligt waarschijnlijk in het diverse karakter van de 
celpopulatie in de kweek en de daarmee samenhangende verschillen in junctionele 
complexen die noodzakelijk zijn voor een complete dichting van de confluente 
monolayer. De aanwezigheid van zowel PAH- als TEA-transporters kon aangetoond 
worden door meting van intracellulaire accumulatie, welke geremd kon worden 
respectievelijk door probenecide en quinine. Remming van fGT en/of ß-lyase 
verminderde het toxische effect van PCBD-GSH, PCBD-CYS en PCBD-NAC. In 
tegenstelling tot de experimenten met de LLC-PKi monolayers hadden aminozuur-
transportsubstraten en probenecide geen effect op de toxiciteit. Blijkbaar is de 
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opname van PCBD-CYS en PCBD-NAC niet de snelheidsbepalende stap in de 
toxiciteit in de primaire kweek van corticale niercellen. De probenecide 
gevoeligheid van de toxiciteit die door anderen is waargenomen moet dus 
veroorzaakt worden door andere mechanismen. 
In deel III worden glutathion-geconjugeerde halohydrochinonen onderzocht. 
Deze conjugaten lijken op broomhydrochinon-glutathion-conjugaten die 
verondersteld worden verantwoordelijk te zijn voor de niertoxische effecten van 
broombenzeen. Het exacte mechanisme van niertoxiciteit is niet bekend. In vivo 
experimenten geven aan dat yGT een belangrijke factor is, zoals in het geval van 
PCBD-GSH. (5-Lyase gemedieerd metabolisme lijkt hier van minder belang te zijn 
dan oxydatief metabolisme resulterend in de vorming van chinonen (Hoofdstuk 1). 
In een eerste poging het in vitro testsysteem te valideren en om te zien of het 
mechanisme van niertoxiciteit van glutathion-geconjugeerd broomhydrochinon 
algemeen geldig is, werden dichloor(glutathion-S-yl)hydrochinon (DC-(GSyl)HQ) en 
trichloor(glutathion-S-yl)hydrochinon (TC-(GSyl)HQ) in vivo bestudeerd 
(Hoofdstuk 6). Toediening (i.v.) van deze stoffen in de chinon vorm veroorzaakte 
niertoxiciteit aangetoond door verhoogde bloed ureum stikstof (BUN) gehaltes, een 
toename in de urinaire excretie van glucose, lactaatdehydrogenase en yGT, en 
pathologische afwijkingen in de nier. Reduceren van de glutathion-geconjugeerde 
chinonen d.m.v. vitamine C veroorzaakte een drastische toename in de 
niertoxiciteit. Deze werkwijze veroorzaakt waarschijnlijk een verhoogd aanbod van 
DC-(GSyl)HQ en TC-(GSyl)HQ aan de nier, doordat hun interactie met nucleofiele 
plaatsen op plasma eiwitten en/of met andere extrarenale macromoleculen wordt 
verhinderd. Verbazingwekkend was dat de remming van Y G T een verdere toename 
in de niertoxiciteit veroorzaakte. 
Blijkbaar speelt yGT een tweeledige rol in de niertoxiciteit van gehalogeneerde 
hydrochinon-glutathion-conjugaten. Dit is verder onderzocht in vitro in 
hoofdstuk 7. Hiervoor is de LLC-PKi cellijn gekozen, aangezien de apicale 
aanwezigheid van fGT deze cellijn tot een goed bruikbaar model maakt voor dit 
doel. In tegenstelling echter tot de experimenten met PCBD-GSH en zijn derivaten, 
konden de in vitro experimenten geen complete opheldering verschaffen omtrent 
het mechanisme van activatie van gehalogeneerde hydrochinon-glutathion-
conjugaten. In een gepostuleerd schema (Fig 7.7) zijn de mogelijke reacties die 
kunnen plaatsvinden met gehalogeneerde GSyl-HQ-conjugaten samengevat en 
wordt een verklaring gegeven voor de verkregen in vitro en in vivo resultaten. De 
resultaten duiden erop dat yGT niet de snelheidsbepalende stap in de toxiciteit is 
en ze geven aan dat fGT enerzijds een detoxificatie initieerd door 
1,4-benzothiazine vorming en/of polymerisatie en anderzijds een activatie teweeg-
brengt door "targetting" van de oxydatie die verantwoordelijk is voor de toxiciteit. 
Daarnaast zijn deze conjugaten zonder metabolisme door fQT niet stabiel en 
kunnen ze gedetoxificeerd worden via oxydatie aan de lucht en vermoedelijk 
polymerisatie. Verder onderzoek is noodzakelijk om de exacte plaats en het exacte 
mechanisme van oxydatie op te helderen. 
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9 .2 . SLOTBESCHOUWINGEN 
De studies beschreven in dit p roe f sch r i f t laten zien dat het mogelijk is de 
in vivo luminale en serosale b lootste l l ing van een proximale tubuluscel te imi teren 
middels b lootste l l ing van een monolayer op een poreuze ondergrond. In de 
toekomst biedt dit systeem de mogeli jkheid het re lat ieve belang van gepolar iseerde 
func t ies van epithel iale cel len van diverse organen en a fkomst te bestuderen en te 
vergel i jken. 
Door gebruik van models to f fen kon worden aangetoond dat de LLC-PKi cell i jn 
een re la t ie f eenvoudig model kan zi jn voor het bepalen van een speci f iek 
n ier tox isch potent ieel van g lu ta th ion - en cys te ïne-con jugaten. Voor dit doel bleek 
de afwezigheid van een o rgan isch-an ion t ranspor t in de LLC-PKi cell i jn geen 
be lemmer ing. Wanneer echter andere chemical iën op hun mogeli jke n ie r tox ic i te i t 
onderzocht dienen te worden , kan de aanwezigheid van een o rgan isch-an ion-
t ranspo r t een voorwaarde z i jn . Dientengevolge zou verdere ka rak te r i se r ing van 
andere cell i jnen zoals de opossum niercel l i jn (Koyama et a l , 1978) of een recent 
ontwikkelde humane niercel l i jn (KRC/Y) (Yano et a l , 1988) z ich moeten r i ch ten op 
de aanwezigheid van deze t r a n s p o r t e r . 
Ten s lo t te onders t repen de exper imenten waar in de rol van Y G T in de n ie r -
tox ic i te i t van g lu tath ion-geconjugeerde gehalogeneerde hydrochinonen bestudeerd 
w e r d , nogmaals het belang van in vivo val idering . Verschi l len tussen in vivo en 
in v i t ro van meer fys ische aard , zoals bijv. zuurs to fd ruk en pH, kunnen 
verschi l lende of addit ionele e f fec ten van s to f fen veroorzaken , die in v i t ro kunnen 
worden gemist wanneer geen rekening word t gehouden met deze versch i l len. 
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